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Abstract
Atherosclerosis is the main cause of mortality and morbidity in West-
ern World, causing more death and disability than all the types of
cancer. Given its high potential danger it is of major importance
to better understand the causes of atherosclerosis, which are linked
to both the lipoprotein metabolism and haemodynamics in arteries.
Together with in vivo and in vitro experiments, in silico models and
simulations allow for a better insight and understanding of the mech-
anisms of atherosclerosis formation.
A multiscale model coming from the integration of a uid dynam-
ics model, and a biochemical model is here presented for the mod-
elling of atherosclerosis at its early stage. An artery-specic ap-
proach was used in the uid dynamics model for modelling the inter-
action between arterial endothelium and blood ow. The low density
lipoprotein (LDL) oxidation leading to immune-response (cytokines-
monocytes/macrophages) and foam cell formation and accumulation
at the basis of plaque formation was described in the biochemical
model. Integration of these modelling approaches led to the creation
of an eective tool for the modelling of atherosclerosis plaque devel-
opment, the atherosclerosis remodelling cycle.
The impact on the disease development of dierent mean blood LDL
concentrations and arterial geometries was analysed. The atheroscle-
rosis remodelling cycle was applied for patient-specic simulation of
plaque formations in a patient presenting with atherosclerosis forma-
tions in the aorta and peripheral arteries. When compared with the
multi-slice computed tomography (MSCT) images, the model high-
lighted atherosclerosis-prone areas, where plaques were found in vivo,
with 91.7% accuracy and replicated 41.7% of the plaques presenting
in the patients.
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Chapter 1
Literature Review
This chapter is a brief review of the various aspects related to the modelling of
atherosclerosis.
Atherosclerosis is a pathology of the cardiovascular system that aects the
arteries. A brief background about the pathophysiology of the disease will be
provided in the rst section of this chapter; describing the structure of the artery,
followed by an overview of the disease development and progression. As the
subject of this thesis is the modelling of the initial state of atherosclerosis, a
more detailed description of this phase, known as fatty streak development, will
be given. A review of the haemodynamic parameters involved in atherosclerosis
formation introduces the next section of this chapter which is devoted to the
description of the mathematical modelling of atherosclerosis. The dierent ap-
proaches used to model the transport of macromolecules inside the artery and
the biochemical interactions that are the basis of atherosclerosis formation will
be explained in the second part of this chapter. A conclusion will be presented
at the end.
1
1.1 Biological background
1.1.1 Overview of the arterial structure
Arteries are a type of blood vessel that transports oxygenated blood away from the
heart, to the cells, tissues and organs of the whole body (except the pulmonary
and umbilical arteries). An artery (Figure 1.1) can be divided into two main
parts, the lumen (the hollow core of the vessel where blood circulates), and the
wall. The arterial wall is formed by three layers: (1) tunica intima, (2) tunica
media and (3) tunica adventitia.
Figure 1.1: Arterial structure.
1.1.1.1 Tunica intima
The tunica intima is the \coating" of the lumen. It is comprised of the endothe-
lium, the subendothelial connective tissue and the internal elastic lamina (IEL)
[1]. The main functions of the intima layer are to prevent the blood plasma from
ltering through the walls and to secrete vaso-active substances into the vessel
lumen and through the vessel wall. This is mostly done by the endothelial cells
(endothelium), the vaso-active cells. The endothelium is the innermost part of
the arterial wall and it has a critical role in regulating the blood/tissue interac-
tion inside the artery. It consists of a paved monolayer of endothelial cells (0.2
{ 0.3 m thick)[2]. These cells have three distinct surfaces, the luminal surface
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(apical), the subluminal surface (basal) and the intercellular surface. The luminal
surface of the endothelium is lined with a carbohydrate-rich layer, the endothelial
glycocalyx[3]. The endothelial glycocalyx is the layer separating the arterial wall
from the blood ow. Among its various functions, it serves as a mechanotrans-
ducer of haemodynamic forces to the endothelium and reduces the permeability
of the endothelial layer to the plasma macromolecules.
The endothelium forms a semipermeable lining for the arterial lumen that
serves to limit the passage of owing macromolecules from the blood into the ar-
terial tissue. Water, and some small solutes, are absorbed by the glycocalyx and
pass through the endothelium via intercellular clefts (20 nm wide)[4]. The inter-
cellular clefts are the spaces between the intercellular surfaces. Junctional strands
(rows of protein molecules) form several tight junctions across the intercellular
clefts, blocking the macromolecules pathway (Figure 1.2). The tightness of these
clefts together with the thickness of glycocalyx denes the permeability of the en-
dothelium. Besides their blood-borne macromolecule retaining role, endothelial
cells also have the power to release vaso-regulative substances such as vasoactive
agents (i.e. Nitric Oxide), anti-haemostatic agents and pro-inammatory agents
(i.e. Cytokines)[2] into the arterial lumen. As part of the body defence against
pathogens, endothelial cells produce adhesion molecules that capture circulating
leukocytes (i.e. monocytes) and lead them to migrate into the aected tissue.
Abnormalities in endothelial function, such as increased endothelial permeability
and overproduction of pro-inammatory agents, are pro-atherogenic factors of
major importance, as will be explained later.
1.1.1.2 Tunica media
The tunica media supplies the mechanical strength of the vessel wall. Its tissue
is made up of a matrix of collagen bres and elastin, in which smooth muscle
cells are embedded[5]. Smooth muscle cells contribute to the compliance of the
arterial wall. By contracting or relaxing, they control the calibre of the blood
vessel and the local blood pressure. This portion of smooth muscle-rich tissue lies
in-between two sheets of elastin, the IEL and the external elastic lamina (EEL)
(Figure 1.1). Both of these consist of a thin layer of fenestrated elastic tissue.
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Endothelial cel Intercelular cleft Glycocalyx layer
Junctional strands
Figure 1.2: Sketch of the endothelial cell monolayer arrangement showing the
glycolyx, intercellular clefts and junctional strands between cells.
1.1.1.3 Tunica adventitia
The outermost portion of the wall is the tunica adventitia. This layer is made
of connective tissue and has the primary purpose of anchoring the vessel to the
surrounding organs. In the case of large arteries, it can contain small blood vessels
called vasa vasorum, which serve to nourish the media[5].
1.1.2 Atherosclerosis
Atherosclerosis is a chronic inammatory disease of the subendothelial region of
the artery. Formation of atherosclerotic plaque leads to thickening and hardening
of the arterial wall, and may cause tissue ischemia and thrombosis. From histo-
logical examination of atherosclerotic plaques[6, 7], it has emerged that there are
six main stages of plaque development (Figure 1.3). The rst stage is represented
by type I (foam cell formation) and type II (fatty streak) lesions[6]. Fatty streaks
are lipid-laden lesions having the appearance of yellow streaks of 1 { 2 mm in
width and up to 10 mm in lenght. These are the earliest visible lesions at the
beginning of the inammatory process, where the blood-monocytes have already
migrated into the arterial wall becoming lipid-laden foam cells and have started
accumulating in the arterial wall. The type III lesion is the intermediate stage or
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pre-atheroma[7]. This is a crucial step towards the formation of a more complex
type of lesion. An initial formation of an extra-cellular lipid pool can be detected
underneath the layer of macrophages and foam cells inside the intima. These
extracellular lipids are the result of cholesterol released from dying foam cells.
The growth in size of the extra-cellular lipid pool is a characteristic of type IV
lesion, also known as atheroma. Atheroma is the rst type of advanced lesion and
is characterised by a deep structural change in the intima caused by the presence
of the lipid pool, also known as the lipid core of the plaque[7]. Around this lipid
core, new brous connective tissue is formed, and calcication of the lipid core
can occur. At this stage, the plaque is dened as type V. New tissue is formed
by smooth muscle cells(SMCs) migrating from the media[8] and collagen, and it
contributes to increasing the size of the plaque.
Endothelial plaque growth
Type I Type I Type II Type IV Type V Type VI
Figure 1.3: Atherosclerosis timeline. Representation of a typical atherosclerotic
plaque development starting from foam cells migration (Type I) and ending with
lesion rupture (Type VI). (Modication of open-source image from http://en.
wikipedia.org/wiki/Atherosclerosis)
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When a lesion surface or a thrombotic deposit develops in a lesion of type IV
or V this becomes a complicated lesion (dened as a type VI lesion). This type
of plaque is highly unstable, and it is clinically the most dangerous type as its
rupture could lead to sudden death of the patient, due to thrombotic stroke. The
dierent stages of atherosclerotic lesion development are shown in Figure 1.3.
The main objective of the present work is the development of a multiscale
computational framework for atherosclerosis. Pre-atheroma lesions have been
chosen as an exemplar application for this framework. A more detailed description
of the biological processes that form the basis of type I{II lesions will be given in
the following section.
1.1.2.1 Early lesion formation
LDL and its role in atherosclerosis
Plasma lipids, such as cholesterol and triglycerides, are essential to life. For exam-
ple, cholesterol is a precursor to hormones and bile acids and is needed for cellular
membrane synthesis, whilst triglycerides are an energy source for both cardiac
and skeletal muscle. Among the dierent carriers of plasma lipids(lipoproteins),
low density lipoprotein (LDL) is the one with the highest concentration of lipids
in its core[9]. LDL is composed of 20 { 40% phospholipids, 9 { 10% free choles-
terol, 40 { 44% of cholesteryl esters, 3 { 5% triglycerides, and 21 { 26% protein
(Figure 1.4)[9]. The core is formed by the neutral lipids (cholesteryl esters, triglyc-
erides), whilst the surface consist of a monolayer of phospholipids and cholesterol.
Within the monolayer, a large protein, apolipoprotein B (ApoB) is embedded,
which is used for receptor-dependent catabolism by the body tissues. The surface
monolayer contains other substances among which -tocopherol (vitamin E), be-
lieved to be the main protector of LDL against oxidation[10]. The quantity of
vitamin E can be approximated to about 6 molecules per LDL particle[11]. Cox
et al.[12] investigated the role of vitamin E in the development of atherosclerosis,
showing that treating cholesterol fed rabbits with -tocopherol protected them
from showing the typical endothelial dysfunction coming from such a diet[12].
LDL is delivered as a nutrient to the arterial tissues by means of two main
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Figure 1.4: LDL particle, the inner core of the macromolecule is shown together
with the apolipoprotein B. (Image after: lipoprotein : LDL complex. In Britan-
nica Online for Kids. Retrieved from http://kids.britannica.com/comptons/
art-149526)
receptor-dependent pathways through which LDL gets internalised by endothelial
cells, nameli; endocytosis and transcytosis[13]:
 Endocytosis is the processing of the LDL particle by the endothelial cell
lysosomes in the nucleus, where the LDL particle is degraded and the choles-
terol released into the cell[14]. Through endocytosis the endothelium gets
the amount of cholesterol required for its cellular membrane synthesis [15].
 Transcytosis is the transport of a macromolecule across the interior of a
cell. The LDL macromolecule is taken up by a vesicle that travels across
the endothelial cell layer and discharges the macromolecule at the sub-
endothelial side of the cell.
The main native LDL (the LDL contained in plasma) receptor expressed by
the endothelial cells is LDL-R, this binds to ApoB and lets the internalisation
processes previously described happen[16]. The expression of the LDL receptors
on the surface of a cell is controlled by intracellular cholesterol levels. When
a cell has enough sterols for its needs, transcription of the receptor protein is
down-regulated and the LDL uptake diminishes. Inhibition of lipid synthesis or
promoting its conversion (and excretion via the liver) stimulates expression of
LDL receptors boosting the uptake and diminishing the main blood LDL level.
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From experiments, it has emerged that the bulk of uptake by the arterial wall
of LDL is not receptor-dependent[17]. Especially in areas of altered haemody-
namics (such as high intraluminal pressure or low wall shear stress (WSS)) that
are detected as atherosclerosis-prone sites, it has been found that the receptor-
dependent pathway contributes to only 10% of the overall transport of LDL inside
the arterial wall[18]. The remaining 90% is due to the penetration of LDL macro-
molecules through endothelial intra-cellular clefts that are \leaky" and allow the
passage of macromolecules through them (Figure 1.9).
Once inside the arterial wall, it is believed that LDL is oxidised by reactive
oxygen species (ROS) (Figure 1.5)[19]. These ROS or free radicals are generated
by the normal metabolic processes of cells or molecules contained in the arterial
wall, such as macrophages and endothelial cells [19]. Interaction between LDL
and free radicals leads to the modication of LDL into a highly cytotoxic lipopro-
tein [20]. Free radicals have a high anity to react with the vitamin E contained
in the LDL particles, having ve orders of magnitude more anity with this than
with other components of the LDL core[21]. Prolonged residency of LDL in a
\highly reactive" environment such as the arterial wall, can lead to the total
depletion of antioxidant vitamin E molecules by the free-radicals from the out-
side layer of LDL.[22] LDL without its protective vitamin E layer is exposed to
oxidation[10], leading to its degradation into the cytotoxic lipoprotein oxidised
LDL (oxLDL) and stimulating the body's immune system to react (cytokine pro-
duction activation and migration of plasma monocytes inside the arterial wall)
(Figure 1.6 A). In vitro experiments performed with oxLDL incubated with cul-
tured endothelial cells have shown that oxLDL particles stimulate the endothelial
cells to release the chemoattractant peptide-1 and macrophage colony stimulat-
ing factor (activation of the immunological response of the body)[12]. Cells such
as monocytes-macrophages belong to the so called receptor-independent LDL
catabolism. Native plasma LDL is not taken up by macrophages, rather, it is
sensed by macrophages receptors only when it is fully oxidised[23] (that is, when
the ApoB protein is fragmented). OxLDL ApoB is modied in a form that is
recognisable by the scavenger receptors present in macrophages and the oxLDL
macromolecule is taken up [23].
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Figure 1.5: LDL particle with six vitamin E molecules on its outside layer loses
a vitamin E as consequence of free radical interaction.
From Monocytes to Foam Cells - The immune response to oxidised
LDL
Monocytes are a type of leukocyte (immune cell) that are produced by myeloid
multipotential stem cells in the bone marrow. They travel in the blood where
they reside for approximately eight hours before entering the connective tissue to
mature into macrophages[24]. In atherosclerotic lesion sites, rolling interactions
between plasma monocytes and endothelial cells layer are mediated by selectins,
and their attachment to these cells to penetrate inside the arterial wall is medi-
ated by integrins[25]; once attached they migrate towards the subendothelial area
(Figure 1.6 B) attracted by cytokines (small cell-signalling protein molecules that
are secreted by endothelial cells and tissue macrophages as a reaction to oxLDL
particles). From in vitro experiments, it has been observed that oxLDL stimu-
lates the recruitment of plasma monocytes to the atherosclerotic site by increasing
the endothelial production of the vascular-adhesion molecule 1 (VCAM-1) and
stimulating the secretion of monocyte chemotactic protein 1 (MCP-1)[25].
The arterial wall macrophages take up oxidised LDL, storing their cholesterol
in cellular lipid droplets (Figure 1.6 B)[26]. Although such uptake is initially ben-
ecial as it eliminates pro-inammatory oxidised LDL from the arterial wall, the
accumulation of these lipids eventually leads to a modication in the macrophage
cellular structure. Macrophages become lipid laden foam cells with an impaired
eux from the arterial wall, and accumulate in the intima to form fatty streaks.
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Figure 1.6: Fatty streak formation. From (a) LDL penetration inside the arterial
wall and oxidation to (b) foam cell formation and (c) accumulation leading to
intimal swelling.
Foam cells stratify in adjacent layers; this leads to the initial arterial intima
thickening that is typical of fatty streak formation (Figure 1.6 C).
Atherosclerosis formation is associated with several systemic factors such as
genetic predisposition (i.e. hypercholesterolaemia), hypertension and behavioural
factors like sedentary lifestyle and smoking[27, 28]. From in vivo observation it
has emerged that, despite these risk factors, atherosclerosis tends to develop in
specic regions of the vasculature, such as curvatures and bifurcations of the
artery[29], suggesting a role played by local haemodynamics in the creation of
atherosclerosis-prone areas.
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1.1.3 Haemodynamic Wall Parameters for the identica-
tion of atherosclerosis-prone areas
Experimental evidence indicates that some properties of the endothelium such
as cell geometry[30], orientation[31] and permeability to macromolecules[32] are
inuenced by haemodynamic forces. The blood ow produces a frictional force on
the endothelial glycocalyx known as haemodynamic shear stress. This frictional
force is dependent on both the blood viscosity and the blood velocity. There are
dierent parameters derived from the haemodynamic shear stress that can be
used as markers of the impact of the haemodynamics on the arterial wall, they
are called Haemodynamic Wall Parameters(HWPs)[33].
The frictional force exerted by blood on the arterial wall is proportional to
the velocity gradient at the wall and the uid viscosity, and it is dened as the
wall shear stress (WSS):
w = 
@
@r

wall
(1.1)
where w is the WSS,  is the dynamic viscosity of the uid,  is the uid
velocity along the boundary and r is the radial distance from the boundary (the
wall). WSS is mechanically transduced from the glycocalyx to the endothelium
underneath, and serves as a regulator of the endothelial cell activity (Figure 1.7).
Blood flow
Glycocalyx layer
Endothelium
Figure 1.7: WSS induced by blood ow on the glycocalyx layer and endothelium.
In the main human arterial vessels, WSS typically varies between 5 and 20
dyn/cm2 (0.5 and 2.0 Pa)[34]. This large range of WSS levels leads each artery
to respond dierently to various stimuli of WSS[35]. According to dierent stud-
ies[34, 36{39], atherosclerosis is more likely to develop in areas where the local
WSS is low (less than 5 dyn/cm2) (atherosclerosis-prone areas). WSS is able to
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inuence the endothelial structure and disrupt the glycocalyx layer[40], and it
might be a key player in the development of vascular pathologies such atheroscle-
rosis[41]. In vitro ndings[32] show that the endothelial cell shape is changed,
and permeability is enhanced in areas of low WSS. The structural change in en-
dothelial cell alignment and shape was found to be particularly severe distal to a
stenosis, where an area of high WSS would be followed by an area of low WSS[32].
The spatial change in the WSS vector is dened as the Wall Shear Stress Gradient
(WSSG)[42].
WSSG =
s
@x
@x
2
+

@y
@y
2
+

@z
@z
2
(1.2)
A study by Lei et al.[43] linked increased vascular permeability to a com-
bination of high WSSG and low WSS. These two HWPs are time-independent
indicators of the onset of atherosclerosis. Time variations in the local haemody-
namic stimuli also aect the endothelial function[44]. In transient environments,
with a pulsatile time-dependent ow, the HWPs used to characterise the haemo-
dynamics include time-averaged WSS (TAWSS) and oscillatory shear index (OSI)
[33].
TAWSS =
1
T
Z T
0
jwjdt (1.3)
where T is the period of time over which the shear stress is averaged. There
is a strong correlation between WSSG and TAWSS and monocyte adhesion pat-
terns, suggesting that these two indices are of major importance when identifying
atherosclerosis in peripheral arteries [33, 41].
The prevalence of atherosclerotic lesions in both the human carotid bifurcation
and the abdominal aorta strongly correlate with low shear regions with an almost
purely oscillatory ow[44, 45]. The OSI is a measure of the degree of deviation
of the WSS from its average direction during pulsatile ow, and it is expressed
as[46]:
OSI =
1
2
0@1 
 1T R T0 jwjdt
1
T
R T
0
jwjdt
1A (1.4)
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OSI has been associated with vascular cell rearrangement and increased en-
dothelial permeability[47] especially in arteries with extensive curvature like the
carotid artery[39]. In the descending abdominal aorta and sub-umbilical pe-
ripheral arteries, ow patterns are not strongly disturbed by ow pulsatility, in
contrast to other arteries such as the thoracic aorta, the coronary arteries and
the carotid arteries[41].
A study by Niwa et al.[48] on bovine cocultured endothelial cells and SMCs,
showed that the number of intimal SMC is inversely proportional to the local level
of WSS, suggesting a role played by WSS even in the later stages of atherosclerosis
development.
Although largely accepted, the theory of low and oscillatory shear as pro-
atherogenic is still subject of study and debate [49]. Investigations are trying
to estabilish the most signicant for atherogenesis development among the dif-
ferent HWPs presented in this section, and to individuate HWPs that could be
atheroprotective [50, 51].
Some studies failed to nd a correlation between TAWSS [52], WSS [53],
and OSI [54] and atherosclerosis formations. As there is lack in a generalized
methodology for analysing this phenomenon, Pfeier et al. [49] argue that the
dierence in the analysis methods used could be leading to contrasting results
[49]. Whilst the studies using visual comparison maps [33], and axial [55] and
circumferencial [56, 57] avereging to compare disease location with local HWPs
agreed with the low shear theory, the majority of studies using the point-by-
point comparison[53, 54] failed to report a connection between observed lesions
and HWPs.
Together with data processing methods, techniques used to individuate dis-
ease location and to reproduce the disease-free environment for haemodynamic
simulations have to be considered [49]. Measurements of intima thickness [53] can
not alone identify atherosclerosis locations [49], and calcium scoring is a good as-
sesment criterion, but only for atherosclerosis at a later stage [49]. Blood ow
assessment is usually done either on subject specic geometries, or on multiple
group studies. The latter one, would consider the same artery in a popula-
tion of diseased and healthy individuals and perform a comparison between the
two. However, of more interest are individual studies, where the specic arte-
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rial anatomy of the subject is considered, before and after the disease formation,
and disease-free vessels are recreated virtually [58, 59]. Although this patient-
specic approximation of the healthy vessel enables the anatomical variations
among individuals to be taken into account, it can also be misleading due to the
chance of reconstruction errors arising. Vertical studies following a population
from healthy to diseased state are needed, together with better techniques for
visualising atherisclerosis formations in-vivo, in order to conduct analysis for the
successful identication of all the HWPs of interest for atherosclerosis formation
[49].
1.2 Computational Modelling
One of the next challenges in medicine is the development of patient-specic di-
agnostic tools for a more targeted treatment and an improved quality of life (also
called \in silico" medicine). Mathematical modelling has the potential to con-
duct \virtual experiments" that are patient-specic and non-invasive, providing
an important tool to move closer towards a future of patient-specic diagnosis
and prognosis. In silico medicine is very challenging as the incredible complex-
ity of human pathophysiology makes it hard to conceptualise and translate into
mathematical form[60].
As part of this chapter a review of the mathematical tools used in the study
of cardiovascular diseases will be presented in the sections below. Mathemati-
cal models of the cardiovascular system can be broadly divided into three main
categories[61], continuum mechanical models of the vascular soft tissue, uid dy-
namical models describing the interaction between blood ow and vessel walls
(also known as transport models) and mathematical models of biochemical prop-
erties of the vasculature (also known as biochemical models).
As atherosclerosis formation involves a complex interplay of mechanical and
biochemical processes, a comprehensive model of atherosclerosis will require the
integration of these various modelling approaches.
Although arterial tissue modelling corresponds to a large sub-section within
this context[62{64], a review on the continuum mechanical models of vascular
tissue will not be given as it is not relevant for the current work. The section
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below will concentrate on the other two modelling approaches that are at the core
of this thesis.
1.2.1 Transport models
The study of the transport of macromolecules (albumin, LDL) from the arterial
lumen to the arterial wall has been the focus of a number of mathematical mod-
els[60, 65]. These models are usually classied according to the level of description
of the uid domain and the solid domain provided.
The simplest modelling approach used to model the arterial wall is the wall-
free model approach, where the arterial wall is described as a simple boundary
condition. The rst application of a wall free model to LDL transport was devel-
oped by Wada et al.[66]. Because of the low amount of data handled, these mod-
els are easy to implement and to compute. As the wall domain is not modelled,
important information for atherosclerosis modelling such as LDL concentration
inside the arterial wall cannot be provided by these models.
A more detailed description of the arterial wall is given by the uid-wall mod-
els. These models consider the arterial wall as a homogeneous layer, with uniform
transport properties throughout; they can capture quantitative information in-
side the arterial wall, albeit, in a simplied way. The most rened modelling
approach to the arterial wall is the multi-layer model. These types of model
describe the arterial wall by considering its several heterogeneous layers. The
multi-layer approach provides the most detailed information on the dynamics of
macromolecules and other molecules, species or cells inside the wall[67, 68]. This
model allows for a more detailed description of the artery, but requires a larger
amount of parameters that are often dicult to estimate from experiments, source
from the literature and implement.
To model the transport of molecules within the uid domain, the simplest
modelling approach is the so-called \lumen-free"[69]. In the lumen-free approach,
the transport of macromolecules inside the lumen is not modelled, and the lumen
is considered as a boundary with a constant concentration of macromolecules.
In the case where the lumen is considered, the transport of macromolecules is
modelled, allowing for a concentration prole of macromolecules inside the lumen
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to be developed.
In the following sub-sections, a review of the various modelling approaches and
techniques used to describe the uid domain of the artery (the arterial lumen),
the arterial uid-solid interface (the arterial endothelium) and the arterial solid
domain (the arterial wall) will be given (Figure 1.8).
 Arterial lumen
 Endothelium
 Intima
 IEL
 Media
EEL
 
Adventitia
Arterial wall
Figure 1.8: Transverse section of the computational domain considered. No dif-
ferentiation among the components of the arterial wall is shown. The image is
not shown to scale.
1.2.1.1 Lumen modelling
In atherosclerosis models, blood ow inside the lumen is usually modelled as-
suming blood as an incompressible Newtonian uid obeying to the Navier-Stokes
equations and the continuity equation[70, 71].

@
@t
ul =  rpl + r2ul + f (1.5)
rul = 0 (1.6)
Where ul is the velocity vector eld in the lumen, pl is the blood pressure in
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the lumen, f is the volume force vector,  is the viscosity of the blood and  is
the blood density[72].
These characteristics though, relate more to the behaviour of plasma alone,
as blood shows a non-Newtonian behaviour known as shear thinning[73]. Shear
thinning behaviour is caused by the cellular structure of blood. At very low
shear rates red blood cells tend to aggregate more, leading to higher blood vis-
cosity. On the other hand, at high shear rates, normal red blood cell aggregates
are disrupted leading to a decreased viscosity. Other modelling approaches have
assumed human blood to be a non-Newtonian uid in order to study local haemo-
dynamics and its role in the location of atherogenesis[74, 75]. Johnston et al. [76]
considered dierent non-Newtonian models and a Newtonian model for the mod-
elling of blood inside human right coronary arteries in a steady state regime.
The WSS patterns were found to be consistent for both the Netwonian and the
non-Newtonian ow [76]. Similarly, corresponding WSS values were predicted
by all the models in areas of high to medium shear stress. Dierences arised in
the simulated areas of low shear stress, where the Newtonian model appeared
to underestimate the value of local WSS [76, 77]. The importance of consider-
ing the non-Newtonian characteristics of blood is higher when modelling areas of
low shear stress and small arterial vessels [76, 78]. For large to medium vessels
(such as the aorta and the iliac arteries) [79], modelling the viscosity of blood as
Newtonian can be considered a valid approximation [80].
The uid environment is often modelled in steady state conditions. Short
term variations in the ow patterns such as the pulsatile nature of blood veloc-
ity, can be averaged to a steady behaviour when considering long term processes
like atherosclerosis. Some studies, however, have shown that the steady state
assumption is inadequate in the presence of complex geometries generating mod-
ied ow patterns[69]. Furthermore, the steady state assumption would prevent
the inclusion of time-dependent HWPs that, as already discussed, might play an
important role in the identication of atherosclerosis-prone areas.
A study by Rappitsch et al.[81] investigated the inuence of steady vs. pul-
satile ow conditions on trans-endothelial ux of macromolecules. It was found
that some features inuencing endothelial transport could not be captured if ow
pulsatility was neglected. Models coupling pulsatile ow with arterial wall mass
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transport have been developed[71, 82], however diculty arises when coupling
transient ow simulations with macromolecule transport over a long period of
time. Wood et al.[69] developed the lumen-free time-averaged (LFTA) approach,
where the pulsatility eect is considered whilst keeping the steady state assump-
tion. They coupled the transient blood ow with the wall domain using time-
averaged values, allowing for dierent time denitions to be used in the dierent
domains considered.
The transport of macromolecules inside the lumen can be modelled using a
convection-diusion equation[82{87]. The transient transport of macromolecules
inside the arterial lumen would be given by:
@cl
@t
+r ( Dlrcl + ulcl) = 0 (1.7)
where Dl is the macromolecule diusion coecient inside the arterial lumen,
and cl is the macromolecule concentration. As previously explained, a simplied
approach to model plasma macromolecules is the \lumen free" approach[69, 72],
where the concentration of macromolecules is kept constant throughout the uid
domain.
1.2.1.2 Endothelial modelling
The endothelium is usually only characterised in multi-layer models, where the
dierent strata of the artery are modelled separately. An example of endothelium
modelling in a simple model such the free-wall model is presented by Wada et
al.[66]. In this free-wall model, the transport of macromolecules in the lumen is
considered in both the axial and the radial direction, with the arterial endothelium
as a boundary condition. At the blood-endothelium boundary, the steady state
amount of LDL passing through the endothelium is modelled as the dierence
between the LDL that is carried to the wall and the LDL that diuses back to
the mainstream
wcw  D@c
@r

r=r0
= Kcw (1.8)
where D is the LDL diusivity and the total ux of LDL to the endothelium
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can be expressed as:
Kcw = nwcw + kcw (1.9)
with cw as the wall macromolecule concentration, n as the fraction of LDL
carried through the vessel wall by ltration ow, w as the ltration velocity of
water through the arterial wall, and K as the endothelial uptake of LDL through
both vesicular transport and receptor-mediated uptake (endocytosis).
A more complete description of the endothelial interface between the arte-
rial wall and lumen was proposed using uid-wall models and multi-layer mod-
els[84, 88]. The endothelium is modelled as a porous membrane where the macro-
molecule (solute) penetrates together with the macromolecule carrier (solvent).
The transport of a solute and solvent through a membrane can be modelled with
the Kedem-Katchalsky equations[60, 69, 83, 89]:
Jv = Lp(pend   end) (1.10)
Js = Pendc+ (1  f )Jvcend (1.11)
Where Jv is the volume ux (solvent ux) and Js is the solute ux through
the membrane (the endothelium), Lp and Pend are the hydraulic conductivity
and permeability of the endothelium, p is the pressure dierence and c is the
solute concentration dierence across the endothelium, cend is the mean solute
concentration inside the endothelium, and  is the osmotic pressure with end
as the osmotic reection coecient. The net ltration pressure in Equation (1.10)
is given by the term pendend, and it stands for the driving force of volume
ux penetration. In vitro ndings show that the LDL concentration in the arterial
wall increases under elevated transmural pressure[90, 91]. In Equation (1.11) the
term (1 f ) represents the frictional reection coecient (or Staverman ltration
coecient); i.e. the extent to which the particles of LDL (the solute) are reected
by the endothelial membrane. The osmotic eect  is usually neglected when
calculating the solvent ux as it is far below the hydraulic pressure gradient
pend[92]. Karner et al.[93] have investigated the inuence of endothelial damage
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and blood pressure on the distribution of albumin in the vascular wall, modelling
the endothelium with the help of Kedem-Katchalsky equations. Their model
showed that the main resistance to the macromolecule ux to the arterial wall is
represented by the endothelium.
The properties of the endothelium have been shown in vitro to be linked to
the local haemodynamics[90, 94, 95], as discussed in section 2.1.3. Sun et al.[88]
developed an initial approach to model haemodynamic eects on the endothe-
lium transport properties using a shear-dependent hydraulic conductivity (Lp) to
calculate the volume ux through it (Equation (1.11)).
Factors that aect the permeability of endothelial cells are still not fully un-
derstood and they constitute an active eld of research[41, 95]. Findings from
Levesque et al. [32] show that in areas of ow recirculation the endothelial cells
have a higher permeability to macromolecules. Some hypotheses attribute the
change in endothelial permeability to the relaxation of the endothelial tissue
leading to an increase in the endothelial clefts gap size[96]. Other experiments
show that in areas of decreased blood ow, endothelial mitosis is stimulated and
accelerated. These experiments suggest a new hypothesis that considers mitotic
cells as \leaky cells" (meaning that the clefts surrounding these cells would no
longer be the normal endothelial tight clefts) (Figure 1.9)[97, 98].
In order to account for this heterogeneous behaviour of the endothelium the
three pores model[99] was created. The three pores model considers three path-
ways through which LDL can penetrate inside the endothelium (Figure 1.9):
Normal cell pathway Endothelial cells take up and metabolise plasma LDL
macromolecules (endocytosis), no passage of LDL is allowed through in-
tercellular clefts as the tight junctions block the passage of solutes with a
radius greater than 2 nm (the average LDL radius is 11 nm).[83]
Vesicular pathway LDL macromolecules travel through the endothelial layer
via vesicles (transcytosis) and are discharged in the arterial wall.
Leaky cell pathway Mitotic endothelial cells present leaky junction (the in-
tercellular protein strands forming the tight junctions are broken down),
these are 40 nm wide clefts that allow macromolecules such as LDL to pass
through them.
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Olgac et al.[83] linked the quantity of mitotic cells to local WSS values, with
an inverse relationship between WSS and number of leaky cells sites. Modied
versions of the Kedem-Katchalsky equations (Equations (2.8) and (2.9)) were
used to include the three pores pathways [99] into their transport model of the
endothelium.
Normal endothelial cels Leaky endothelial cel
Tight junction Vesicles Leaky junction
Figure 1.9: Diagram representing endothelium as described by the three pores
model. Perpendicular cross section view showing two normal endothelial cells
and a leaky endothelial cell. The three macromolecule transport pathways: tight
junctions, vesicles and leaky junctions are shown.
Further extensions to this model included the heterogeneous endothelial trans-
port properties and the glycocalyx layer[84]. Another approach to the Kedem-
Katchalsky equations is to model the solvent ux through the endothelial clefts
and the leaky junctions of the endothelium using the steady state Navier-stokes
and continuity equations (Equations (1.5) and (1.6)) with the velocity u as the
solvent velocity through the leaky clefts or junctions:
 rplj + r2ulj = (ulj r)ulj (1.12)
where plj is the pressure in the corresponding leaky cleft or junction, and the
material density and viscosity  and  are taken for blood plasma.
The ux of solute (LDL) through the endothelial leaky junctions was coupled
to the solvent ux with a convection-diusion equation[87, 100] in a steady state
environment:
r ( Dljrclj) + ulj rclj = 0 (1.13)
where all the clj is the LDL concentration in the leaky junction and Dlj is the
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diusion coecient of LDL through the leaky junction.
To account for the semi-permeable endothelial coating represented by the
glycocalyx, Brinkman's equation for a porous medium was used:

Kpl
ul =  rpl + 
l
r2ul (1.14)
rul = 0 (1.15)
where l andKpl are the porosity and hydraulic permeability of the glycocalyx,
pl is the pressure and ul is the supercial velocity vector of the glycocalyx.
Brinkman's equation (Equation (1.14)) was used to link the pressure drop
with the velocity across the porous media[91]:
ul =   k
l
rpl (1.16)
Brinkman's equation (Equation (1.14)) allows a heterogeneous material with
more than one pore size to be modelled, by adding a viscous term to Darcys Law
(Equation (1.16)) (in order to account for the presence of a solid boundary, the
glycocalyx).
Yang et al. [100] modelled transendothelial macromolecule transport using an
extended version of the Brinkman's equation (accounting also for the temperature
of the membrane) coupled with a convection-diusion equation (Equation (1.13))
in a volume-averaged stationary form[91, 100]. The convection-diusion equa-
tion was here improved by including the Staverman ltration and the osmotic
reection coecient, to model the membrane pores behaviour in relation to the
macromolecule penetrating them.
1.2.1.3 Arterial wall modelling
Characterisation of transport of macromolecules inside the arterial wall is at the
centre of atherosclerosis models. The two main approaches characterising the
wall beyond a boundary condition are the uid-wall models and the multi-layer
models. Fluid-wall models consider the arterial wall as a single layer composed
of intima and media[82, 85{87]. Multi-layer models [84, 89, 100] dierentiate
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between the dierent arterial wall layers considering the intima, the IEL and the
media (Figure 1.8) separately. The adventitia is usually treated as the arterial
wall limiting boundary with a xed macromolecule concentration value[88].
The arterial intima and media are usually modelled as porous layers with
homogenous transport properties. In uid-wall models, the concentration eld
of macromolecule in the arterial wall is computed with a convection-diusion-
reaction equation in steady state (Equation (1.17))[83, 88] or in transient condi-
tions (Equation (1.18))[71]:
 Dwcw +Kslrcw uw = kcw (1.17)
@cw
@t
+rcw uw = Dwcw + kcw (1.18)
where the transmural velocity uw is described by Darcys Law[83, 89, 91, 100]
or Brinkmans equation[82, 84]. Dw is the diusivity of the macromolecule in the
wall, Ksl is the solute lag coecient[88], and k is the rate constant for chemical
reaction of the macromolecule inside the arterial wall [71, 83, 88]. When modelling
LDL transport, this reaction accounts for the degradation of the macromolecule
and therefore has a negative sign, becoming a sink for LDL concentration. When
intima and media are not dierentiated, the transport constants used are usually
values describing the behaviour of the media, this simplication is not far from
reality as the media corresponds to 97% of the intima-media wall thickness[93].
In multi-layer models, a dierent equation would be used for each layer, with the
transport coecients changed accordingly[84, 93].
When considered, the IEL is usually modelled as a membrane with shear-
dependent transport properties. The same approach used for the endothelial layer
is used for IEL, where the leaky junctions are substituted by fenestrated pores.
IEL is modelled using the Kedem-Katchalsky equations[89], or using Brinkman's
equation for porous media[84], or by coupling the Brinkman's equation with
convection-diusion equations[71].
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1.2.2 Biochemical models
Several models have tried to characterise the dierent bio chemical processes lead-
ing to atherosclerosis formation. Ross[101] dened atherosclerosis as a chronic
inammatory disease, dierent mathematical models have been developed[102,
103] based on this assumption. Ibragimov et al.[102, 104] proposed an initial
approach for the modelling of this inammatory process concentrating on inter-
cellular interactions, such as chemotaxis (the movement of a cell along a chemical
gradient). They created a system of partial dierential equations(PDEs) that
modelled the spatial distribution of the dierent species involved in atheroscle-
rosis development; immune cells, SMCs, debris (dead cells, produced by degra-
dation of immune cells or SMCs), chemoattractant (i.e. cytokines), native LDL
and oxidised LDL. Their movement was considered to be due to purely diusive
behaviour and chemotaxis. The PDEs for the transient spatial concentration of
immune cells (Equation (1.19)) and debris (Equation (1.20)) are shown below:
@n1
@t
= r

1rn1  X011
n1
c1
rc1  X013
n1
c3
rc3

  d1n1 (1.19)
@n3
@t
= r (3rn3) + d1n1 + d2n2   F (n3; c3)n1 (1.20)
Where X is the tactic sensitivity function, modelling the chemotactic motility
as an advective term, 1 is the motility coecient depending on the concentration
of the chemical species or their density and their position, and 3 is the diusion
coecient, depending on the species position. The parameters d1 and d2 are
the degradation rates of immune cells and SMCs becoming debris, and F is the
decrease in debris due to the immune response. The oxidation of LDL is modelled
here as a single reaction, by simplication of the detailed model developed by
Cobbold et al.[22]
Oxidation of LDL is considered to be a central event in atherosclerosis forma-
tion. Stanbro[105] rst modelled the oxidation of a single LDL macromolecule by
a free radical (Peroxonytrite) using an ordinary dierential equation (ODE). LDL
oxidation modelling was improved by Cobbold et al.[22] who proposed a math-
ematical model of in   vitro LDL oxidation, using a system of time-dependent
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ODEs. This model of oxidation is centred on the interaction of free radicals and
the LDL protective layer of vitamin E (-tocopherol). Each LDL particle with
an intact layer of vitamin E would be protected from oxidation; however as a
consequence of persistent residence of LDL inside a free-radical rich environment
(the arterial wall) the protective layer would degrade and the LDL macromolecule
would eventually oxidise. To model the interaction between LDL and free radicals
a second order kinetic reaction was used:
LDLn +R
k   ! LDLn 1 (1.21)
Applying the law of mass action, the transient change of concentration of
LDLn 1 would be:
dLDLn 1
dt
= kLDLnR (1.22)
The subscript n belongs to the interval [8; 0], meaning that there are eight
possible states of LDL transformation/degradation, from LDL with six vitamin
E (native LDL) to oxLDL (Figure 1.5). The depletion of the vitamin E layer
leaves the LDL macromolecule prone to oxidation, with the nal state of the
chemical cascade being the oxLDL. To the authors' knowledge, this is the most
detailed model of LDL oxidation that has been developed.
The oxidation of LDL was not modelled directly by El Khatib et al.[103,
106], but it was used as a tuning variable for the intensity of the inammatory
process. The model of atherosclerosis formation proposed was characterised by a
system of reaction-diusion equations describing M the density of immune cells
(monocytes, macrophages) and A the density of the cytokines secreted by the
immune cells: 8<:@M@t = d1 @
2M
@x2
+ f1(A)  1M
@A
@t
= d2
@2A
@x2
+ f2(A)M   2A
(1.23)
Where the function f1 represents the recruitment of monocytes as a conse-
quence of oxLDL and the function f2 models the cytokine production rate. A
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traveling wave solution to the system as: 
A(t; x)
M(t; x)
!
= W (x  ct) (1.24)
represents the propagation of the chronic inammatory reaction, where c is
the speed of the wave. This modelling approach to atherosclerosis was further
developed by Calvez et al.[107]. In this work, oxLDL, monocytes/macrophages
and foam cells were considered. Their PDE for modelling the evolution of oxLDL
(Ox) was: 8>>><>>>:
@tOx + div(vOx) = d1Ox   k1Ox M
@y=h = (x)C
@y=0 = 0
(1.25)
where the second term on the right hand side of the PDE is the conversion
of macrophages (M) into foam cells using a second order kinetic reaction. The
diusion of oxLDL in the domain is given by the rst term on the right hand side.
The second term on the left hand side models the lesion growth; it allows for the
considered tissue to be displaced at speed v following the progression of plaque
growth; the oxLDL is transported within it (transport of oxLDL in the lesion
growth was neglected when computing the model). The boundary conditions for
this PDE are 0 at the adventitial boundary (y = 0) and a concentration of native
LDL (C) dependent on the WSS () at the boundary with the lumen (y = h).
The permeation of native LDL into the arterial wall was modelled as a function
of local WSS, allowing the inammatory model to be coupled with the blood
ow[108]. The model of atherosclerosis was completed with the simulation of
lesion formation:
dh
dt
=
k1
Ah
QOx QM (1.26)
The lesion growth (h) is modelled as vertical growth of the intima due to the
formation of foam cells, given by the product of the quantity of oxLDL (QOx)
and macrophages (QM), calculated as the integral of the concentration over the
height of the domain (for the 1D model). Study of the temporal development of
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the inammatory response was at the centre of the modelling approach proposed
by Ougrinovskaia et al.[109] Here, the authors built a system of ODEs, represent-
ing the interactions between oxLDL and monocytes leading to the development
of foam cells. Following the approach of Calvez et al.[107], they ignored the
oxidation of LDL and the changing of monocytes to macrophages as the small
time scale of these events (hours to days) can be considered negligible when com-
pared to the time scale of atherosclerosis formation (months to years). Plaque
growth was not directly modelled here, but foam cell accumulation was treated
as characterisation of plaque growth behaviour.
A more advanced modelling of plaque growth was attempted by Zohdi et
al.[62] The authors developed a model of arterial plaque growth and rupture,
linking their plaque growth to the accumulation of monocytes in the arterial
wall:
_a = K (1.27)
This is a standard growth equation[110] where _a is the growing thickness of
intima, K is the growth rate constant, and  is a function of monocytes accumu-
lation.
This model represents what at the beginning of this section was dened as a
continuum mechanical model of the vasculature soft tissue, and is included here
to conclude this review on the modelling of the biochemical processes leading
to plaque growth. The biochemical models of plaque development are not suit-
able for modelling the tissue changing properties typical of the evolution of the
atheroma. To further model the atheroma and its rupture, the model will require
a more detailed depiction of the arterial tissue, following the approach developed
by Zohdi et al.[62]
As mentioned at the beginning of this section, a complete model of atheroma
formation and evolution would need to combine all the dierent modelling branches
briey described and reviewed[61] here. Fluid dynamic models are needed to
characterise the plaque location and evolution, biochemical models are needed
to describe the processes leading to plaque formation and continuum mechanical
models are needed to understand the evolution of the atheroma and to model the
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impact of the disease on the arterial tissue.
1.2.3 Multiscale modelling
Complex biological processes, such as atherosclerosis occur at various levels of
organisation (from the molecular and cellular scale, to the level of the whole
organism)[111]. Modelling these processes requires us to take into consideration
these various levels, which will lead to the creation of a multiscale model. Ingram
et al.[112] identied three main tasks when creating a multiscale model. The rst
step is the identication of the dierent time and length scales, and the relative
biological processes that they capture. This leads to the creation of a Scale
Separation Map, as dened by Hoekstra et al.[113], where each area represents a
submodel[111] with its denition of space and time. A scale separation map can
be built with either a top-down or bottom-up approach. A middle-out approach
can also be used: from the submodel that is the richest in terms of information
or data, to the other levels[112, 114].
The second step is the development of a submodel for each level considered.
The choice of the modelling technique depends on the biological system and on
the type of behaviour to be recreated. A discrete approach is often used at the
microscale (sub-cellular/cellular level). Modelling approaches such as agent based
modelling (ABM)[115] and cellular automata (CA) [116] allow for the description
of individual cells behaviour. These formalisms have been used to model SMCs
proliferation during in-stent restenosis [115] and the reaction of the endothelial
cells to the blood ow [117]. At the tissue level and organ level, the elements in
the sub-model are usually considered as a continuum and a 3D spatial description
is required. At this level, the submodel is usually described with mathematical
approaches such as PDEs [118], or coupled ODEs [116]. The continuum spatial
description can be reduced to a simpler a-dimensional representation. This type
of reduction is called a lumped-parameter model, and it is often used to model
arterial networks [119].
Moving from the micro scale to the macro scale, the modelling approach
usually changes from discrete to continuum [120]. However, multiscale models
that are discrete[117] or continuum across the dierent scales [118] can also be
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found.
The last step is the integration of the dierent submodels in a coherent mul-
tiscale model, and the creation of a multiscale framework. This is perhaps the
most challenging task, as the information owing between the submodels is what
would dene the correct functioning of the whole multiscale model[112]. Gener-
alised environments are being developed to handle and couple sub-models. One
example of these environments is the Multi-scale Simulation Library (MUSCLE)
developed by Sloot et al.[114]. This library would allow the implementation of
CA, ABM and other formalisms across dierent scales [121]. Another eort has
been made by the Physiome Project, developing an XML based service to in-
tegrate scales (ModelML), as well as for representing micro-scale (CellML) and
macro-scale (FieldML) processes [122]. These multiscale frameworks or environ-
ments[114] have found a number of applications in cardiovascular modelling, such
as modelling of the arterial wall evolution[115] and heart modelling [122].
1.3 Conclusion and key advantages of the pro-
posed model
Atherosclerosis is the result of an intricate series of events. The triggering fac-
tor of this disease is the penetration of LDL inside the arterial wall, and its
subsequent oxidation[101]. The immune system reacts to the presence of oxLDL
initiating a chronic inammatory response[101] that leads to plaque formation. In
vitro experiments show a strong correlation between local haemodynamics and
atherosclerosis formation, identifying arterial geometry as a risk factor[29]. In
silico experiments have been developed to test the various hypotheses emerging
from in vivo and in vitro studies and to gain a better understanding of the pro-
cess of plaque formation[22, 58]. Mathematical models have described the process
of atherosclerotic plaque formation from dierent perspectives, concentrating on
dierent aspects of the disease. The interaction between local haemodynamics
and arterial wall has been modelled primarily by uid dynamic models, with
shear-dependent endothelium transport properties[83, 84]and heterogenous char-
acterisation of the dierent arterial wall layers[84]. Biochemical models mainly
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address species interactions leading to the plaque formation. Characterisation of
the arterial tissue properties is at the centre of continuum mechanical models,
attempting to describe the structural changes due to atheroma development[62].
The main objective of this thesis is the development of a multiscale framework
for the computational modelling of atherosclerosis at its early stage. This frame-
work could be adapted according to patient-specic data and biomarkers, such
as mean blood LDL levels, and the endothelial reaction to the local WSS.The
main biochemical aspects of fatty streak formation are considered; from the LDL
oxidation cascade[22] to plaque formation due to foam cell accumulation. The
authors here developed a model linking the uid dynamics with the biochemi-
cal processes in the atherosclerosis development, as already attempted by Calvez
et al.[107]. Coupling a biochemical model with a uid-wall transport model to
describe plaque growth, will allow investigation of the inuence of plaque forma-
tion on both the local haemodynamics and the progress of the overall disease.
Details of this framework and the exemplars used to demonstrate its use will be
presented in Chapters 2 { 5.
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Chapter 2
Atherosclerosis Model
This chapter presents a detailed explanation of the atherogenesis model used as
an example for the multiscale framework that is the focus of this thesis.
As described in the previous chapter, atherosclerosis is a complex disease
involving the dierent strata of the arterial wall as well as the arterial lumen.
In this model, the heterogeneous environment of the arterial domain was divided
into dierent sub-domains, with homogeneous properties; the arterial lumen, the
arterial endothelium and the arterial wall. Dierent modelling approaches were
used to better describe each one of sub-domains and the dynamics taking place
within them.
A chronic systemic disease like atherosclerosis spans from molecules to organs,
and involves processes lasting from seconds to years. The use of a multiscale
modelling approach with dierent spatial and temporal scales, allowed for a more
targeted and feasible modelling of the atherosclerosis formation.
In the following section the fundamentals of the model are presented, with
each sub-domain described separately. The multiscale modelling approach used
will be explained in Section 2.2.
2.1 Model description
The governing equations of the atherosclerosis model are the subject of this rst
section. In order to explain the model, the \path" of a virtual LDL macromolecule
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migrating from the blood stream and penetrating the arterial wall will be followed.
The rst sub-domain to be described will be the arterial lumen. The arte-
rial endothelium will be described next. Finally, the arterial wall model will be
explained.
The disease formation is modelled as a continuum process.
A list of the variables used in this model (alongside a brief description) is
presented in Table 2.1. These variables will appear throughout the rest of the
chapter.
Figure 2.1 shows a simplied description of the arterial domain including the
dierent sub-domains dened in this model. The dierent sub-domains presented
in Figure 2.1 will be shown separately (Figure 2.3, Figure 2.9, Figure 2.10) within
each of the following sections to provide a brief summary of the modelling ap-
proach used to model the biochemical and transport phenomena included in the
model.
Arterial lumen
Endothelium
Arterial wall
Adventitia
Figure 2.1: Transverse section of the modelled artery showing the dierent sub-
domains considered.
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Table 2.1: List of variables used in the governing equations of the atherosclerosis
model.
Symbol Quantity Value Ref
 LDL Radius 11 nm [83]
Atot Endothelial surface Area 0.015625 mm
2, mesh dependent [83]
D1 LDL diusion coecient in
blood
5 10 12 m2/s [83]
Dw LDL diusion coecient in
the wall
810-13 m2/s [83]
Dm Monocytes diusion coe-
cient in the wall
110-3 mm2/s [108]
K Darcys permeability of ar-
terial wall
2.910-18 m2 [83]
ke LDL oxidation constant 3 M
-1 s-1 [22]
k0 LDL oxidation constant for
fully Vitamin E depleted
LDL
610-5 M-1 s-1 [22]
km Foam Cell formation con-
stant
110-6 s-1 *
K5 Cytokine action 1 10 7 s-1 *
llj Length of leaky junction 2 nm [83]
Lp;nj Hydraulic conductivity of
normal junctions
1:58 10 9 m(s mmHg) [123]
Pv Diusive permeability of
vesicular pathway
1:92 10 11 m/s [83]
Rcell Radius of the endothelial
cell
1510-3 mm [83]
rw LDL degradation rate 3 10 4 s-1 [83]
 Solvent drag coecient Leaky cells: 0 [124]
Normal cells: 1 [83]
w Half-width of the leaky
junction
20 nm [83]
s0 Scaling factor 0.5 *
p Pressure dierence across
the endothelium
18 mmHg [123]
p Plasma viscosity 0.001 Pa s [83]
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2.1.1 Arterial Lumen Model
The arterial lumen is considered as a uid sub-domain. A description of the
analytical tools used to characterise the haemodynamics and the transport of
LDL and monocytes inside the arterial lumen is given and explained below.
2.1.1.1 Haemodynamics
Blood was modelled as a steady, homogeneous, incompressible uid with constant
viscosity. In our model, blood rheology was not considered and its properties
were kept constant with a viscosity of  = 0.0035 Pa s and a density of  =
1050 kg/m3 throughout the whole domain[83]. Although these assumptions are a
simplication of reality, as mentioned in Section 1.2.1.1. of the previous chapter, a
simple blood model was deemed enough for the exemplar multiscale application
that is the object of this work [80]. The haemodynamics of the problem are
calculated using the Navier-Stokes equations. Navier-Stokes equations are partial
dierential equations that describe mass, momentum and energy conservation in
a uid.
Continuity Equation:
@
@t
+r (U) = 0 (2.1)
Momentum Conservation Equation:
@(U)
@t
+r (U U) =  rp+r  + SM (2.2)
where p and  are the pressure and stress tensor respectively, U is the ow
velocity. The term SM accounts for the momentum of forces external to the
system.
The computational solution of this problem was performed in the Computa-
tional Fluid Dynamics Solver Ansys CfX v.14 (Ansys, Inc., Canonsburg, PA)
(Figure 2.3).
Computational Fluid Dynamics is the computational implementation of nu-
http://www.ansys.com/Products/Simulation+Technology/Fluid+Dynamics/Fluid+
Dynamics+Products/ANSYS+CFX
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merical methods and algorithms aimed at the characterisation and solution of
uid based problems. It allows for a uid physical domain to be solved given its
dening equations of state, boundary conditions and geometry. By dividing the
domain of interest into primitive elements, a discrete solution of the problem can
be found. The discretised form of the domain is called the computational mesh
(or grid).
Ansys CfX v.14 uses a Finite Volume approach. In this technique the primitive
elements consists of a discrete control volume (Figure 2.2). The equations of state
are discretized over each control volume of the domain, leading to a system of
linear conservative equations:
X
nbi
anbi '
nb
i = bi (2.3)
where for each control volume i, ' is the solution, a is the equation coecient,
b is the right hand side term, and nb is the neighbour of the control volume
considered. This system of equations is solved all together, using a coupled solver
approach.
Ansys CfX v.14 oers dierent numerical methods to solve the advection term,
in this analysis the high resolution scheme was used. Shape functions are used
to calculate the spatial derivative and the pressure gradient with second-order
accuracy. To prevent pressure-velocity decoupling, the Rhie Chow correction
term is applied to calculate pressure [125, 126]. The equations are solved in time
with a fully implicit scheme. In steady state environment, the time-step of the
time discretization acts as an \acceleration parameter", allowing for a quicker
converging of the system to its steady state solution.
To solve the discrete system of linearized equations Ansys CfX v.14 uses an
Algebraic Multigrid approach [127]. The solver virtually coarsen the grid during
the solving iterations. This coarsen mesh imposes equations conservation over
larger control volumes, improving the convergence rate. When approaching the
end of the solving process the grid is re-rened to obtain the accurate solution.
For further information on Ansys CfX v.14, please see the user manual[128].
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Node
Element Centre
Control Volume
Element
Figure 2.2: Control volume denition. The dierent elements forming the control
volume, together with the mesh nodes and the elements centres are shown.
2.1.1.2 Description of the Lumen-Free Approach
Concentration inside the arterial blood was considered constant for both LDL
and monocytes, following a lumen-free approach (Figure 2.3)[69].
Figure 2.3: Detail of Figure 2.1 showing the model specications for the arterial
lumen.
The LDL concentrations (clum) implemented in the lumen correspond to the
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mean LDL particle concentration (LDLp)[129].
Monocytes in the blood stream (Mlum) are considered to be in excess, follow-
ing the assumption of an immune system that would provide constantly available
monocytes, when required. As they are recruited by cytokine action, the control-
ling factor on the quantity of monocytes entering the arterial wall is represented
by the severity of the cytokine stimuli.
The cytokines action will be further discussed in the section relative to the
arterial wall (Section 2.1.3).
2.1.2 Endothelium Model
The model described in this section correlates the transport of macromolecules
such as LDL through the endothelium as a result of the haemodynamic stimuli
exerted on the endothelium.
Monocyte transport through the endothelium was not modelled. As a con-
sequence to the activation of the immune system, it is assumed that monocytes
can travel freely through the endothelium to reach the targeted macromolecules
(oxLDL).
2.1.2.1 Correlation between Endothelial Shape Index and Wall shear
stress (WSS)
As explained in the previous chapter, endothelial behaviour is heavily inuenced
by local haemodynamics (Section 1.1.4). The ndings of in vivo experiment
show that in presence of laminar ow, the endothelial cells appear as spindle-
shaped and aligned in the direction of the ow [32, 130] (Figure 2.4a). In areas
of altered haemodynamics they present dierently [32]. When exposed to high
WSS, endothelial cells tend to be very elongated and have a smaller surface area
(Figure 2.4b), whilst in areas of low WSS they show a more circular shape [32]
(Figure 2.4c). These more rounded shape endothelial cells (leaky cells) show an
increased permeability, creating areas of higher macromolecular migration inside
the arterial wall (Figure 2.5).
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(a) (b)
(c)
Figure 2.4: Light micrographs of endothelial cells. (a) Endothelial cells under
laminar ow conditions, the cells are aligned in the ow direction (idicated with
an arrow). (b) In areas of high shear the cells present as very elongated. (c) More
circular cells with less evident alignment are observed in areas of low shear and
high recirculation. Image bar = 100 m(Images after [32]).
To relate endothelial permeability to local WSS, a relationship between WSS
and endothelial cells Shape Index (SI) was taken from the experimental ndings
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Flow
Normal cell - aligned
in ow direction
Flow recirculation
Leaky cell
Leaky junction
Normal cell - not 
aligned in ow direction
Figure 2.5: Pavement arrangement of the endothelial cells, showing cells align-
ment with ow direction. Leaky junctions surrounding the more circular cells
(leaky cells), lead to an increased permeability to macromolecules.
of Levesque et al.[32] The Shape Index (SI) is a denition of the cellular shape,
with a number going from one to zero; where a circle has a SI of one whilst a line
has a SI of zero.
In their experiment, Levesque et al.[32] created an articial stenosis in the aor-
tas of ten mongrel dogs. Endothelial cell reaction to the modied haemodynamics
caused by the stenotic neck can be seen in Figure 2.6, where the endothelial SI
recordings together with the WSS values along the artery are plotted[32]. It can
be observed that the maximum SI is located in the area immediately after the
stenosis, highlighting an area of high haemodynamic disturbance[32]. From these
data a direct relationship between endothelial SI and local WSS in the aorta
emerges (Figure 2.7); where an increase in the SI is shown to be linked to a
decrease in the local WSS.
To use this relationship in arteries other than the aorta, and considering the
heterogeneity in the arterial haemodynamics, a generalised form of the SI function
was developed.
It was assumed that a reasonable value of normal WSS for the aorta could be
calculated using the Poiseuille law for laminar ow in a straight pipe[131]:
 =
4  Q
  r3 (2.4)
where  is the viscosity and was taken as the one of dog blood, 8.5 cen-
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tipoise[32]. The radius r considered was the one of the cast model (5 mm) and
the volumetric ow rate, Q, was xed as to have a Reynolds Number of 450[32].
[ dynes/cm^ 2]
Figure 2.6: Variation of wall shear stress plot together with shape index function
with position through the model. Experimental data from Levesque et al.[32]
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Figure 2.7: Shape Index as function of wall shear stress values. Experimental
data from Levesque et al.[32]
From Equation (2.4) the normal value of WSS for the uid domain in Levesque
et al.[32] was 0 = 26 dynes=cm
2. Linking SI to the ratio of local WSS to Poiseuille
WSS (0), rather than to the absolute value of local WSS recorded in Levesque
et al.[32], allowed to generalise the relationship between SI and local WSS. The
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data coming from Levesque et al.[32] normalised by 0 were represented by a
continuous function, following the Olgac et al.[83] approach:
SI2 =  0:2435  
0
0:3537
+ 0:4025 (2.5)
Where  is the local WSS value, 0 is the Poiseuille WSS and 0.4025 is the
maximum SI that an endothelial cell can assume. As it can be seen from Fig-
ure 2.8, experimental data show a linear relationship between the endothelial SI
and WSS until the WSS has decreased by more than 95% of its normal value.
This area, approaching the zero value for WSS is highly non-linear, with scat-
tered values. The mean value among the scattered results for the SI function,
calculated as 0.4025 was set as the maximum value.
The developed SI function, linking the local WSS normalised by the theoretical
normal value of WSS (0) for the artery in question, helped to obtain a more
artery-specic model.
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Figure 2.8: Shape Index as function of wall shear stress values normalised by
0 = 26 dynes=cm
2. Experimental data from Levesque et al.[32]
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2.1.2.2 Membrane Transport Model
To model the LDL passage through the endothelium, a modied version of the
Kedem Ketchalsky's equations for membrane transport[83] was used (Figure 2.9):
Jv = Lp(p  d) (2.6)
Js = Pi(clum   cw;end) Pe
ePe   1 + Jv(1  )clum (2.7)
where Jv is the volumetric ux through the endothelium, Lp is the hydraulic
conductivity, p is the pressure dierence through the endothelium, d is the
osmotic reection coecient and  is the osmotic pressure (negligible, when
compared with the hydraulic pressure through the endothelium)[83]. The os-
motic pressure is the pressure applied to the uid that would oset migration
through the membrane, and the osmotic reection coecient represents the abil-
ity of the membrane to discriminate between the solute and the solvent. Js is
the solute ux through the endothelium. The solute ux can be divided into a
convective component entering the membrane Jv(1  )clum and a diusive com-
ponent represented by the rst term of Equation (2.7), with Pi being its diusive
permeability, Pe the modied Peclet number[83], cw;end the LDL concentration in
the arterial wall at the sub-endothelial layer and  the solvent drag coecient.
Pe =
Jv(1  )
Pi
(2.8)
The Peclet number indicates the relative importance of convective and dif-
fusive transport over the pore entrance.
As explained in the endothelium model section (Section 1.2.1) in Chapter 1,
following the three pores approach[99], there are three main pathways through
which macromolecule penetration can occur: leaky endothelial cell junctions,
normal endothelial cell junctions and vesicular pathways. The vesicular pathway
is not eligible for the case of volume ux transport, as vesicular exchange cannot
produce a net volume ux[83], therefore the bulk of volume ux through the
The standard Peclet number formula Pe = LvD , where L is the characteristic length, v is
the velocity and D is the diusion coecient in the media.
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Figure 2.9: Details of Figure 2.1 showing the model specications for the arterial
endothelium.
endothelial membrane is given by:
Jv = Jv;lj + Jv;nj (2.9)
where Jv;lj is the ux through leaky junctions and Jv;nj is the ux through
normal junctions. Following the same approach of Olgac et al.[83], the arterial
wall was modelled with the help of an electrical analogy, where the ow is driven
by a pressure dierence, analogous to the current driven by a dierence in voltage,
and the resistance to the ow entering the arterial wall is given by the endothelial
layer.
Jv =
pend
Rend
(2.10)
where pend is the pressure dierence through the endothelium, taken from
experimental values[123]. Rend is the resistance of the endothelium and it was
calculated as the parallel sum of the resistance of leaky junctions and normal
junctions[83].
1
Rend
=
1
Rlj
+
1
Rnj
(2.11)
where Rlj is the resistance through the leaky junction, and is calculated as:
Rlj =
1
Lp;lj
(2.12)
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and Rnj is the resistance through the normal junction pathway, calculated as:
Rnj =
1
Lp;nj
(2.13)
To describe the LDL transport through normal junctions the hydraulic con-
ductivity (Lp;nj) was taken from experimental results (Table 2.1). In the three
pores theory[99], solute ux does not occur through normal endothelial cell junc-
tions, but it only occurs through endothelial leaky cell junctions and vesicles:
Js = Js;lj + Js;v (2.14)
where the solute ux through the vesicular pathway (Js;v) is calculated as
10% of the solute ux through the leaky junction pathway (Js;lj)[18, 83]. Having
dened the transport properties through both the vesicular pathway and the
normal junction pathway (Table 2.1), the remaining transport properties to be
dened are the ones describing the leaky junction pathway.
Leaky cells have an abnormally high permeability to macromolecules such as
LDL, a factor which can be linked to magnitude of WSS acting on the endothe-
lium. As shown in the previous chapter, experimental ndings show that in areas
of low WSS and high endothelial SI, the number of mitotic cells is increased[98],
leading to the following relationship between endothelial SI and number of mitotic
cells (MC)[83]:
MC = 0:003739e14:75 SI (2.15)
For a given portion of endothelium, it has been shown that the quantity of
mitotic cells that are leaky is approximately 80.5% and since these represent ap-
proximately 45.3% of the total number of leaky cells in that area[98], the number
of leaky cells(LCs) can be calculated as:
LC =
MC  0:805
0:453
(2.16)
The leaky junction is assumed to be twice the width of the normal cleft (i.e.
40 nm)[132], seeing it as a ring surrounding the endothelial cell (Figure 2.5), and
treating the endothelial cell as spherical, the area of the leaky cell is calculated
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as:
Alc = (Rcell + 2w)
2 (2.17)
Where Rcell is the radius of the endothelial cell (Table 2.1) and w is the half-
width of the leaky cleft. The ratio of endothelium () covered by leaky cells is
then calculated:
 =
MC Alc
Atot
(2.18)
Having dened the proportion of leaky cells over normal cells, and therefore
the proportion of leaky junctions over normal junctions, the transport properties
of the endothelium can be determined. The total hydraulic conductivity of the
endothelial leaky junctions is dened as:
Lp;lj =  Lp;slj (2.19)
where Lp;slj is the hydraulic conductivity of a single leaky junction and is
calculated as in Olgac et al.[83]
Lp;sj =
w2
3pllj
(2.20)
where w is the half-width of the leaky junction and llj is the length of the
leaky junction (Table 2.1).
The diusive permeability of a single leaky junction is:
Ps;lj =
D1
llj
(2.21)
with the total leaky junction diusive permeability calculated as:
Pt;lj = Ps;lj   k1 (2.22)
where D1 is the diusion coecient of LDL in blood and llj is the length of
the leaky junction; k1 represents the limited diusivity of LDL through a pore
45
given its molecular radius[83] and is calculated as:
k1 = 1  
llj
(2.23)
with  being the radius of an average LDL particle (Table 2.1).
2.1.3 Arterial Wall Model
Once inside the arterial wall, the LDL and monocytes were characterised by
means of their transport and chemical interactions (Figure 2.10). A monolayer
approach was used, considering the arterial intima and media with IEL and EEL
as forming one single layer. The adventitial layer was considered as the limiting
boundary of the monolayer and neglected from the model, as it does not play an
active role in the initial stage of atherosclerosis formation.
Figure 2.10: Details of Figure 2.1 showing the model specications for the arterial
wall.
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2.1.3.1 LDL Transport
The transport of LDL inside the arterial intima-media layer has been modelled
in the direction normal to the arterial lumen via a convection-diusion-reaction
equation[83]:
dcw
dt
=  uw rcw +Dwcw   rwcw (2.24)
The transmural velocity uw is calculated using Darcys law:
uw =
k
p
rp (2.25)
where p is the viscosity of plasma. The transport properties of the arterial
wall with respect to LDL are described by the arterial wall Darcys permeabil-
ity k and the diusion coecient Dw. The last term of Equation (2.24) is the
degradation of the LDL particles, with rw as the reaction coecient.
The LDL uxes (Equation (2.6) and Equation (2.7)) were imposed normal
to the endothelium and they provided the sub-endothelial layer boundary value
for cw;end (Equation (2.24)); a LDL value of
cw;adv
cw;end
= 0:005 as from experimental
ndings from Meyer et al.[90] was used at the boundary corresponding to the
adventitia (cw;adv) (Figure 2.11). The portion of reacting LDL (rwcw) is the
quantity prone to degradation and it represents the source term for the LDL
oxidation model which will be described in the next section.
47
Figure 2.11: Macromolecule transport through the artery wall and endothelium;
where c is the macromolecule concentration,  end and  adv are the boundary
conditions at the endothelium and adventitia layer respectively.
2.1.3.2 LDL Oxidation
LDL oxidation is believed to be one of the triggering factors of atherosclerosis
formation. As described in section 1.1.2.1 (LDL and its role in atherosclerosis),
once inside the arterial wall the LDL will be exposed to oxidation by free radi-
cals[22]. Its antioxidant defence, represented by the vitamin E contained in its
outermost layer, will be depleted during the interaction between LDL and free
radicals, leaving the LDL lipid core prone to oxidation.
On average six molecules of vitamin E are associated with an LDLmolecule[11];
following the model developed by Cobbold et al.[22] each interaction with a free
radical would deplete one of these vitamin E (Figure 1.5).
LDLn +R
k   ! LDLn 1 (2.26)
where Ln represents the LDL particle with n vitamin E, R is the free radical
and ke is the kinetic constant for vitamin E oxidation. When the vitamin E is
totally depleted, LDL will become prone to oxidation.
LDL0 +R
k0   ! LDLox (2.27)
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L0 is the vitamin E depleted LDL, Lox is the oxidised LDL and k0 is the LDL
oxidation kinetic constant. The kinetic constant for oxidation of LDL k0 is of a
much lower rate than ke, as the cholesterol core of LDL has a lower reactivity
respect to the vitamin E[21].
As free radicals were assumed to be always available, their concentration vari-
ation in time was neglected and a xed value was adopted. The chemical reactions
of the oxidation cascade are considered to follow a rst order reaction kinetics,
the concentration of the reaction product depends solely on the concentration of
the reactant.
Following the law of mass action, the concentration in time of the dierent
LDL species in the oxidation cascade was:
dL5
dt
= rwcw   keRL5 (2.28)
dL4
dt
= keRL5   keRL4 (2.29)
dL3
dt
= keRL4   keRL3 (2.30)
dL2
dt
= keRL3   keRL2 (2.31)
dL1
dt
= keRL2   keRL1 (2.32)
dL0
dt
= keRL1   k0RL0 (2.33)
dLox
dt
= k0RL0   kmLoxMw (2.34)
The native LDL particle with 6 Vitamin E (L6) is represented here by the
quantity of LDL prone to degradation (rwcw) coming from Equation (2.24).R
represents the free radicals, modelled here as a xed quantity of 1 M. The last
equation of the chemical cascade (Equation (2.34)) models the concentration of
oxidised LDL. The second part of Equation (2.34) accounts for the degradation
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of oxidised LDL by interaction with plasma macrophages (Mw).
Oxidised LDL is noxious to the body and its presence triggers an immune re-
sponse[12]. Cytokines are secreted by the endothelial cells, leading to recruitment
and migration of plasma monocytes into the arterial wall.
2.1.3.3 Monocytes Transport
Monocyte migration into the arterial wall is the body's immune response to ox-
idised LDL (Section 1.1.2.1 { From Monocytes to Foam Cells { The immune
response to oxidised LDL). Once inside the arterial wall the assumption is made
that all monocytes will dierentiate into macrophages, neglecting the time needed
for their dierentiation. Their transport has been imposed in the normal direction
to the arterial lumen and modelled with the following diusion-reaction equation
(Figure 2.10):
dMw
dt
= DmMw   kmLoxMw (2.35)
As a consequence of the activation of the immune system, monocytes were free
to travel through the endothelial layer. Following the same principle, macrophages
are also relatively free to travel inside the arterial wall, and show a high diusion
coecient (Dm) (Table 2.1). The reaction term represents macrophages becoming
foam cells after taking up oxLDL, with the kinetic constant km (Table 2.1) show-
ing the rate of this reaction. The transport of monocytes-macrophages does not
present an advection term. This term should represent the chemical force given
by chemotaxis[102], and is in this case ignored; with the chemotaxis action rep-
resented merely by the activation of cytokines regulating the inux of monocytes
in the arterial wall. The sub-endothelial interface boundary condition:
Mw;end = K5Lox (2.36)
shows a monocytes source proportional to the quantity of oxLDL (Lox) by a
factor K5 (Table 2.1), representing the cytokines secreted by the endothelial cells
in response to the oxLDL produced by the chemical cascade (Equations (2.28)
to (2.34)). At the media-adventitia interface a constant concentration value as
for the LDL model was used,
Mw;adv
Mw;end
= 0:005 (Figure 2.11).
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The product of the interaction between oxLDL and macrophages is the for-
mation of foam cells.
2.1.3.4 Foam cell formation and accumulations
Once a macrophage is lled up with oxLDL, it will become a lipid laden macrophage,
also known as a foam cell. The interaction between oxLDL and macrophages has
been modelled as a rst order kinetic reaction:
LDLox +Mw
km    ! Fw (2.37)
giving the following change in foam cells concentration with time:
dFw
dt
= kmLoxMw (2.38)
Fw is the quantity of foam cells in the arterial wall and km is the kinetic
constant for foam cells formation. Foam cells do not have any transport term in
their equation as they are not \supposed" to move inside the arterial wall. Once
created, they are unable to migrate out of the arterial wall and constrained in
term of space, where they eventually form a stratied aggregation (Figure 2.12).
Foam cell stratication is the basis of the fatty streak formation.
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Foam cell
Figure 2.12: Electron micrograph of sub-endothelial fatty streak with two layers
of foam cells (image bar = 1 m). Lipid droplets can be visualised inside the
foam cells. The gure on the right shows the close hexagonal packing technique
used to approximate the foam cells stratication in the modelled arterial wall.
Electron micrograph image from Faggiotto et al.[6].
To resemble the fatty streak structure, shown in Figure 2.12, foam cells were
assumed to have a constant volume and spherical shape. Their quite regular
pattern of stratication was modelled as following close hexagonal packing (Fig-
ure 2.12). The volume occupied by the foam cells would be:
VF =
Fw;n Fw;V
0:7450
(2.39)
with Fw;n as the number of foam cells given by:
Fw;n = Fw NA (2.40)
where Fw is the foam cell concentration, NA is Avogadro's number, and Fw;V
is the volume of a spherical foam cell with a radius of 20 m[6]. VF is the volume
that the foam cells stratication formed in the model would occupy. At the early
stage of formation this stratication of foam cells would be easily accommodated
in the arterial wall portion considered, which has a volume (V ) of:
V = Atot  IMT  s0 (2.41)
with IMT being the intima-media thickness and Atot the considered portion
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of endothelium. The space available for the accommodation of new material
without signicant structural modication in the arterial wall is represented by
the scaling factor s0. When the volume represented by the accumulated foam
cells is larger than V , the portion of arterial wall considered will start swelling:
h =
VF   V
Atot
(2.42)
with h as the intima-media thickness (IMT) growth in the normal direction,
leading to the initial stage of atherosclerotic plaque formation, the fatty streak.
2.2 Multiscale Modelling
Atherosclerosis is a lifelong systemic disease. From a modelling point of view
the previous sentence can be loosely translated as, \atherosclerosis is a biological
process taking place over a wide spatial and temporal domain". In this chapter,
the dierent processes occurring in the biological domain of the model have been
described. This \biological domain" is the nutshell of the model, where all pro-
cesses taking place are described in both the spatial and the temporal domain
(Figure 2.13). The biological domain is very heterogeneous, spanning a range of
timescales from quick molecular interactions to slow organ remodelling. These
features make the biological domain extremely hard to characterise in terms of
time and space, as there is a very large spatial and temporal span to cover. How-
ever, each of the biological processes has to be described in the most accurate
way, so, diculties arise in dening a level of characterisation and precision that
are needed to satisfy each of them.
53
Figure 2.13: The biological domain (atherosclerosis) as a function of the time
domain, represented by the life time of a human being, and the spatial domain,
spanning from molecules, to tissues, to the whole organism.
One of the complexities of modelling a biological process lies in the choice of
the right scale of denition. Choosing only one scale might be too coarse and lack
denition in some processes, whilst a too ne scale would lead to over loading the
model with data, making it very expensive or impossible to compute. This is the
reason why it is important to choose the most appropriate scale for each domain,
or sub-domain, using a multiscale modelling approach.
2.2.1 Spatial Scales
The three subdomains of this model have dierent spatial requirements. The uid
sub-domain, the arterial lumen, models the haemodynamics inside the artery. Its
spatial scale needs to capture the uid behaviour precisely, and it is represented by
54
the control volume in the computational uid dynamics (CFD) mesh (Figure 2.14)
(the choice of the optimal mesh for the computed domain will be discussed in the
section relative to the Fluid Domain Discretisation in Chapter 4 and 5).
The surface area of endothelium and arterial wall considered (Atot) was set
accordingly to the CFD mesh element area (Table 2.1, Figure 2.14). Dierent
spatial scales were used to model the endothelium and arterial wall sub-domains
in the radial direction, as this is the direction of macromolecular transport. The
endothelium was modelled as a membrane, where the transport of LDL was in-
dependent of its spatial discretisation. The spatial scale of the endothelium sub-
domain in the radial direction was dened by the endothelium thickness[40].
In the arterial wall, a spatial scale of mm was used. This scale allowed a
precise denition of the distribution of macromolecules inside the arterial wall to
be obtained that compares well with literature data[90], as will be shown in the
following chapters.
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Figure 2.14: Slice of the model artery, showing: arterial lumen, endothelium and
arterial wall and the considered endothelium and arterial wall surface area (Atot).
In the radial direction, the lumen is represented by a CFD mesh element, the
endothelium by an element of its own thickness and the arterial wall discretised
by elements on a scale of m.
2.2.2 Temporal scale
The dierent processes involved in the modelling of atherosclerosis span from
seconds to years. Among these dierent processes,biochemical interactions in the
arterial wall, such as LDL oxidation chemical cascade, are the ones covering the
shorter time span of action. Such processes need very short time scales in order
to be properly characterised consequently, the time scale for the arterial wall,
where these processes take place, was set to seconds.
The endothelium was modelled as a quasi-steady domain. Its transport prop-
erties are constant in time as long as the lumen haemodynamics are unchanged.
Being the interface between the arterial wall (intima and media) and the blood
ow (a domain modelled as steady state), the endothelium links information
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coming from both sides, i.e., the arterial wall and the lumen. The change
in LDL ux through the endothelium is dependent on its concentration gradi-
ent(Equation (2.7)), which is given by a dierence in the LDL concentration
between the arterial lumen and the arterial wall. The concentration gradient
update happens in monthly intervals, as this is the time needed for the arterial
wall model to reach a steady solution for the given boundary conditions. After
stability in the arterial wall concentration is reached, the change in ux due to the
concentration gradient can be calculated and the endothelium LDL solute ux
changed accordingly. The update in the solute ux of LDL through the endothe-
lium is entirely dependent on the change in LDL concentration in the wall so long
as the haemodynamics are kept constant. A change in the haemodynamics would
lead to a change in the whole transport properties of the arterial endothelium,
and a change in the whole endothelial-arterial wall model behaviour.
The time denition of the model will be further discussed in Chapter 3.
2.3 Summary of model assumptions and limita-
tions
This model is proposed as an exemplar application and represents an initial ap-
proach towards a more \integrated" modelling of atherosclerosis. Dierent as-
pects of atheroma formation, involving haemodynamics and the transport and
biochemical interaction of species were considered, leading to a multiscale frame-
work of the overall process.
The haemodynamics of the problem was solved with the help of nite volume
computational uid dynamics software, Ansys CfX v.14. In areas where WSS is
extremely low (less than 5 dyn/cm2)[36], the endothelial cells become \leaky" and
show higher permeability to macromolecules. The endothelial layer was modelled
as a membrane, where the membrane matrix is constituted by the endothelial
cells and the pores of the membrane by the intra-cellular junctions, which would
allow the passage of LDL through them when \leaky". Transport through this
membrane was modelled with a shear-dependent modied version of the Kedem-
Katchalskys equations.
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Migration of LDL from the blood stream to the arterial wall leads to an
accumulation of LDL macromolecules inside the intima-media. A Convection-
Diusion-Reaction equation models the transport of LDL inside the arterial wall.
Interaction of LDL with ROS in the arterial wall leads to oxidation of LDL, mark-
ing the initial stage of atherosclerosis formation[133]. Once oxidised, LDL trig-
gers the activation of cytokines and signalling proteins, recruiting blood-stream
monocytes. These monocytes automatically become macrophages once inside the
arterial wall and their distribution follows a Diusion-Reaction equation. The -
nal stage of this biochemical model is the interaction of macrophages with oxLDL,
leading to the formation of foam cells.
Stratications of foam cells are the core constituents of the initial atheroma.
The growing atheroma has an impact on the overall model only when the swelling
appears in the arterial wall. This swelling alters the haemodynamic patterns and
redenes the behaviour of endothelial cells to LDL transport, initiating a new
cycle with dierent transport boundaries and consequently dierent atheroma
formation.
This integrated model allows description of the major phenomena that form
the basis of atherosclerosis both separately, for a more detailed characterisation,
and together to understand the dynamics of their interaction. As will be dis-
cussed further in the following chapter, great eort was devoted to make this
model fast and versatile to implement, allowing for various hypotheses such as
dierent model variables (i.e. dierent mean blood LDL concentrations) and ar-
terial geometries (from idealised geometries to patient-specic geometries) to be
easily tested.
Testing of various hypotheses was fundamental, as the information available
in the literature (used to validate and test models of atherosclerosis) is often
heterogeneous in terms of methods, quality and outcomes and often corresponds
to simplied in vitro experiments when presenting only partial aspects of the
problem. A valid example to illustrate this argument is the function linking en-
dothelial cell Shape Index to local values of WSS[32, 83]. In vitro experiments
on human endothelium show that the endothelial cells did not change their mor-
phology for more than a shape index of 0.58 in post-stenotic areas[134]. The
majority of experimental data is based on experiments on non-human endothelial
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cells including dog endothelial cells[32]. The SI reaction shown by these cells in a
similar haemodynamic environment is 18% more severe in comparison to human
cells[134]. The dierence in these results might arise from dierent experimental
conditions and inter-species dierences as, canine endothelial cells and human
endothelial cells might react dierently to given haemodynamic stimuli[35]. The
issue raised by SI data could be applied to many of the values upon which this and
the majority of models in the literature are calibrated. It is beyond the purpose
of this thesis to discuss the validity of experiments done on non-human speci-
mens in non-physiological environments, but is worth considering them among
the limitations of this type of model.
2.4 Conclusion
A mathematical model of atherosclerosis formation was presented in this chap-
ter. The model is based on a continuum, conservative approach. The artery
modelled was divided into three sub-domains, arterial lumen, endothelium and
arterial wall. Each of these sub-domains had their own spatial and temporal scale
of denition. As the ner spatial scale adopted was deemed large enough with
respect to the molecular size of the agents considered, the agents were treated
macroscophically and described in terms of their concentration. Mass transport
across the arterial wall was coupled to the xed lumen concentration with the
help of the semi-empirical relations of Kedem and Kaltchasky, for transport across
the endothelium. The change in concentration inside the arterial wall over time
was modelled with the help of diusion-convection-reaction (LDL) and diusion-
reaction equations (monocytes/macrophages). The diusion driven concentration
gradient was modelled with the mathematical and observational Fick's law. When
considered, the concentration change due to convection was driven by pressure
gradient across the arterial wall following Darcy's law. The chemical reactions
leading to LDL oxidation and foam cell formation were modelled using the law of
mass action. Agents within the considered sub-domains were modelled with the
help of these well understood and widely used formalisms, derived from exper-
imental ndings and in-vitro observations. Discretising the very heterogeneous
arterial environment in homogeneous sub-domains and the complex phenomenon
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of atherosclerosis in its core processes allowed for a more detailed modelling. As
atherosclerosis is ultimately the product of these processes and their interactions,
a holistic modelling approach was needed to create an integrated atherosclerosis
model. The subject of the next chapter is this integrated atherosclerosis model
called the Atherosclerosis Remodelling Cycle.
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Chapter 3
Atherosclerosis Remodelling
Cycle
Based on biological principles, key events and processes in the formation of
plaque were identied for the development of a mathematical model (Chapter
2). Atherosclerosis is the result of interactions between these core processes,
modelled here with the help of a workow.
This workow, created to model the development of early stage atheroscle-
rosis formation in silico is called the atherosclerosis remodelling cycle. It con-
sists of both a theoretical part devoted to the theoretical re-integration of the
sub-processes, and a computational part, devoted to the computational imple-
mentation of the model, with the aim of creating a unique tool for the model
of atherosclerosis. The two parts of the atherosclerosis remodelling cycle will be
presented separately, as two workows. As the computational workow is the
computational implementation of the theoretical workow, it will be presented
last.
3.1 Theoretical workow
The atherosclerosis remodelling cycle denes the whole process of plaque forma-
tion, from capturing key haemodynamic variables that aect the permeability of
the endothelium, to intima-media thickening and lumen remodelling as a conse-
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quence of atherosclerosis formation. Figure 3.1 illustrates the theoretical workow
of the atherosclerosis remodelling cycle. The three arterial sub-domains dening
the arterial lumen, endothelium and arterial wall are represented by the three
white boxes. The orange coloured boxes (II, V, VIII, XI, and XIV) describe
the LDL-related behaviour/processes within the three subdomains. The green
coloured boxes dene the monocyte-macrophage behaviour in the artery (III,
XVI). The grey boxes are the initial (I) and nal (XVIII) elements of this work-
ow. The arrows between boxes represent an exchange of information from one
box (output) to another box (input). The information exchanged is represented
in the workow by the symbol next to the arrow.
The core elements of the model are presented in this workow. These core
elements can be a single or a series of model equations and variables. Table 3.1
lists the workow entries including equations and variables.
The Navier-Stokes equations (I) are used to model the dynamics of blood ow
inside the arterial lumen. The endothelial transport properties are inuenced
by haemodynamic variables, here characterised by WSS (IV). WSS values are
input into the endothelium model and more precisely, to the shear dependent
permeability part, represented by the Shape Index (SI) function (V).
Depending on the value of local WSS, the endothelium will have a proportion
of cells that will behave as leaky (VII). The quantity of leaky cells () denes
the permeability of the endothelium to the macromolecule of interest (LDL). The
portion of leaky cells together with the quantity of LDL available for transport
(VI), set as a xed quantity in the lumen (II), denes the lumenal conditions for
the three pores transport model (VIII), describing the dierent pathways through
which LDL travels inside the endothelium.
The LDL solute and volume ux (X), having passed through the endothelium
enters the arterial wall, where the LDL transport is characterised by a convection-
diusion-reaction equation (XI). As LDL accumulates inside the arterial wall, its
concentration in the arterial wall subendothelial layer changes (XII), altering
the transport of LDL through the endothelium (X). The reaction term (rwcw)
in (XI) accounts for the dierent LDL degradation processes inside the arterial
wall; representing the concentration of particles undergoing a chemical variation,
this quantity (XIII) was considered as the concentration of native LDL particles
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mFigure 3.1: Theoretical workow of the atherosclerosis model.
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Table 3.1: Workow (3.1, 3.2) entries with the corresponding set of equations or
quantities that they represent
Flowchart Equations Variable Units Description
I 2.1, 2.2 Navier-Stokes equations
II, VI clum mol/m
3 Lumen-free approach {
Mean blood LDL concen-
tration
III, IX Mlum mol/m
3 Lumen-free approach {
Blood monocytes concen-
tration
IV WSS Pa
V 2.4, 2.5 Shape Index Function
VII 2.15 - 2.18  Quantity of leaky cells
VIII 2.6 - 2.14,
2.19 - 2.23
Three Pores Transport
Model
X Js; Jv mol/m
2s, m/s Solute Flux, Volume Flux
XI 2.24, 2.25 LDL Convection-
Diusion-Reaction
equation
XII cw;end mol/m
3 Sub-endothelial LDL con-
centration
XIII rwcw mol/m
3s Degrading LDL concen-
tration
XIV 2.28, 2.34 LDL Oxidation
XV Lox mol/m
3 Oxidised LDL
XVI 2.35 Monocytes/macrophages
Diusion-Reaction equa-
tion
XVII kmMw mol/m
3s Degrading macrophages
XVIII 2.38, 2.39 Foam cells formation and
accumulation
XIX 2.41, 2.42 m Arterial Wall Growth
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in the oxidation cascade (XIV). The nal product of the oxidation cascade is the
arterial wall concentration of oxidised LDL (XV). Oxidised LDL (oxLDL) is one
of the most important elements in this model as it is the triggering factor of the
atherosclerosis inammatory process.
OxLDL causes the recruitment of monocytes from the arterial lumen, a xed
and constantly available quantity (III) of immune cells. Monocytes are free to
travel inside the arterial wall (IX) and are dependent on the quantity of oxi-
dised LDL(XV). This denes the severity of the inammation. Inside the arterial
wall, monocytes turn into macrophages and their transport follows Diusion-
Reaction behaviour (XVI). The reaction term of (XVI) represents the concen-
tration of macrophages that interacts with the oxLDL. The interaction between
macrophages (XVII) and the quantity of oxLDL (XV) leads to the formation of
fatty laden macrophages called foam cells (XVIII). Unable to leave the arterial
wall, foam cells stratify, eventually leading to wall thickening and remodelling
(XIX). Remodelling of the arterial wall is the result of the inammatory process
described herein, and marks the end of the atherosclerosis remodelling cycle.
Alteration of lumen geometry has an impact on haemodynamics, which in-
uences the overall cycle, creating a feedback loop. After the lumen geometry
has been altered, another atherosclerosis remodelling cycle can be initiated to
simulate plaque progression further in time.
As explained in the previous chapter (Section 2.2.2), this model is dened
by dierent temporal scales. Figure 3.2 shows a simplied version of the model
theoretical workow (Figure 3.1) where only the information exchanged between
the various sub-processes of the model (white boxes) can be visualised together
with the temporal setting of the model. The blue, orange and purple boxes show
the dierent time domains used in this model. The two white boxes with the
concentration of LDL (VI) and monocytes (IX) used in the lumen-free approach
are xed concentrations in this model, and are therefore not inuenced by any
time scale.
Starting from the centre, the innermost blue box shows the time domain of
the arterial wall model. This is the smallest time domain, and it is set to accu-
rately dene the dynamics happening in the biochemical and transport processes
happening in the arterial wall. The orange box is the time domain used to update
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the endothelial transport model according to the concentration of LDL present in
the arterial wall. The outermost time domain, the purple box is the time length
of the whole atherosclerosis remodelling cycle, set to adjust the arterial lumen
geometry according to the developing atherosclerosis plaque. When the calcula-
tions in the atheroma model produce a \growth", i.e., the arterial wall reaches a
thickness of h, it is considered that the impact of the change in geometry on
the WSS pattern is not negligible, consequently the arterial geometry is updated
to account for this change.
This h value is xed as 1% of the radius of the artery in question. This
threshold value was assumed as the maximum arterial deformation allowed, before
the impact of the changing geometry on the haemodynamics had to be considered
and a new atherosclerosis remodelling cycle started.
As previously mentioned, when this condition is met, the geometry of the
artery is modied according to the arterial growth calculated in Equation (2.42),
following a procedure that will be presented in the next section. Changing the
arterial geometry will lead to a change in the haemodynamics and consequently a
change in the local endothelium transport properties, leading to a whole system
update. A second simulation cycle will now start to simulate growth further in
time.
So far the theory behind the model and the integration of the various elements
from a theoretical point of view have been described. In the following section,
the computational implementation of this model will be discussed.
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Figure 3.2: Theoretical Workow of the atherosclerosis model. The in-
puts/outputs of g. 3.1 are represented together with the model time scales.
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3.2 Computational Workow
Two dierent computational tools were used to model the dierent subdomains.
A CFD software, Ansys CfX v.14, was used for the simulation of blood ow inside
the lumen. The transport model and biochemical model of arterial endothelium
and arterial wall was developed and implemented in Matlab (The MathWorks,
Natick, MA).
The computational workow is shown in Figure 3.3. This workow can be
divided into two parts. The red borders represent the initialisation cycle, and
the green borders characterise each cycle after the initialisation cycle. The black
borders show the parts that are common to both.
The boxes lling in the workow are of three colours. Each of the dierent
colours represents the computational tool used to implement that part of the
model: red colour is for Ansys CfX v.14 and blue colour for Matlab. Exchange
between Matlab and Ansys CfX v.14 was done with the help of Microsoft Excely
(Microsoft Corporation, Redmond, WA), shown in the green colour boxes.
This workow will be explained following the order of computational imple-
mentation. The initialisation cycle will be explained rst, and then the other
cycles will follow.
3.2.1 Atherosclerosis remodelling initialisation cycle
As already mentioned in the previous chapter, the Navier-Stokes equations, de-
scribing the haemodynamics in the arterial lumen for the given geometry and
boundary conditions, are solved in Ansys CfX v.14. Once the solution for a given
geometry has been computed, the variables of interest are extracted from the
CFD model and saved in an Excel le. For a surface of n nodes, the data would
http://www.mathworks.it/products/matlab/
yhttp://office.microsoft.com/en-gb/excel
68
Figure 3.3: Computational workow of the atherosclerosis model.
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be exported in matrix form with each string representing a dierent variable:266666664
N1 x1 y1 z1 n^x1 n^y1 n^z1 WSS1
N2 x2 y2 z2 n^x2 n^y2 n^z2 WSS2
N3 x3 y3 z3 n^x3 n^y3 n^z3 WSS3
...
Nn xn yn zn n^xn n^yn n^zn WSSn
377777775
(3.1)
where the rst column is the node number, from second to the fourth column
x, y and z coordinates of the node respectively, from the fth to seventh column
the projection of the normal vector in the x, y and z direction and the last column
the WSS value at that nodal location.
Each variable stored in Equation (3.1) is individually processed in Matlab.
The WSS nodal values are extracted from this matrix and selected following a
specied criteria. The nodal number (N1:n) is used as an identifying index for each
of the extracted WSS values. If the WSS value at the nodal location is greater
or equal to the Poiseuille WSS value for the given arterial branch as calculated
in Equation (2.4), the node is discarded, and no arterial wall displacement (h,
Equation (2.42)) is assigned to that node.
If the criterion is satised and the extracted WSS value is less than the calcu-
lated WSS Poiseuille value (Equation (2.4)), the node having that WSS value will
be selected. This WSS value is used as the lumen side condition (IV in Figure 3.1)
for the endothelium and the arterial wall model, implemented in Matlab.
Following the WSS selecting criteria, a new matrix of selected surface nodes
are formed: 266666664
N1 1 x1 y1 z1 n^x1 n^y1 n^z1 WSS1
N2 2 x2 y2 z2 n^x2 n^y2 n^z2 WSS2
N3 3 x3 y3 z3 n^x3 n^y3 n^z3 WSS3
...
Nn n xn yn zn n^xn n^yn n^zn WSSn
377777775
(3.2)
where the rst column is the node number, representing also the node index
in the parent matrix (Equation (3.1)). The second column is the node positioning
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index in the current matrix, the third to fth column are the x, y and z coor-
dinates of the node respectively, the sixth to eight column the projection of the
normal vector in the x, y and z direction and the last column the WSS value on
that surface node. Matrix (3.2) is a sub-matrix of (3.1), as it is the product of
the element selection performed on the Matrix (3.1). WSS based node selective
criteria, identies the atherosclerosis-prone areas. Narrowing the area of interest
allows for reduced data handling.
Once the lumen side boundary conditions have been set, the endothelium-
arterial wall model can be implemented in Matlab. One of the assumptions of
the model is that the transport of species occurs in the radial direction (direction
normal to the lumen surface) only, hence, there is no exchange of information
between neighbouring nodes (longitudinal direction) (Figure 2.11). The Matlab
model of the endothelium and the arterial wall can be solved for each node sep-
arately. For increased computational eciency, the selected surface nodes of the
CFD model with their section of endothelium and arterial wall model are clus-
tered in packages and solved in parallel. For parallelisation purposes a remote
cluster (UCL Computer Science Cluster, total of 2500 cores, typical node with
dual socket E5-2620, 48GB of memory and 128GB SSD (solid-state drive)) was
used. The Matlab implementation would have to handle a much larger number
of nodes at once without parallelisation. It follows that this parallelisation allows
for a further decrease in the computational power required for this model.
The result of the endothelium and arterial wall model is an arterial wall growth
value for each one of the CFD surface nodes considered. This growth value
represents the thickening of the arterial wall and will result in a deformation
of the arterial surface to accommodate the growth in IMT (h), as calculated
from Equation (2.42). The displacement (h) value will be imposed on each
of the surface nodes of the arterial lumen model. An increase in the arterial
wall thickness would result in a displacement of the arterial lumen surface nodes
towards the centre, as atherosclerosis formation leads to a decrease in the arterial
lumen diameter.
Using the indexing number (N1:n) the displacement (h) corresponding to
each one of the surface nodes for both the pro-atherosclerotic areas and for areas
where the displacement was imposed as zero, can be inserted in the original matrix
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for the surface nodes. The following matrix will be created:266666664
N1 x1 y1 z1 n^x1 n^y1 n^z1 WSS1 h1
N2 x2 y2 z2 n^x2 n^y2 n^z2 WSS2 h2
N3 x3 y3 z3 n^x3 n^y3 n^z3 WSS3 h3
...
Nn xn yn zn n^xn n^yn n^zn WSSn hn
377777775
(3.3)
Where N1:n is the indexing number, the second to fourth entry are the node
coordinates, the fth to seventh entry are the nodes normal vector projections,
and the last entry is the node displacement.
The information stored in Matrix (3.3) is used to calculate the nodal displace-
ment to be imposed on the surface nodes of the CFD lumen geometry, using the
point translation technique (Figure 3.4). For a single node, the new position
coordinates Xnew, Ynew and Znew are given by:
Xnew = X  n^x h (3.4)
Ynew = Y  n^y h (3.5)
Znew = Z  n^z h (3.6)
Where X, Y , Z are the nodal coordinates of the initial geometry and n^x h,
n^y h, n^z h, are the displacement vectors with magnitude h and direction
n^x, n^y, n^z. Applied to the Ansys CfX v14 model geometry surface, the
new coordinates of the nodes are given by:
266666664
x1new y1new z1new
x2new y2new z2new
x3new y3new z3new
...
xnnew ynnew znnew
377777775
=
266666664
x1 y1 z1
x2 y2 z2
x3 y3 z3
...
xn yn zn
377777775

266666664
n^x1 n^y1 n^z1
n^x2 n^y2 n^z2
n^x3 n^y3 n^z3
...
n^xn n^yn n^zn
377777775

266666664
h1
h2
h3
...
hn
377777775
(3.7)
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Figure 3.4 shows the mesh deformation technique used for modelling lumen-
imposed deformation caused by the arterial wall growth. A node (Figure 3.4a)
is translated to a position at a distance h in the direction normal to the node
(Figure 3.4b). Considering the node as part of the surface mesh (Figure 3.4c),
the mesh deformation coming from the node translation can be visualised in
Figure 3.4d.
(a) (b)
(c) (d)
Figure 3.4: a. Node of the surface mesh represented in its x, y, z spacing with the
projection of the normal vectors in the x, y and z directions. b. Translation of
the node along a vector with magnitude h in the direction normal to its surface.
c. Node located in a portion of the surface mesh grid. d. Displacement of that
node downwards (towards the arterial lumen) and remodelling of the grid around
it.
The node translation calculated can be imposed onto the surface nodes of the
Ansys CfX v.14 model.
In order to instruct Ansys to perform the correct mesh deformation the fol-
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lowing matrix needs to be utilised:266666664
x1 y1 z1 x1new y1new z1new
x2 y2 z2 x2new y2new z2new
x3 y3 z3 x3new y3new z3new
...
xn yn zn xnnew ynnew znnew
377777775
(3.8)
Where the rst three entries are the nodal coordinates and the fth to seventh
column are the new x, y and z coordinates that the nodes will have after the
translation has been performed.
As mentioned at the beginning of this section, the end of an atherosclerosis
remodelling cycle is marked by the arterial wall deformation. In this case, the
deformation marks the end of the rst cycle, or initialisation cycle. To characterise
the plaque development further in time, after the initialisation cycle has nished,
another cycle will start. This is represented in Figure 3.3 by the green framed
part of the workow.
Once the atherosclerosis remodelling cycle has ended, the endothelium and
arterial wall models are temporary interrupted as the wall growth threshold cri-
terion (h) has been reached (Figure 3.1). Among the surface nodes, if at least
one had a wall displacement value that satised the criteria:
h = h (3.9)
where h is 1% of the artery radius. The developed growth threshold crite-
rion has been satised and the CFD geometry is remodelled accordingly.
3.2.2 Atherosclerosis remodelling cycle
In order to continue calculating the arterial wall growth, the endothelium-arterial
wall transport model had to be retrieved from the point where the simulation was
interrupted. As this cycle is the continuation of the previous cycle, the transport
model of the arterial wall is not re-initialised. The concentration value for each
point in the discretised arterial wall at the time when the previous cycle was
interrupted is utilised as the initialisation value for the current simulation cycle.
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Because in certain areas the IMT increased due to plaque formation, the
thickness of the arterial wall is not equal to the initially imposed IMT (used in
Equation (2.42)) anymore. The new IMT thickness is given by:
IMTc = IMTc 1 +h (3.10)
Where IMTc is the intima-media thickness at the current cycle, IMTc 1 is the
intima media thickness of the previous cycle and h is the nodal displacement.
Because this cycle is the continuation of the previous cycle but with an up-
dated geometry, the processes that started in the previous cycle must continue.
Even in the case where the new value for WSS would allow for a normal en-
dothelial behaviour to be restored, the previously triggered inammatory process
would not stop immediately and arterial swelling could still take place in these
areas.
Preservation of the previously started inammatory process will lead to a
modication of the node-selective WSS threshold criteria, as shown in Figure 3.3.
To account for the modication of the pro-atherogenic area due to arterial
change, nodal pre-selection represented by the WSS threshold criterion is now
divided into two steps.
No displacement is assigned to the Ansys CfX v14 surface nodes if they
do not belong to an area that was previously, or it is currently, identied as
atherosclerosis-prone (the WSS at the current and previous time cycles is equal
or more than the Poiseuille WSS value for the given geometry (Equation (2.4)).
If the current WSS value is less than the Poiseuille value, those nodes are selected
as belonging to the atherosclerosis-prone area. Finally, if the current WSS at the
node is more than the Poiseuille value, but in the previous time cycles that node
belonged to an atherosclerosis-prone area this would mean that some inamma-
tory process had been triggered there and can still continue. The node does not
belong to an atherosclerosis-prone area anymore, as the endothelium recovered
to a normal behaviour due to changes in the local haemodynamics. However, it
did once belong to an atherosclerosis-prone area and the inammatory process
triggered could lead to further arterial wall deformation. It results that the en-
dothelium and the arterial wall are modelled for both the case of WSS with a
75
lower value than the Poiseuille WSS at the current cycle and for the nodes that
at least in one of the previous time cycles were part of an atherosclerosis-prone
area.
As it can be seen from the workow in Figure 3.3, the remaining part of
the cycle does not dier from what was previously described. The result of this
cycle, as it was for the initialisation cycle is a wall deformation value (h) to be
imposed to the Ansys CfX v.14 model surface nodes.
3.3 Discussion
The atherosclerosis remodelling cycle was presented in this chapter. This work-
ow was developed to create a modelling tool that would consider the develop-
ment of the initial state of atherosclerosis, from the penetration of LDL through
the arterial wall to the formation of the atherosclerotic plaque. This tool was
created integrating in silico the dierent sub-processes leading to atherosclerosis
formation presented in the previous chapter.
The interactions between the dierent sub-processes were established with the
help of a theoretical workow that was then implemented computationally, using
the most appropriate tools.
In this chapter, the atherosclerosis remodelling cycle workow was divided
into its theoretical part (theoretical workow) and its computational part (com-
putational workow).
The theoretical part was presented in the rst workow, where the dierent
core elements considered in the model were integrated together. Each of these
core elements represent dierent parts (i.e. model equations and variables) of the
theoretical model presented in Chapter 2 (Table 3.1).
A subset of the theoretical workow, showing the time scales of the atheroscle-
rosis remodelling cycle was presented in Figure 3.2. Following the multiscale
modelling approach presented in the previous chapter, three dierent time scales
were employed in this model. The rst and smallest time scale are set to describe
the arterial wall model. The second time scale is used to update the endothelium
model accordingly to the change of LDL concentration inside the arterial wall.
The third time scale is the time length of the entire atherosclerosis remodelling
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cycle, the time needed by the modelled plaque to develop and reach a wall thick-
ness of h. At the end of the cycle, a value of arterial wall growth will be used
to update the geometry of the artery considered. The WSS patterns will change
accordingly, leading to a change in the penetration of macromolecules through
the endothelium and, therefore, updating the whole atherosclerosis remodelling
cycle. This will happen when the arterial wall growth developed in the model will
have reached a certain threshold quantity (h, Equation (3.9)). As the arterial
wall growth is the result of an accumulation process, it follows that this time
will be of varying length, becoming shorter as the inammatory process becomes
more severe.
Modelling the atherosclerosis formation as a continuum process allowed cap-
turing the dynamics of this complex systemic disease for years of development at
a feasible computational cost.
The computational implementation workow of the atherosclerosis remod-
elling cycle (Figure 3.3) was developed with the aim of producing a comprehensive
tool for the multiscale modelling of atherosclerosis.
Dierent tools were used for the computational implementation of the model.
The haemodynamics in the arterial lumen were modelled with the help of a CFD
software Ansys CfX v.14. The arterial endothelium and arterial wall were mod-
elled and implemented with the help of Matlab, using a coupled biochemical and
transport model.
This computational workow presents a valid alternative to patient-specic
modelling and simulation of plaque, as it is separated into individual components
and harnesses the power of parallel computing to perform computational tasks
that would be otherwise intractable, in order to simulate long periods of time.
The endothelium-arterial wall model could be solved for each node inde-
pendently as there is no data transfer in the nodal tangential direction (Fig-
ure 2.11). This allowed for easy parallelisation of the endothelium-arterial wall
model, accelerating the computation speed. Furthermore, a pre-selection of the
pro-atherogenetic areas in the arterial model, allowed for smaller set of the areas
to be analysed within the geometry of interest (Figure 3.3) leading to a substantial
decrease in the amount of information to be handled.
The atherosclerosis remodelling cycle can handle every geometry type and is
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ecient in processing big data loads, making it an eective tool for the modelling
of atherosclerosis.
Arterial lumen narrowing coming from atherosclerosis formation is modelled
for each node on the wall surface of the modelled CFD domain. A point transla-
tion technique (Equations (3.4) to (3.6)) is used to displace the considered surface
node in the normal direction at a distance h (Equation (2.42)) resulting from
the arterial wall growth for that node. This localised nodal displacement allows
for a greater versatility in the type of geometry that can be deformed and higher
control on the type of deformation imposed, allowing for atherosclerosis forma-
tion to be modelled in irregular geometries like the anatomies of patient-specic
arteries.
3.4 Conclusion
The atherosclerosis remodelling cycle presented here is a feedback loop model.
The model cycle nal output inuences the model initial input in the next cycle.
Once a disease-prone environment has been identied (WSS low areas) a se-
ries of events causes the formation of an inammation triggering factor (LDL
oxidation) leading to the development of the disease. In the case of a chronic
inammatory disease such atherosclerosis, the disease cycle does not end with
the formation of the plaque but keeps developing until the pro-atherogenic en-
vironment exists. This behaviour represents a feedback loop cycle, constantly
repeating itself, until the pro-inammatory condition is present. It is following
this principle that the atherosclerosis model was developed.
In the following chapter, implementation results of this workow will be pre-
sented. Two idealised geometries will be used in order to establish the validity of
the method in a simplied setting.
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Chapter 4
Atherosclerosis Modelling On
Idealised Arterial Geometries
The implementation of the atherosclerosis remodelling cycle was rst carried out
on idealised arterial geometries and the results of this implementation is the
subject of this chapter. As presented in Chapters 2 and 3, the model is highly
dependent on the haemodynamics of the arterial model (via the WSS), so a
rst implementation using these idealised geometries allowed for easier testing
in a controlled setting. This implementation, however, will be generalised and
expanded and the study of a patient-specic case will be presented in Chapter 5.
First, the initial implementation of the atherosclerosis model was on a ide-
alised, straight coronary artery with an axisymmetric geometry and in a steady
state regime. At a second stage, the model was then improved to account for
the formation of the atherosclerotic plaque in time (also dened as "evolution"
in Chapters 4 and 5) and was nally generalised to accommodate the progression
of plaque in any geometry. This transient model was tested on an axisymmetric
idealised geometry similar to the geometry employed for the steady state model.
Finally, a non-axisymmetric idealised artery was used to test the model and the
methodology on a more complex geometry.
The simulation details of the atherosclerosis model implementations on the
idealised arterial geometries will be presented in the rst part of this chapter.
The second part of this chapter will be devoted to the presentation of the
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results coming from these dierent implementations. The results will be presented
in the same order used in the methodology section. First the steady state model
(Section 4.1.1), then the transient model (Section 4.1.2). A discussion over the
methodology and the results will follow (Section 4.2), to nish with the conclusion.
4.1 Methods
The steady state and transient models shown in this chapter are based on two
arteries among the most common for atherosclerosis formation in the body[83,
131], i.e., the coronary artery and the femoral artery.
4.1.1 Steady-state model
As previously discussed, the rst implementation of this model was in steady
state conditions, i.e., only location and severity of the formation were considered.
This work is the subject of a published paper[135].
4.1.1.1 Idealised geometry of a coronary arterial stenosis
Computational Geometry
A straight axisymmetric geometry of a coronary artery was implemented (Fig-
ure 4.1) as in Olgac et al.[83]. The artery was modelled with a 40% stenotic
reduction of the lumen. The stenotic neck was introduced as an element of
haemodynamic disturbance to create a pro-atherogenic environment, as evidence
in the literature suggests that geometry can be a risk factor for the development
of atherosclerosis[29].
The arterial geometry is shown in Figure 4.1. The stenotic neck is 2 Ra long,
and it is located 8 Ra downstream of the inlet. The artery has an un-stenosed
radius Ra = 1.85 mm, and it is 60 Ra long.
The choice of using two dierent arteries as exemplars came from the fact that through
the development of the generalised model, the patient-specic available data was obtained from
peripheral arteries, among which femoral arteries.
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Figure 4.1: Axisymmetric straight idealised geometry of a coronary artery. Not
shown to scale.
Boundary conditions and implementation setup
Each one of the arterial model sub-domains had specic boundary conditions and
parameters for this implementation. These are described below.
Arterial Lumen
A parabolic velocity prole was imposed at the inlet [83] as described by Equa-
tion (4.1).
u(r) = 2U
"
1 

r
Ra
2#
(4.1)
where u(r) is the velocity, U is the time averaged mean velocity of blood in
the considered artery and was chosen as U = 24 cm/s for the carotid artery [83]
and r is the radial location.
At the outlet, a constant pressure of 70 mmHg was used[90]. No slip conditions
were set at the wall boundary.
A rst analysis was carried out to analyse the impact of high levels of plasma
lipids on plaque development. Two dierent mean blood LDL concentrations
(clum) were considered as xed values in the lumen: a moderately high value of
mean blood LDL level of 5.5 mol/m3and a more severe case of 7.77 mol/m3[135].
These values were implemented as the LDL concentration in the lumen-free
model, and correspond to a pathological state dened as LDL hyperlipoproteine-
mia, an abnormally high level of low density lipoproteins in blood[136], which
could be linked with premature and severe atherosclerosis formation[137].
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Arterial endothelium
The shape index function dening the relationship between WSS local values and
endothelial cell shape explained in Chapter 2 is described by Equation (4.2) as
follows:
SI1 = 0:380e
( 0:79WSS) + 0:225e( 0:43WSS) (4.2)
As the geometry, parameters and boundary conditions of the coronary model
were close to the in silico experimental settings of[83] the SI function in Equa-
tion (4.2) was considered suitable for this implementation.
Given the steady state regime, there was no time change in the solute ux
through the endothelium. The concentration of LDL inside the arterial wall
(cw;end) was considered negligible as it is much smaller than the mean blood LDL
concentration (clum). Equation (2.7) was simplied as:
Js = Piclum
Pe
ePe   1 + Jv(1  )clum (4.3)
And can be arranged as:
Js = Pappclum (4.4)
Where the apparent permeability (Papp) represents the eects of traversing all
the permeation pathways across the membrane and is dened as:
Papp = Pi
Pe
ePe   1 + Jv(1  ) (4.5)
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Arterial Wall
The arterial wall was dened with an IMT = 0.34 mm, in accordance with the
dimensions of a human coronary artery[138]. To solve for the transmural veloc-
ity (uw) calculated using Darcys law (Equation (2.25)), a pressure boundary of
pend = 100 mmHg and padv = 17:5 mmHg was imposed at the sub-endothelial
and adventitial boundary respectively[90].
Fluid domain descretisation
The lumen was meshed in Ansys Workbench v14. The mesh created was a struc-
tured mesh of 567800 quadrilateral elements and 1023455 tetrahedra. The total
number of elements was 1691255. Five inated boundary layers were used at the
wall boundaries.
4.1.2 Transient Model
To simulate the development of the atherosclerosis formation in time, a transient
model (as shown in Chapter 2) was developed. Peripheral arteries are among
the most common locations for atherosclerosis formation. The artery used as a
blueprint here was the common femoral artery. The fairly \straight" anatomy of
this vessel allowed for a good test case, as the idealised case was close to the real
one. Two dierent scenarios were considered as shown below.
4.1.2.1 Idealised Geometry of a Common Femoral Artery Stenosis
Computational geometry
A straight pipe with a stenotic neck was created (Figure 4.1). The measurement
and physiological parameters were chosen as corresponding to a femoral artery,
with Ra = 3 mm[131].
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Boundary conditions and implementation setup
The boundary conditions for this implementation are described below.
Arterial lumen
A parabolic prole was imposed at the inlet of the uid domain following Equa-
tion (4.1). The value for the time averaged mean velocity (U) was imposed as
U = 7:7 cm/s. This velocity value was derived from the average WSS value in the
common femoral artery (CFA),WSS = 0:36 Pa [39]. Although the mathematical
model of lipoprotein accumulation and fatty streak formation was solved in time,
the CFD model was solved for steady state conditions.
A stress free condition was used at the outlet[131]. No slip conditions were
set at the wall boundary.
A mean LDL particle concentration of clum = 1358 nmol/L[129] was used as
xed value for mean blood LDL concentration in the lumen, to solve for the LDL
transport model.
Arterial endothelium
Endothelial cell SI function was dened as the relationship between SI and local
WSS normalised by the Poiseuille value of WSS for the considered artery, as
explained in Chapter 2.
SI2 =  0:2435  
0
0:3537
+ 0:4025 (4.6)
Where the Poiseuille WSS 0 = 0:36 Pa. An artery-specic form of the SI
function was implemented, as the artery does not have the same anatomical
characteristics to match the experimental data presented in Levesque et al.[32].
Arterial wall
Consistent with the anatomy of the human femoral artery, the IMT was set as
0.562 mm[139]. The transmural velocity (uw) was considered as homogeneous
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throughout the arterial wall, and it was set to a value of uw = 1:78  10 8
m/s[90].
Fluid domain discretisation
Ansys Workbench v14 was used to mesh the uid domain. Only a quarter of the
geometry for 0    90 was meshed, the remaining geometry was simulated
with the help of symmetry planes.
The mesh had a total of 3333998 elements among which 2961378 tetrahedra;
the mesh was structured. Five inated boundary layers were used at the wall
boundaries.
4.1.2.2 Idealised Geometry of an S-shaped Common Femoral Artery
In the area just above the knee, the femoral artery shows a very mild S-shaped
curvature. When the leg is exed, a number of successive small short bends
appear, giving the artery a wave-like appearance. In younger people these bends
disappear when the leg is extended however, in older people they persist[131].
This sequence of bends could cause haemodynamic conditions leading to the
creation of atherosclerosis-prone areas.
Computational geometry
An S-shaped femoral artery was built (Figure 4.2), following the same approach
as in Hoogstraten et al.[131].
The artery has a radius Ra = 3 mm; both inlet and outlet are straight seg-
ments of 15 mm length and the two bends are both of 35, with a radius of
curvature of 39 mm[131].
Boundary conditions and implementation setup
As this implementation is for a common femoral artery, the boundary conditions
and implementation settings are the same as the ones used for the previous case
of the idealised geometry of a femoral artery stenosis.
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2 Ra
15 mm 24.5 mm 24.5 mm 15 mm
Figure 4.2: Geometry of an S-shaped femoral artery. Not shown to scale.
Fluid domain discretisation
An unstructured mesh was created in Ansys Workbench v14. The mesh had
a total of 2551977 elements with 2123257 tetrahedral elements. Five inated
boundary layers were used at the wall for improved mesh structure. A grid
independence study was used to choose the most adequate mesh for the current
analysis, the details are shown in Appendix A.
4.2 Results
4.2.1 Steady-state Model
The wall shear stress distribution along the computational geometry has been
compared with the analytical solution of WSS for a Poiseuille ow in a straight
tube with the same radius (Ra), mean inlet velocity U and uid density  (Fig-
ure 4.3). The analytical solution corresponds to the WSS at the inlet and after
the reattachment point at the outlet, showing that the mesh used is appropriate.
A peak in the WSS value can be seen at the stenosis, due to ow acceleration
(Figure 4.4) in the lumen narrowing. The uid after the stenotic neck shows the
vena-contracta behaviour, with decreased value of WSS and formation of recir-
culation zones near the wall boundaries, indicating possible atherosclerosis-prone
areas.
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Figure 4.3: Local value of WSS as a function of the axial location z. The ana-
lytical solution of the Poiseuille ow is plotted here for comparison. Boundary
conditions: inlet parabolic velocity prole (Equation (4.1)), outlet stress free.
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Figure 4.4: Velocity streamlines in the stenotic areas. The recirculation zone
after the stenotic neck is shown.
The formation of areas with increased transport of plasma macromolecules
and at higher risk of atherosclerosis can be visualised by looking at the endothe-
lial apparent permeability (Papp) along the artery (Figure 4.5). The endothelial
permeability has a steady value until approaching the stenotic area, where a rst
minor increase at the separation point is followed by a major increase in the
area of highest ow recirculation. The point of minimum WSS (Figure 4.3) and
maximum endothelial permeability is labelled in Figure 4.5 as z0. After the reat-
tachment point, the ow perturbation caused by the stenosis fades, leaving the
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ow back to its normal dynamics (z1).
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Figure 4.5: Apparent permeability (Papp) of endothelium as a function of the axial
location z. The point of minimum WSS and maximum endothelial permeability
(z0) is shown, together with the point where normal haemodynamic conditions
are regained (z1).
Computations were performed for two dierent concentrations of mean blood
LDL (clum); a moderately high concentration of 5.5 mol/m
3 and a more severe
case with 7.7 mol/m3.
The concentration distributions inside the arterial wall for the two dierent
mean blood LDL concentrations implemented are shown in Figure 4.6. Here, the
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LDL arterial wall values were taken at z0 at the end of the rst atherosclerosis
cycle, before the lumen remodelling for plaque formation has occurred. The case
of 7.7 mol/m3 shows an almost 50% increase in LDL concentration inside the
arterial wall compared with the less severe case (5.5 mol/m3) of hyperlipopro-
teinemia. An increase in both the endothelial permeability and the concentration
of mean blood LDL available in the lumen leads to a consistent increase in the
ux of LDL penetrating inside the arterial wall, making the high permeability
areas more susceptible to atherosclerotic growth.
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Figure 4.6: LDL arterial concentration proles taken at point z0 along the vessel
length. The two proles corresponding to the dierent LDL mean blood concen-
tration implemented are shown.
Figure 4.7 shows the WSS pattern and geometry outline for the most severe
case of hyperlipoproteinemia (7.7 mol/m3) at the beginning and at the end of the
rst atherosclerosis remodelling cycle. Plaque formation is shown at the end of
the rst atherosclerosis cycle (Figure 4.7b) in the area of low WSS (Figure 4.7a)
where the endothelial permeability was shown to be high (Figure 4.5).
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Two atherosclerosis remodelling cycles were performed in steady state for the
two dierent mean blood LDL concentrations. Plaque development was present
in both cases as shown in Figure 4.8.
At the end of the rst atherosclerosis cycle, hyperlipoproteinemia caused
plaque development to occur in the post-stenotic area. Figure 4.9 shows (a) LDL
endothelial apparent permeability at the end of the rst atherosclerosis model
cycle for a mean blood LDL level of 5.5 mol/m3 (b) and a mean blood LDL level
of 7.7 mol/m3. Comparing the endothelial permeability before (Figure 4.5) and
after plaque formation (Figure 4.9), changes in the endothelial local transport
properties can be visualised. The permeability in the recirculation zone for a
mean blood LDL level of 5.5 mol/m3 (Figure 4.9a) shows two peaks in value
with a drop in the middle, created by the newly formed plaque. Figure 4.9b
also shows two value increases in the endothelial permeability. The rst increase
corresponds to the ow separation point, the second increase is in the recircula-
tion zone caused by the initial stenosis, where the permeability appears majorly
modied from its behaviour in the initial geometry conguration (Figure 4.5).
The drop in permeability distal to the plaque is much more developed for the
most severe case of hyperlipoproteinemia (7.7 mol/m3) (Figure 4.9b) than for 5.5
mol/m3 (Figure 4.9a), showing that the newly formed plaque has enough of an
impact on the ow to bring the endothelial permeability back to normal values.
This plaque generates also a new recirculation zone downstream (Figure 4.9b),
leading to another increase in the endothelial permeability and creating a new
atherosclerosis-prone area. At the end of the second atherosclerosis remodelling
cycle (Figure 4.8b) in agreement with the endothelial apparent permeability be-
haviour in Figure 4.9b, a second plaque forms downstream from the rst plaque.
Information on the severity of the simulated lesion, such as plaque size and
number of plaques is summarised in Table 4.1. For the mean blood LDL level of
5.5 mol/m3 there was an atherosclerotic formation in the post stenotic branch;
this plaque grew in size but did not initiate the formation of another plaque.
Conversely, from the implementation of a 7.7 mol/m3 mean blood LDL level a
fairly large atherosclerotic formation was present after the rst atherosclerosis
remodelling cycle (plaque cross sectional area of 0.588 mm2). During the second
atherosclerosis remodelling cycle, the rst plaque grew in size and another plaque
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formed.
Table 4.1: Simulation Results
LDL Mean
Blood
Concentration
(mol/m3)
5.5 7.7
Plaque number Plaque cross
sectional area
(mm2)
Plaque number Plaque cross
sectional area
(mm2)
1st Simulation 1 0.147 1 0.588
2nd Simulation 1 0.366 1 0.8
2 0.56
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(a)
(b)
Figure 4.7: Wall Shear Stress contour plot and pattern along the vessel length for
the most severe hyperlipoproteinemic case (7.7 mol/m3) taken at : (a.) the begin-
ning of the atherosclerosis remodelling cycle and (b.) the end of the atherosclerosis
remodelling cycle. Notice that the maximum value showed on the contour plot is
for the range of WSS going from 1.541 Pa s to the peak value.
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Max R:   1st Plaque 11.03%
Max R:   1st Plaque 11.95%
(a)
Max R:   1st Plaque 31.6%
Max R:   1st Plaque 31.6%
        2nd Plaque 31.2%
(b)
Figure 4.8: Atherosclerotic formation with percentage of maximum normalised
radial reduction (R). R = r0
R0
, where r0 is the radial reduction at the time step.
A. Lesion growth for a mean blood LDL level of 5.5 mol/m3. B. Lesion growth
and second lesion formation for a mean blood LDL level of 7.7 mol/m3.
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Figure 4.9: LDL endothelial apparent permeability (Papp) as a function of the
axial location z. Endothelial transport property taken at the end of the rst
atherosclerosis cycle for a mean blood LDL level of (a) 5.5 mol/m3 and a mean
blood LDL level of (b) 7.7 mol/m3
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4.2.2 Transient Model
4.2.2.1 Idealised geometry of a common femoral artery stenosis
The computational mesh used shows a WSS that corresponds well with the ana-
lytical solution of WSS for a Poiseuille ow in a straight tube with same radius
(Ra), ow mean velocity U and uid density  (Figure 4.10).
Figure 4.10: Local value of WSS as a function of the axial location z. The
analytical solution of the Poiseuille ow is here plot for comparison. Boundary
conditions: inlet parabolic velocity prole (Equation (4.1)), outlet stress free.
The haemodynamic patterns are qualitatively similar, hence, the apparent
permeability (Papp) taken at the beginning of the initialisation cycle plotted along
the stenotic common femoral artery (Figure 4.11) and the apparent permeability
for the stenotic coronary artery (Figure 4.5) show the same trend; highlighting
similar atherosclerosis-prone areas. The endothelial response to WSS is dened
by an artery-specic SI function Equation (4.6), derived from the experimental
results of Levesque et al.[32] tuned for the artery in question, as shown in Section
2.1.2, Chapter 2.
In areas of high endothelial permeability, LDL penetration would occur. Once
inside the arterial wall, interaction of LDL with free radicals would initiate a
chemical cascade, leading to the formation of oxidised LDL and foam cells. An
illustration of the behaviour of the dierent reactants in the modelled chemical
cascade is given in Figure 4.12.
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Figure 4.11: Apparent permeability (Papp) of endothelium as a function of the
axial location z.
Figure 4.12a shows the chemical cascade leading to the oxidation of LDL. A
xed concentration of 1.323 nmol/L corresponding to the subendothelial LDL
concentration at the global WSS minima after 6 years of simulation time was
imposed as the initial concentration of native LDL (LDL with 6 vitamin E). The
behaviour of the LDL oxidation cascade is in agreement with Cobbold et al.[22].
However, as the change in concentration of the free radicals due to the kinetic
reaction was neglected and free radicals were assumed constant, there is a dierent
time response in the LDL oxidation process compared to the results shown in
Cobbold et al.[22]. The interaction between wall monocytes/macrophages and
oxidised LDL leading to the formation of foam cells is shown in Figure 4.12b.
Foam cell formation and accumulation indicates presence of an inammatory
process. The consequence of this inammatory process would be the formation
of atherosclerotic plaque.
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(a)
(b)
Figure 4.12: (a) Temporal prole of the LDL oxidation cascade. A xed concen-
tration of 1.323 nmol/L was imposed as the initial concentration of LDL with 6
Vitamin E (L6). (b) Temporal prole of foam cell formation; the oxidised LDL
and LDL prone to oxidation are included.
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In the presence of a stenosis (40% radial reduction of lumen), the model
predicts that an initially healthy artery would develop a plaque of maximum
thickness of  h after 6 years (where h is equal to 1% of the artery radius).
The deformation imposed on the CFD mesh to account for plaque formation is
shown in Figure 4.13. The relative error in the mesh displacement was calculated
as:
e =
pI   pII
h
(4.7)
Where pI is the position where the mesh node p was displaced to by Ansys
CfX v14., pII is the analytical displacement that node p should have had following
equations (Equations (3.4) to (3.6)) and h is the displacement in the normal
direction. The minimum error was found to be zero, with a maximum error of
9% for the node where the maximum displacement was applied. This error does
not only arise from computational inaccuracy, but it can be attributed to the
passive displacement of the node considered due to the surrounding nodes being
displaced.
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Flow direction
Total Mesh Displacement                                 [m]
Figure 4.13: Contour plot of a total mesh displacement showing the plaque for-
mation after 6 years. Part of the side view is shown. A zoomed detail of the
geometry side view shows the plaque. The mesh displacement contour plot is not
symmetric. This is most likely due to a non-uniform mesh. Other factors inuenc-
ing mesh displacement could be numerical artifacts linked to mesh-displacement
errors and/or problems related to local minima and dierences in the mesh el-
ements. The ow in the post-stenotic area is not at levels of global linear in-
stability, as the Reynolds Number never reaches the critical value of 722 [140,
141].Although, a transient to turbulent behaviour is still present, leading to local
ow perturbations and dierences in the local minima [141].
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4.2.2.2 Idealised geometry of S-shaped common femoral artery
The haemodynamics for this case can be visualised from the velocity contour plot
in Figure 4.14.
Flow detachment areas are minimal in the lower wall distal and proximal to the
S-shaped curvature, and more prominently in the upper wall, in the area between
the rst bend and the second bend. These ow detachment areas generate a
local decrease in the uid velocity and recirculation areas and local changes in
the endothelial transport properties (Figure 4.15). This is dierent to the case
discussed previously, where a sharp cross-sectional narrowing in the arterial lumen
generated large areas of ow recirculation, the ow recirculation is less severe.
Flow direction
Velocity                                                   [m s^-1]
Figure 4.14: Velocity contour plot for a mid plane. Flow detachment is present in
areas proximal and distal to the double bend in the lower wall. Flow detachment
to the upper wall is present at the end of the rst bend and at the beginning
of the second bend. Boundary conditions: inlet parabolic velocity prole Equa-
tion (4.1), outlet stress free.
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Figure 4.15: Apparent endothelial permeability (Papp) taken at the beginning of
the initialisation cycle as a function of the axial location. The apparent perme-
ability in the upper wall (blue) shows an increase in the area between the two
bends. Two minor increases can be seen in the lower wall (red), in the area distal
and proximal to the double bend. These peaks show areas of local increase in the
endothelial permeability, which can be considered atherosclerosis-prone areas.
For a case in which there are mild changes in the endothelial transport prop-
erties from the normal endothelial behaviour, the simulated atherosclerosis for-
mation would take longer to develop. Starting from a healthy artery, this model
predicts that after 17 years of simulated time, plaque development would occur.
Atherosclerosis formation was modelled further in time and a second atheroscle-
rosis remodelling cycle computed. The contour plot of total mesh displacement
after 17 years and 6 months is visualised in Figure 4.17.
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Figure 4.16: Contour plot of a total mesh displacement showing the plaque for-
mation after 17 years. Top view and side view are shown. A zoomed detail of
the geometry side view shows the plaque.
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Figure 4.17: Contour plot of a total mesh displacement showing the plaque for-
mation after 17 years and 6 months. Top view and side view are shown. A
zoomed detail of the geometry side view shows the plaque.
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4.3 Discussion
The model and workow presented in this thesis show initial concrete steps to-
wards a more ambitious target of developing a patient-specic predicting tool
for atherosclerosis plaque formation and development. To achieve this goal, the
atherosclerosis modelling framework needs to characterise appropriately the pro-
cess of formation of plaque. Disease location, severity and rate of progression are
the three issues central to this study.
Initially, the computational framework was developed for steady-state sim-
ulations. Neglecting the transient aspect of atherosclerosis allowed a simplied
testing model able to link the haemodynamics to the processes behind the forma-
tion of plaque in the arterial wall to be built. The haemodynamics of an idealised
stenotic coronary artery geometry were modelled following the approach of Ol-
gac et al.[83]. The variation of the local endothelium transport properties were
made dependant on the local haemodynamics. The vena-contracta led to the
creation of larger endothelial permeability areas after the stenotic narrowing and
subsequent plaque formation in these areas. This compares well with literature
ndings in the literature which show that atherosclerosis formation usually occurs
downstream of a stenosis[95].
A constant mean blood LDL concentration value was used for each simulation,
neglecting local variations in concentration[142].
Two dierent hyperlipoproteinemic blood LDL levels were implemented. Ar-
terial wall concentration proles were taken at the point of highest endothelial
permeability (z0) to analyse the eect of dierent mean blood LDL concentrations
(Figure 4.6). A higher concentration of LDL in the arterial wall would trigger a
more acute inammatory process, leading to a more severe atherosclerosis forma-
tion[143]. The distribution of LDL inside the arterial wall was consistent with in
vivo[90] experimental results.
Development of atherosclerotic plaque was modelled for the two dierent mean
blood LDL levels. Dierences in plaque formation for the cases analysed show the
dependency of atherosclerosis severity on mean blood LDL levels (Figure 4.8).
The plaques developed in the tract downstream of the stenosis caused a local
variation in the endothelial transport properties. In the initial geometry the
104
maximum local permeability was at the recirculation area caused by the stenosis
(Figure 4.7a and Figure 4.5).As a consequence of plaque formation, haemody-
namics and the endothelial permeability in the location of the newly formed
plaque changed (Figure 4.9). Endothelial permeability to macromolecules also
appeared to have increased further downstream of the plaque formation in the
most severe hyperlipoproteinemia case (Figure 4.9b). This new high endothe-
lial permeability location is linked to the formation of a new local WSS minima
(Figure 4.7b) caused by the plaque formation. To analyse how the atheroscle-
rosis would progress given the change in the haemodynamic environment, a new
simulation was performed. There was a further development in size for the rst
plaque formation for both of the hyperlipoproteinemia cases (Table 4.1). As al-
ready shown by the local increase in endothelial transport properties, a second
plaque developed in the most severe hyperlipoproteinemia case. This result (mul-
tiple stenosis) mimics the several subsequent plaque formations that can be found
in arteries such as the common femoral artery and the popliteal[95].
The development of atherosclerosis with time was modelled in a stenotic
common femoral artery. The relationship between endothelial transport proper-
ties and haemodynamics was represented by a normalised Shape Index Function
Equation (4.6). This SI function allows for a more artery-specic description of
the endothelial behaviour.
Once inside the arterial wall, the LDL starts interacting with free radicals
until full oxidation occurs. The chemical cascade shown in Figure 4.12a shows
the temporal degradation of LDL from its native form (L6) to its fully oxidized
state (Lox). Foam cells start forming after 3 hours from the start of the process
(Figure 4.12b), and are still forming throughout the rst day of the inamma-
tory process. An in vitro experiment showing the time it takes for the lipids
to metabolise inside the macrophage foam cells shows that lipid accumulation is
carried out mainly in the rst 24 hours[144]. This model does not analyse the
lipid accumulation in the macrophages. However, by showing that foam cells
start forming in the rst 24 hours, it indicates a behaviour that is in agreement
with that observed in vitro[144].
A sensitivity analysis was carried out on the parameters involved in the mod-
elling of cytokine activity and foam cell formation rate. The model plaque growth
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was relatively sensitive to these parameters, as shown Appendix B. Further anal-
yses must be conducted on these parameters for validation purposes.
The rst signs of atherosclerosis in the stenotic common femoral artery devel-
oped after 7 years of simulated time (Figure 4.13). The plaque location is in the
area of increased endothelial permeability to macromolecules (Figure 4.11) and
is coherent with the results for the stenotic coronary artery. To the best of the
authors' knowledge, there is no available data in the literature to validate plaque
development for a stenosis of 40% radial reduction, in which a severe haemody-
namic disturbance is present. The same parameters and boundary conditions were
used for the case of the S-shaped geometry. Geometry can be identied as one
of the main risk factors for atherosclerosis[29], as the creation of atherosclerosis-
prone areas is highly dependent on the local haemodynamics. Arterial tortuosity
is among the most common causes of atherosclerosis formation in the periph-
eral arteries[145]. For arterial single curvatures, it has been observed that there
is likelihood for atherosclerosis to form in the inner curvature of the vessel[146,
147]. For a more complex tortuosity like S-shaped curvatures (formed by two sub-
sequent single bends, as shown in Figure 4.2), dierent haemodynamic patterns
from a single curvature would develop, as already investigated in Hoogstraten
et al.[131].
The ow velocity pattern (Figure 4.14) compares well with the study of
Hoogstraten et al.[131]. Analysing the behaviour of the endothelial transport
properties (Papp), there is indication of atherosclerosis-prone areas. These areas
coincide with the inner curvature of the rst bend, comparing well with the nd-
ings by Wood et al.[146] and Smedby et al.[147]. The area of the inner curvature
for the second bend also shows the formation of another, milder, atherosclerosis-
prone area. As previously mentioned, atherosclerosis formation would become
evident in this geometry after 17 years (Figure 4.16). Evidence suggests that
for subjects with no atherosclerotic predisposition, fatty streak formation can be
detected in adolescents and young adults[148, 149].
Another atherosclerosis model cycle was carried out, to follow the atherosclero-
sis development further in time. The threshold IMT growth (h, Equation (3.9))
was reached for this second cycle after 6 months. Whilst the results are in good
agreement with evidence from the literature with regards to the time of develop-
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ment of the rst formation of plaque and for the location of the plaque, the rate
of growth of the plaque developed (corresponding to the time length of the sec-
ond atherosclerosis model cycle) appears to be too fast. Measurements of plaque
thickness from CT scan images taken at periodic time intervals have been carried
out to assess the rate of growth, showing a linear behaviour[150, 151]. This rate of
growth is measured on plaques that are far more developed than the initial fatty
streak formation, with a calcied formation, implying that other factors such as
smooth muscle cells migration might have already played a role[8]. As only the
mechanisms at the base of initial atherosclerosis formation[133] have been consid-
ered in this study, the focus was on producing a proof of concept, i.e., multiscale
computational framework able to simulate the initial stages of plaque formation.
Other mechanisms would have to be introduced to model the development of the
plaque more accurately. Improvements are discussed in the last chapter of this
thesis.
4.4 Conclusion
An initial implementation of the atherosclerosis formation model was carried out
on three dierent idealised geometries roughly corresponding to the characteristics
of human arteries of interest. The eect of local haemodynamics on endothelial
transport was rst observed in a stenotic coronary artery in a steady state regime.
Dierent levels of mean blood LDL were introduced in the simulation, to observe
the role played by LDL as a risk factor. Location of plaque development was
found to be entirely dependent on the haemodynamic pattern; whilst severity
of formation was inuenced by the concentration of LDL in the lumen. Further
analysis was carried out for a transient case and implemented in two dierent
types of common femoral arteries; a stenotic common femoral artery and an S-
shaped common femoral artery. The mean blood concentration of LDL was kept
constant in this analysis. The plaque development in the stenotic common femoral
artery developed much faster than in the latter case, showing how the disturbance
in the haemodynamics inuences both the location of the plaque and the pace
of growth. The haemodynamic behaviour in the S-shaped femoral artery was
more physiological than the stenotic artery, as it was closer to conditions found
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in healthy arteries. The fatty streak in this artery developed at a slower pace than
in the stenotic artery, and it was in good agreement with in vivo observations of
fatty streak formation in young adults[148, 149].
The atherosclerosis plaque development will be implemented in real patient
geometries in the next chapter.
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Chapter 5
Patient Specic Modeling of
Atherosclerosis Formation
The aorta and peripheral arteries are among the prevalent sites for atherosclerosis
formation in the human body[152]. Currently, clinical assessment of peripheral
artery disease (PAD) is based on criteria such as walking distance and Ankle
Brachial Pressure Index (ABPI)[153]. Further investigations that conrm the
diagnosis on patients that showed positive responses to those examinations in-
clude Doppler ultrasound imaging, or more invasive imaging techniques such as
Magnetic Resonance Angiography (MRA) and Computed Tomography Angiog-
raphy (CT Angiography). Usually the patient has to undergo these semi-invasive
procedures at regular time intervals, to monitor the disease progression.
A tool able to predict the prevalence and severity of the disease with only one
initial invasive procedure required would improve the patients' quality of life, and
provide a useful prognostic tool for clinicians.
In this chapter, patient-specic simulations of atherogenesis achieved via im-
plementing the atherosclerosis remodelling cycle (Chapter 3) for one patient are
presented. Dierent locations on the same patient were analysed and are de-
scribed below. Studying only one patient enabled the impact on the model of
other atherosclerosis factors such as genetic predisposition or inter-patient vari-
ability and life-style contrasts between patients to be neglected, and is a useful
proof-of-concept for the methodology and hypotheses proposed in this thesis.
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To describe the haemodynamics of the arterial ow appropriately, anatomical
details and velocities used for the dierent arterial branches were specic for the
patient. Other data, such as mean blood LDL particles and IMT were taken from
gender specic population-averaged data [129, 139, 154].
The patient-specic anatomical geometry data was acquired from multi-slice
computed tomography (MSCT) images obtained from University College London
Hospital (UCLH). Informed consent and approval from the ethical committee
were obtained by the managing clinician (Ethics number: 13/EM/0143). An
approximation of the patient's healthy anatomical state was obtained through
segmentation of the vessel lumen, including the detected calcied plaques. Three
dierent Cases were analysed, each one considering a dierent segment of the
arterial tree (Figure 5.1). Case 1 modelled atherosclerosis in a portion of the
descending aorta together with the two common iliac arteries (CIAs), the external
iliac arteries (EIAs) and internal iliac arteries (IIAs). Case 2 and 3 considered
atherosclerosis in the right and left CFAs respectively, with their descending
branches, the deep femoral arteries (DFAs) and the supercial femoral arteries
(SFAs).
The methodology behind the patient-specic data processing and the simula-
tion setup will be presented here. Results coming from the implementation of the
atherosclerosis model with the real patient data showed formation of atheroscle-
rosis in the segments of the arteries under study. Comparison between the model
identied atherosclerosis-prone areas, the computed atherosclerosis formations
and the calcied plaques detected from MSCT observation showed good agree-
ment. This will be further discussed in the sections below. A brief conclusion
will follow.
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DLeft EIA
Figure 5.1: Diagram of the human circulatory system, with the three arterial
segments considered in the modelled Cases highlighted. The geometries obtained
from MSCT images segmentation are shown together with the names of the dif-
ferent branches.
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5.1 Methods
5.1.1 Image acquisition and processing
A 50 year old male patient was selected for this study. The study was carried
out retrospectively on data stored in the UCLH and the UCL Medical School
database. Two sets of contrast enhanced MSCT angiograms were selected. The
rst set of contrast enhanced MSCT was performed on the abdomen and pe-
ripheral arteries with a SOMATOM Sensation Siemens 64 CT-system (Siemens
Medical Solutions, Forchheim, Germany). An initial non-contrast enhanced scan
was carried out for calcium scoring and plaque detection (Figure 5.2a). The pa-
rameters of the scan were: slice thickness 5 mm for the non-contrast and 1 mm
for the contrast, KVP 120, zero gantry/detector tilt, exposure time 500 ms, x-
ray tube current of 305 mA for the non-contrast and 325 mA for the contrast,
rotation direction CW, patient position FFS, convolution Kernel B30f for the
non-contrast and B31f for the contrast. The second set of MSCT angiogram was
performed 13 months later on the abdomen and peripheral arteries of the patient
for follow up. The second set of contrast enhanced MSCT was performed with
a SOMATOM Sensation Siemens 16 CT-systemy (Siemens Medical Solutions,
Forchheim, Germany). Only the non-contrast scan was analysed for calcium
scoring in comparison with the rst set. The parameters of the non-contrast scan
were: slice thickness 5 mm, KVP 120, zero gantry/detector tilt, exposure time
500 ms, x-ray tube current of 37 mA, rotation direction CW, patient position
FFS, convolution Kernel B30f. The smooth Kernel ltering used (B30f) allowed
for a smaller attenuation of calcium within the tissue, simplifying plaque scor-
ing[155]. A sample slice of the rst set of MSCT showing vessel lumen resolution
with application of contrasting agent (a) and without contrast (b) is shown in
Figure 5.2.
The data coming from the MSCT Angiography was stored following Digital
Imaging and Communication in Medicine (DICOM) standards and image pro-
cessing was carried out with the help of the image processing software ScanIPz
http://www.healthcare.siemens.co.uk
yhttp://www.healthcare.siemens.co.uk
zhttp://www.simpleware.com/software/scanip
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(a) (b)
Figure 5.2: MSCT angiogram transverse slice of the same section taken with (a)
contrasting agent and (b) no contrasting agent. The descending aorta can be
visualised (red square). The lumen is highlighted with white colour (contrast-
ing agent) in slice (a). The lumen is still visible when no contrasting agent is
present but is not dierentiated from the surrounding tissue. A calcied plaque
of the descending aorta can be visualised in slice (b). The plaque is shown as
a white formation on the left hand side of the lumen. The calcied plaque can
be visualised clearly when no contrasting agent is present (b), the plaque is not
detectable in slice (a).
(Simpleware Ltd, UK). ScanIP is image processing software designed for visualis-
ing and segmenting MSCT angiogram images (and other types of medical images
supported by the software) to create 3D representations of the regions of interest.
The image processing carried out in Scan IP to obtain a 3D reconstruction of
the geometries used in this study is described in the following section, together
with a brief introduction to MSCT angiogram imaging.
5.1.1.1 Image processing
Computed tomography is a medical imaging technique used to generate three-
dimensional (3D) images of internal body structures. To generate the images the
patient is exposed to a series of x-ray beams. These rays are detected by a digital
x-ray detector. The x-ray source and detector are placed on the diametrically
opposite sides of the device (Figure 5.3b) and the patient is placed in the centre.
In conventional CT scanning, the source and the detector are rotated around the
body and for each gradient of rotation an x-ray image is generated and stored.
In MSCT, also known as helical (spiral) CT scanning, the x-ray beam rotates
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tracing a helix of raw data. Each rotation generates data specic to an angled
plane of section. The data is interpolated to give the estimated value in the axial
plane[156].
As dierent materials absorb the x-rays dierently, based on x-ray absorption
the scanner can dierentiate among dierent materials in the body such as cal-
cium and soft tissue. This dierentiation is however less clear when capturing
similar materials like dierent tissue types, making arterial anatomy within the
body dicult to detect. An intra-arterial contrast agent is used to highlight the
arterial lumen and to visualise the arterial anatomy of interest.
(a) (b)
Figure 5.3: (a) Computer tomography machine (Image after: http:
//www.merckmanuals.com/home/special_subjects/common_imaging_tests/
computed_tomography.html). (b) The patient is in a supine position and is
passed through a circular hollow section, where the x-ray source and x-ray
detector are located (Image after Zhang et al.[157]).
The projected x-ray image represents a very thin transverse slice of the body
scanned. As the CT image corresponds to a thickness, the pixel used to represent
the image has a thickness as well, becoming a volumetric element. The elements
composing a CT image are volumetric pixels, also called voxels.
A CT slice image is pictured in a grey-scale (Figure 5.2) with dierent colour
intensity corresponding to dierent materials detected inside the scanned body.
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5.1.1.2 Image segmentation
An initial selection of the images to be processed in ScanIP for further analy-
sis was performed on the contrast MSCT slices at hand. The stack of images
corresponding to the area of interest (from the kidneys to the femoral heads)
was cropped and selected. This initial data selection was performed to ease data
handling by neglecting the regions of no interest.
A threshold segmentation algorithm was used on the selected stack of images
to create a mask. A mask reconstructs the 3D geometry of the object represented
in the MSCT angiogram. The threshold segmentation is achieved based on the
greyscale intensity. The greyscale intensity is a dening criterion that allows
dierent objects to be identied and selected separately, based on their shade of
grey. As the grey-scale intensity selected was for a pixel close to white colour,
the bones and the arterial lumen (where the contrast agent is located, showed in
white in the MSCT), together with the calcied portion of the arterial lumen,
are selected on the MSCT images. These elements now belong to the same mask,
as opposite to the rest of the elements in the MSCT scan that belong to the
background data.
After the rst segmentation, the MSCT image is processed further. The
arterial lumen of interest is selected by applying the ood ll segmentation tool
(ScanIP, Simpleware Ltd., UK) on a pixel belonging to the arterial lumen. This
is a region growing algorithm that selects the areas to ll on a similarity and
connectivity based criterion. The ood ll would select all the pixels connected to
the selected one (seed point) with the same grey-scale intensity. A mask with one
continuous structure of the arterial lumen is created (Figure 5.4). Morphological
lters and cavity ll lters are applied to the new mask to delete object mistakenly
captured by the ood ll segmentation, and to ll up the internal gaps that might
be present in the arterial lumen mask.
To reduce image noise and remove artefacts from the handled data, a recursive
Gaussian smoothing lter[158] is applied to the mask. The result of these mask
manipulations is a smooth uniform and homogeneous representation of the 3D
geometry of the arterial tree segment of interest(Figure 5.5a).
Region growing algorithm is a region-based segmentation method. The region to be seg-
mented is dened through the selection of an initial \seed point" within it.
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To create the geometry of Case 1 (Figure 5.1); the descending aorta with the
two CIAs, EIAs and IIAs, a further geometry manipulation was needed. The
descending aorta was aected by atherosclerosis formation proximal to the right
CIA, preventing the contrast agent from highlighting this segment (Figure 5.4). In
order to re-create the arterial geometry before the occurrence of any disease, and
as a rst approximation for this proof-of-concept, this tract of the iliac artery was
reconstructed manually. Reconstruction of the right common iliac was performed
using the paint tool (ScanIP, Simpleware Ltd., UK) in ScanIP. This tool allows
individual voxel handling on each slice of the MSCT scan. Manual voxel selection
was done on each MSCT slice following the boundary of what was identied to be
the right CIA lumen. Figure 5.4a shows a CT angiogram transverse slice of the
right and left CIAs (Figure 5.1). The lumen of the left CIA is shown in golden
colour. This is the mask created with the ood ll threshold segmentation. The
red mask in the MSCT image is the lumen of the right CIA. This was the lumen
reconstructed using the paint tool. The entire anatomy of the patient descending
aorta with the two CIAs, EIAs and IIAs was reconstructed (Figure 5.4b).
The three geometries obtained from the processed MSCT images are re-
constructions of the arterial lumen anatomies before the development of the
atherosclerosis formation. An approximation of the geometry of the patent lumen
is attained by including the portion of the lumen with the calcied plaque in the
geometry reconstruction. It is acknowledged that there are limitations to this
approach and these will be discussed in this chapter.
The geometries are exported from ScanIP and meshed in Ansys ICEM CFD
software (Ansys, Inc., Canonsburg, PA) for 3D ow simulation.
5.1.1.3 Generation of a Computational Mesh for a Real Patient Ge-
ometry
Ansys ICEM CFD is a mesh generator and mesh optimisation tool that allows the
acquisition and processing of very complex geometries. The geometries generated
in ScanIP were edited in Ansys ICEM CFD to optimise mesh creation for the
CFD analysis.
http://www.ansys.com/Products/Other+Products/ANSYS+ICEM+CFD
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(a) (b)
Figure 5.4: (a) MSCT angiogram transverse slice showing the two CIA lumen.
Coloured in golden colour is the mask given by the region growing threshold. The
red lumen was manually selected as no contrast agent was present in this portion
of the artery. (b) The 3D geometry of the mask is shown. The red portion is
the right CIA manually added. The dashed line shows the position of the MSCT
slice.
The geometry had to be modied to apply ow boundary conditions. The
edges representing the nal tract of the dierent branches did not originally have
sharp edges suitable for imposing ow boundary conditions. Using Ansys ICEM
CFD cutting tools, surfaces normal to the ow were generated at the inlet and
outlets of the geometry.
In the atherosclerosis model developed, the endothelial transport changes to
the local WSS is artery-specic, as explained in Chapter 2, Section 2.1.2. The
endothelial reaction to the local WSS was tuned according to the artery haemody-
namics, given its lumen diameter and mean blood velocity. The dierent arteries
in the anatomical section considered were selected allowing for the application
of artery-specic transport properties. Cutting tools were used to separate each
branch from the rest of the geometry (Figure 5.5b). Geometry selection of the
individual arterial branches allows an artery-specic approach.
As the inlet boundary prole did not present a regular circular surface, an
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articial inlet was created to impose parabolic ow velocity at its boundary. A
circular surface normal to the inlet was created upstream from the real inlet. The
loft surface over several curves (ScanIP, Simpleware Ltd., UK) tool was used to
create a surface linking the circular surface and the real inlet. This inlet pipe
created would gently modify its cross section from the perfectly circular prole
of the circular surface to the irregular prole of the real inlet (Figure 5.5c). The
circular surface was used as the new inlet of the arterial geometry. The same
approach of creating a cylindrical prolongation to the arterial inlet has been used
in Antiga, Selimovic et al.[159, 160].
An initial volumetric robust Octree mesh of the geometry was created. Prism
layersy were added at the wall boundary for a rened mesh structure. A tetrahe-
dral mesh was then generated with the Delaunayz method. This type of algorithm
requires a parent mesh to generate a new mesh. The new mesh retains the same
characteristics imposed to the parent mesh. The Delaunay is a robust and fast
method to generate high quality meshes.
The Delaunay mesh was processed for quality checking and smoothing.
5.1.1.4 Plaque scoring and segmentation
Plaque scoring was performed on non-contrast MSCT slices in conjunction with
Mr O. Agu, consultant general vascular and endovascular surgeon at UCL Hospi-
tals. The rst set of MSCT angiogram showed relatively patent common femoral
arteries with atherosclerosis formation in the descending aorta and left and right
CIAs. The records show that the second set of MSCT angiograms were performed
13 months later on the abdomen and peripheral arteries of the patient for follow
up. There was no evidence of newly formed calcied lesions. The calcied plaques
detected were segmented manually (Figure 5.6a) and highlighted with a mask of
contrasting colour(Figure 5.6b). The 3D geometry of the lumen appears then
The Octree mesh method is a meshing algorithm allowing for faster computation. The
mesh is not uniformly rened, larger elements are maintained, and renement is performed
only where necessary[161]
yPrism layers are added at the boundaries to improve mesh quality near the walls.
zThe Delaunay method is a mesh generating algorithm needing an existing surface mesh.
Based on Delaunay tetra mapping, this algorithm increases the mesh renement maintaining a
high speed of computation[161]
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(a) (b) (c)
Figure 5.5: Geometry of the descending aorta with the two CIAs, EIAs and IIAs
showing the meshing process in Ansys ICEM CFD (Ansys, Inc., Canonsburg,
PA). (a) The geometry coming from CT segmentation is cut at the extremities
to create inlet/outlet boundaries. (b) The dierent arterial branching are then
selected. (c) An articial inlet of circular cross section is added upstream of the
geometry inlet, and a volumetric mesh of the geometry is created.
with plaques of contrasting colour, allowing for better visualisation of the disease
(Figure 5.6c). The 3D geometry of the artery (with the highlighted plaques) for
each one of the arterial segments considered will be shown in the results section
of this Chapter.
5.1.1.5 Velocity data acquisition and processing
The velocities shown in the patient's records were taken with Doppler echocar-
diography at the time of the second MSCT angiogram and these were used for
the simulations as there are no velocity recordings for the patient's rst check-up.
Being a retrospective study, only data already available were used. To obtain an
approximation of the mean velocities values, the velocity prole images for the
arteries of interest were selected from the Doppler echocardiography report.
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Extraction of data from the images was carried out using Image J, an open
source tool for the analysis of scientic images, and MATLAB. The velocity prole
was extracted from the Doppler echocardiography report using the Image J plot
analysis tool plot prole. The coordinates of the dierent points of the velocity
function were extracted; conversion was applied to express the grey-scale intensity
in terms of velocity value and the distance (in pixels) in terms of the time period.
The extracted velocity curve was then processed in MATLAB. The mean velocity
was obtained by integrating the velocity curve over its time period. Figure 5.7
shows the process of the velocity prole acquisition performed from the Doppler
echocardiography images.
Having introduced the general methodology employed for real patient data
acquisition and processing, the patient-specic atherosclerosis modelling cases
developed in this study (Figure 5.1) will be presented in more detail.
For the three patient-specic atherosclerosis simulations (Cases 1-3, Figure 5.1),
the boundary conditions and implementation settings for the CFD arterial lumen
model, the transport model and the biochemical model are the same as the ones
used for the transient simulation of the idealised common femoral artery (Chapter
4, Section 4.1.2).
http://rsb.info.nih.gov/ij/
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(a) (b)
(c)
Figure 5.6: Plaque scoring. Detail of a MSCT slice of the descending aorta
(already shown in Figure 5.2). (a) The calcied plaque contour is highlighted
with a black line. (b) The plaque is painted with a contrasting colour (light blue)
from the arterial lumen (purple). (c) Geometry of the descending aorta with the
two CIAs, EIAs and IIAs showing segmented plaques in contrasting colour.
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(a)
(b)
(c)
Figure 5.7: Velocity prole acquisition from Doppler echocardiography images.
The velocity prole, shown in the red box (a) was extracted with ImageJ (b) and
then processed in Matlab (c).
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5.1.2 Case 1: Model of the Descending Abdominal Aorta
with the two common iliac arteries (CIAs), the ex-
ternal iliac arteries (EIAs) and internal iliac arteries
(IIAs)
5.1.2.1 Geometry specications and computational implementation
The geometry of the descending aorta with the two common iliac arteries, the
external iliac and internal iliac arteries created from the segmentation of the rst
set of MSCT scan is shown in Figure 5.8.
Figure 5.8: Geometry of the descending aorta with the two common iliac arteries,
the external iliac and internal iliac arteries.
The geometry encloses the patent lumen and the calcied plaques. The right
common iliac artery has been articially re-created to simulate a virtually disease-
free vessel. The area of the real inlet of the descending aorta is A0 = 2:96 10 4
m2 and the area of the added inlet pipe is Ainlet = 4:522 10 4 m2. A parabolic
velocity prole (Equation (4.1)) was imposed at the inlet of the aorta. The mean
velocity for the descending aorta extracted from velocity recording taken with
Doppler echocardiography at the time of the second MSCT angiogram was used.
The mean velocity for the descending aorta was U0 = 24:574 cm s
-1. The mean
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velocity imposed at the inlet of the added pipe (U) was calculated according to
the radial dimension of the added inlet pipe using ow conservation law:
U = U0
A0
Ainlet
(5.1)
Three segments of the geometry were considered for atherosclerosis modelling,
i.e., the descending aorta and the left and the right common iliac arteries. From
MSCT plaque scoring these segments emerged to be the ones with atherosclerosis
formations(Figure 5.9). Simulations were carried out separately on each of the
dierent segments. To use an artery-specic approach, the Poiseuille wall shear
stress was calculated for each segment (Equation (2.4)). The left common iliac
and right common iliac inlet cross sectional areas were measured to be A0;leftCIA =
5:47  10 5 m2 and A0;rightCIA = 9:95  10 5 m2. The mean ow velocities for
these two branches could not be retrieved from the Doppler echocardiography
data available, as the lumen occlusion in the right common iliac branch disturbed
the haemodynamics, making the velocity recordings not t for purpose. The left
common iliac and right common iliac mean ow velocities were approximated
using Ansys CfX Post v.14 as U0;leftCIA = 0:267 m s
-1 and U0;rightCIA = 0:354
m s-1. The inlet information such as cross sectional area and mean velocity
allowed for the Poiseuille WSS for each of the considered arterial segments to be
calculated. The resulting Poiseuille WSS was 0 = 0:3553 Pa for the descending
aorta, 0 = 0:683 Pa for the left common iliac artery and 0 = 0:88 Pa for the
right common iliac artery. This Poiseuille WSS was used as 0 in Equation (2.5)
allowing for the endothelial response to local WSS to be artery-specic (Chapter
2, Section 2.1.2.1).
5.1.2.2 Fluid domain discretisation
The Ansys ICEM CFD mesh for Case 1 was a Delaunay unstructured mesh
with prismatic layers at the wall boundary for increased resolution. A grid in-
dependence study showed that a mesh with 6,972,969 elements was suitable to
accurately describe the uid dynamics in the portion of the artery considered.
The dierence in the computed WSS values between meshes was calculated as a
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relative error (e):
e =
WSSfiner(z) WSScoarser(z)WSSfiner(z)
 (5.2)
where WSS is the local value of WSS , z is the spatial location and finer
and coarser is the coarsness of the meshes compared. Between the nest con-
sidered grid (10 million elements) and the chosen grid the calculated maximum
relative error was 2.4%. Details of the grid independence study carried out using
Equation (5.2) are shown in Appendix C.
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Figure 5.9: MSCT segmented geometry of the Model of the descending aorta
with the two common iliac arteries, the external iliac and internal iliac arteries.
The atherosclerotic plaques are segmented in contrasting colour (light blue) from
the patent lumen (purple). The detected plaques are numbered.
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5.1.3 Case 2: Model of the Right Common Femoral Artery
(CFA), with the Deep Femoral Artery (DFA) and
the Supercial Femoral Artery (SFA)
5.1.3.1 Geometry specications and computational implementation
The segmented patent lumen geometry of the right common femoral artery, with
the deep femoral artery and the supercial femoral artery is shown in Figure 5.10.
Figure 5.10: Geometry of the right common femoral artery, with the deep femoral
artery and the supercial femoral artery.
The area of the CFA inlet was A0;rightCFA = 3:610 5 m2 and the area of the
inlet added pipe was Ainlet = 5:67  10 5 m2. Mean velocity for the right CFA
as extracted from Doppler echocardiography velocity recordings was U0 = 0:3516
m s-1. Flow continuity was applied to calculate the mean velocity at the added
inlet pipe.
MSCT plaque scoring was carried out on the right CFA, with the DFA and the
SFA. As shown in Figure 5.11, a plaque formation was detected at the initial seg-
ment of the deep femoral artery. The reduced dimensions of the vessel considered
and the low level of calcication in the arterial wall among other factors, made
the plaque scoring results uncertain. For comparison with in vivo observations, a
simulation of atherosclerosis formation was performed in the deep femoral artery.
For the artery-specic endothelial transport model, the mean ow velocity
U0;rightDFA = 0:104 m s
-1 and the cross sectional area A0;rightDFA = 1:27  10 5
m2 for the deep femoral artery were extracted from CfX Post v.14. The calculated
Poiseuille WSS was 0 = 0:724 Pa.
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5.1.3.2 Fluid domain discretisation
The Ansys ICEM CFD mesh for Case 2 was a Delaunay unstructured mesh with
prismatic layers at the wall boundary for increased resolution. The mesh chosen
for this study was of 1,215,885 elements, as there were negligible dierences in
the haemodynamics solution when compared with a ner grid. There was a
maximum error of 3% between the computed WSS in the nest considered grid
(1.9 million elements) and the chosen grid calculated using Equation (5.2). The
grid independence study is shown in Appendix C.
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Right CFA
Right DFA
Right SFA
Figure 5.11: MSCT segmented geometry of the model of the right common
femoral artery, with the deep femoral artery and the supercial femoral artery.
The atherosclerotic plaque is segmented in contrasting colour (light blue) from
the patent lumen (purple). The detected plaque is numbered.
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5.1.4 Case 3: Model of the Left Common Femoral Artery
(CFA), with the Deep Femoral Artery (DFA) and
the Supercial Femoral Artery (SFA)
5.1.4.1 Geometry specications and computational implementation
The geometry of the disease-free segmented lumen of the left common femoral
artery, with the deep femoral artery and the supercial femoral artery is shown
in Figure 5.12.
Figure 5.12: Geometry of the left common femoral artery, with the deep femoral
artery and the supercial femoral artery.
The inlet area of the left CFA was A0;leftCFA = 6:0910 5 m2, with a surface
area of the inlet added pipe of Ainlet = 7:84 10 5 m2.
The mean velocity for the left CFA as extracted from Doppler echocardio-
graphy recordings was U0 = 0:207 m s
-1. Flow continuity (Equation (5.1)) was
applied to calculate the mean velocity at the inlet of the added pipe. The endothe-
lial response to the local WSS values was tuned with the calculated Poiseuille law
WSS for the left CFA, given the inlet radial dimension and the mean ow velocity.
The Poiseuille WSS was calculated to be 0 = 0:657 Pa.
MSCT plaque scoring was carried out on the arterial segment of the left CFA
with the DFA and the SFA as shown in Figure 5.13. The lesions identied were
in the left CFA. As for Case 2, given the small extent of calcication detectable
in the MSCT images, there is uncertainty in the plaques detected and segmented.
Atherosclerosis formation was analysed in the model of the left CFA.
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5.1.4.2 Fluid domain discretisation
The uid domain of the left CFA, with the DFA and the SFA was meshed with
Ansys ICEM CFD. The mesh created was a 1,111,901 elements Delaunay unstruc-
tured mesh with prismatic layer at the wall boundary for increased resolution.
The dierence (Equation (5.2)) in the calculated WSS between the nest con-
sidered grid (1.9 million elements) and the considered grid was 3.1%. The grid
independence study for this geometry is showed in Appendix C.
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Left CFA
Left DFALeft SFA
Figure 5.13: Geometry of the model of the left common femoral artery, with
the deep femoral artery and the supercial femoral artery. The atherosclerotic
plaques are segmented in contrasting colour (light blue) from the patent lumen
(purple). The detected plaques are numbered.
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5.2 Results
5.2.1 Case 1: Simulation Results
As discussed in Chapter 2, WSS governs the endothelial transport property of
macromolecules in this model. The WSS pattern for Case 1 is shown in Fig-
ure 5.14. Whilst areas of high WSS are evident, areas of interest for atherosclero-
sis formation are not highlighted. A rescaled plot of the WSS in the descending
aorta, aiming to better dierentiate the areas of low WSS is shown in Figure 5.15.
The maximum limit of this re-scaled plot is set as the Poiseuille WSS value for
a pipe with the same radial dimensions and ow inlet velocity of the descending
aorta (Table 5.1). The areas of WSS equal or above the Poiseuille value are not
dierentiated as these are the areas with normal endothelial behaviour. On the
contrary, areas below the Poiseuille WSS value are visible and local minima of
WSS are highlighted, showing potential pro-atherogenic areas. To highlight the
artery-specic pro-atherogenic areas, a re-scaled WSS contour was plot for each
artery separately (Figures 5.15 to 5.17). For each artery the Poiseuille WSS value
(Table 5.1) was set as the maximum value in the corresponding re-scaled contour
plot.
The most severe atherosclerosis formation in the descending aorta would reach
the threshold level of h (equal to 1% of the considered artery radius) after 16
years and 8 months, concluding the rst atherosclerosis remodelling cycle for the
descending aorta. Careful consideration must be given to the meaning of the
time indication of atherosclerosis formation in these simulations. The anatomi-
cal features were extracted from an adult patient and it was assumed that the
arterial tree of the patient would reach full anatomical development in 18 years,
without presenting any atherosclerosis formation, and with arterial lumen and
an arterial wall fully patent. Following this, the model estimates the patient
will have early atherosclerosis lesion formation in around 34 years and 8 months.
The most severe atherosclerosis formation for the left common iliac and the right
common iliac would reach the respective threshold value h after 16 years and
11 months and 16 years and 10 months, also corresponding to 34 years and 11
months and 34 years and 10 months respectively. The plaque formation in the
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Table 5.1: Case 1 summary. The results of MSCT plaque scoring segmentation
for each modelled artery, together with the mean blood velocity (U0) and the
calculated Poiseuille WSS (0) are given.
Case 1 In vivo detected plaques U0 [ms
-1] 0 [Pa]
Descending
Abdominal
Aorta
1
2
34
2
0.24574 0.3553
Left CIA
7
8
0.267 0.683
Right CIA
5
6
0.354 0.88
descending aorta, the left common iliac artery and the right common iliac artery
can be visualised in Figures 5.18 to 5.20. Here the mesh displacement contour
plots are shown, indicating areas where the mesh nodes were displaced to account
for plaque formation. Plaque development corresponds to areas of local haemody-
namic perturbations. Figure 5.21 shows the ow velocity cross sectional contour
plots before the atherosclerosis formation at the location where the plaque will
develop. The contour plots are numbered and are shown inside the geometry
and zoomed-in on the side of the geometry. The plaque formations (Figures 5.18
to 5.20) correspond to the areas of local ow velocity decrease. Comparison be-
tween modelled atherosclerotic formations (Figures 5.18 to 5.20) and the plaques
observed in vivo (Figure 5.9) shows partial agreement. Some of the plaques
developed in the model were not detected from MSCT plaque scoring. Further-
more some of the plaques shown in the MSCT plaque scoring were not developed
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during the simulation. However, as shown in the re-scaled WSS contour plots
for the three dierent arteries (Figures 5.15 to 5.17), all the plaques found in
the MSCT plaque scoring would correspond to areas that were highlighted as
atherosclerosis-prone.
Figure 5.14: Model of the descending aorta with the two common iliac arteries,
the external iliac and internal iliac arteries global WSS contour plot.
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(a) (b)
(c) (d)
Figure 5.15: Re-scaled WSS contour plot of the descending aorta. The plot
maximum WSS detectable is the Poiseuille WSS for the descending aorta 0 =
0:3554 Pa.
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(a) (b)
(c) (d)
Figure 5.16: Re-scaled WSS contour plot of the left common iliac artery. The
plot maximum WSS detectable is the Poiseuille WSS for the right common iliac
artery 0 = 0:68 Pa.
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(a) (b)
(c) (d)
Figure 5.17: Re-scaled WSS contour plot of the right common iliac artery. The
plot maximum WSS detectable is the Poiseuille WSS for the left common iliac
artery 0 = 0:88 Pa.
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Figure 5.18: Mesh deformation contour plot for the descending aorta with the two
common iliac arteries, the external iliac and internal iliac arteries. Plaques occur-
rence was modelled solely in the descending aorta. Areas of mesh displacement
indicate plaque formation.
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Figure 5.19: Mesh deformation contour plot for the descending aorta with the
two common iliac arteries, the external iliac and internal iliac arteries. Plaques
occurrence was modelled solely in the left common iliac artery. Areas of mesh
displacement indicate plaque formation.
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Figure 5.20: Mesh deformation contour plot for the descending aorta with the
two common iliac arteries, the external iliac and internal iliac arteries. Plaques
occurrence was modelled solely in the right common iliac artery. Areas of mesh
displacement indicate plaque formation.
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Figure 5.21: Surface velocity contour plots at the location of plaque development
for the descending aorta with the two common iliac arteries, the external iliac
and internal iliac arteries. The contour plots are shown in the geometry, and their
enlarged cross-section view is showed separately. The numbers link the contour
plots in the geometry with the separate cross section view. The picture is not
shown not to scale.
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5.2.2 Case 2: Simulation Results
The velocity streamlines for blood ow in the right CFA and its branching arteries
are shown in Figure 5.22. There is a large dierence in the volumetric blood
ow and local ow velocity between the DFA and SFA. This dierence in the
haemodynamics between the branches arteries underlines the need for an artery-
specic endothelial response to local WSS. A globally dened endothelial response
to local WSS would lead to consider the entirety of the DFA as atherosclerosis-
prone, given the lower ow velocity detected here. The global WSS contour plot
is shown in Figure 5.23. The re-scaled WSS plot for the deep femoral artery, using
the Poiseuille WSS value (Equation (2.4) and table 5.2) for a straight pipe with
the same inlet velocity and radial dimensions of the artery is shown in Figure 5.23.
The identied plaque in the MSCT plaque scoring (Figure 5.11 and table 5.2) is
identied in the contour plot as an area of low WSS.
Table 5.2: Case 2 summary. The results of MSCT plaque scoring segmentation
for the modelled artery, together with the mean blood velocity (U0) and the
calculated Poiseuille WSS (0) are given.
Case 2 In vivo detected plaques U0 [ms
-1] 0 [Pa]
Right SFA 0.104 0.724
The simulation shows that the patient would develop atherosclerosis in the
DFA after 20 years and 5 months, starting from a point in which the anatomical
characteristics of the patient would not in principle change in time (as discussed
for Case 1). Figure 5.24 shows the mesh deformation contour plot for the deep
femoral artery showing plaque formation. Only one plaque is present in the seg-
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ment proximal to the artery bifurcation. From MSCT observation (Figure 5.11),
a plaque formation in this area was not evident.
Figure 5.22: Velocity streamlines for the model of the right common femoral
artery, with the deep femoral artery and the supercial femoral artery.
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Figure 5.23: Global WSS contour plot for the model of the right common femoral
artery, with the deep femoral artery and the supercial femoral artery.
Figure 5.24: Re-scaled WSS contour plot of the right deep femoral artery. The
plot maximum WSS detectable is the Poiseuille WSS for the right deep femoral
artery 0 = 0:724 Pa
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Right DFA
Figure 5.25: Mesh deformation contour plot for the right common femoral artery,
with the deep femoral artery and the supercial femoral artery. Plaques occur-
rence was modelled solely in the deep femoral artery. The contour plot of mesh
displacement indicates the area where the nodes were displaced to model the
plaque formation.
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5.2.3 Case 3: Simulation Results
Velocity streamlines are shown in Figure 5.26. The area of the common femoral
artery (Figure 5.1 and table 5.3) proximal to the bifurcation with the deep femoral
artery shows ow detachment. Plaque 3 observed in vivo (Figure 5.13) is located
in this area of ow detachment. The re-scaled WSS plot for the common femoral
artery, scaled with the maximumWSS as the Poiseuille WSS value (Table 5.3) for
the same radial dimension and mean inlet ow velocity is shown in Figure 5.27.
The small artery branching out of the CFA was not considered in the simulation.
From this plot, two main atherosclerosis-prone areas emerge in the CFA, the area
distal to the DFA and an area distal to the small artery branching out of the
CFA.
Table 5.3: Case 3 Summary. The results of MSCT plaque scoring segmentation
for the modelled artery, together with the mean blood velocity (U0) and the
calculated Poiseuille WSS (0) are given.
Case 3 In vivo detected plaques U0 [ms
-1] 0 [Pa]
Left CFA 1
2
3
0.207 0.657
Atherosclerosis growth was simulated for the CFA, and after 20 years and 9
months (starting from the developed artery), an atherosclerosis formation was
shown. This can be seen in the mesh deformation contour plot Figure 5.28. The
simulated atherosclerotic plaque formed in one of the areas that the re-scaled
WSS contour plot showed as pro-atherogenic. This plaque does not precisely
correspond to what was detected from MSCT plaque scoring; however, it could
be representing plaque 1 (Figure 5.13) in a more distal location.
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Figure 5.26: Velocity streamlines for the model of the left common femoral artery,
with the deep femoral artery and the supercial femoral artery.
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(a) (b)
(c) (d)
Figure 5.27: Re-scaled WSS contour plot of the left common femoral artery. The
plot maximum WSS detectable is the Poiseuille WSS for the left common femoral
artery 0 = 0:6572 Pa.
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Left CFA
Figure 5.28: Mesh deformation contour plot for the left common femoral artery,
with the deep femoral artery and the supercial femoral artery. Plaques occur-
rence was modelled solely in the left common femoral artery. The area of mesh
displacement indicates the plaque formation.
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5.3 Discussion
The in silico atherosclerosis formation framework developed in this thesis and
described in Chapters 2-4 was used to simulate patient-specic plaque formation
in a proof-of-concept model. The patient-specic anatomical data were obtained
from MSCT angiogram images. Doppler echocardiography images were used to
calculate ow time-averaged mean velocities. The patient selected for this study
had atherosclerosis formations in the peripheral arteries. Having a patient that
already had developed the disease allowed for comparison between the simulations
and in vivo observations in order to test the framework, establish its viability and
qualitatively validate the results.
Three cases with dierent sections of the patient's arterial tree were considered
and arterial lumen geometries were segmented from MSCT images. To obtain
the characteristics of the lumen geometry before disease occurrence, the plaques
detected were segmented together with the free lumen. In Case 1, the right
common iliac artery was articially re-created as stenosis blockage prevented the
MSCT contrast agent from identifying it.
An artery-specic approach was used to model the endothelial transport re-
sponse to local WSS. Two dierent types of WSS contour plots were used to
analyse the haemodynamics in the modelled arteries. The areas of high WSS
could be analysed with a global WSS contour plot (Figures 5.14 and 5.23). How-
ever, this plot would not highlight the areas of low WSS (of more interest for this
analysis as potentially prone to atherosclerosis). An artery-specic WSS contour
plot was developed re-scaling the global WSS contour plot, by setting the maxi-
mum WSS as the calculated Poiseuille WSS value for a pipe with the same cross
sectional dimension and mean ow velocity of the artery considered (Tables 5.1
to 5.3).
The geometries of the three sections with highlighted segmented plaques (Fig-
ures 5.9, 5.11 and 5.13) show a good agreement with the pro-atherosclerosis ar-
eas highlighted by the WSS re-scaled contour plots (Figures 5.15 to 5.17, 5.24
and 5.27) as shown in Table 5.4. All the plaques detected in the MSCT corre-
spond to areas of low WSS with the exception of plaque 2 (Figure 5.13) in the
left common femoral artery (Figure 5.27).
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Table 5.4: Summary of the in vivo observed plaques together with the model
diagnostic indices (the MSCT images with the segmented plaques are Figure 5.9
for Case 1, Figure 5.11 for Case 2 and Figure 5.13 for Case 3). Two diagnostic
atherosclerosis indices were used to assess the agreement with in-vivo observations
: plaque in highlighted atherosclerosis-prone areas (the modelled WSS pattern
showed atherosclerosis-prone areas corresponding to the location of the in-vivo
observed plaque) and plaque simulated by the model (a modelled plaque devel-
oped in the location of the in-vivo observed plaque).
Case Artery Plaque
observed in
MSCT
images
Plaque in
highlighted
atherosclerosis-
prone
areas
Plaque
simulated
by the
model
Case 1
Descending abdominal
aorta
1,2,3 X X
4 X X
Left CIA
7 X X
8 X 
Right CIA 5,6 X 
Case 2 Right DFA 1 X 
Case 3 Left CFA
1 X X
2  
3 X 
As already discussed in the previous chapter, areas of low WSS are caused by
a local decrease in the ow velocity (Figure 5.21), leading to a local increase in the
transport properties of the endothelium and the creation of pro-atherogenic areas.
Velocity Contour Plots 1 and 4 (Figure 5.21), show the velocity behaviour and
arterial cross section at the location of Plaque f (Figure 5.18) that did not cor-
respond to the observations in vivo (Contour Plot 1) and Plaque a (Figure 5.18)
that did correspond to a plaque observed in vivo (Contour Plot 4) (Plaque 2,
Figure 5.9). A local decrease in the ow velocity caused by the distal bifurcation,
leads to the formation of Plaque a (Contour Plot 4, Figure 5.21). On the con-
trary, Contour Plot 1 shows a local velocity decrease caused by an irregularity in
the artery cross sectional shape. Errors in the segmentation of MSCT geometry
can lead to the creation of geometric artefacts, altering the haemodynamics in
the artery simulated. Atherosclerotic Plaque f (Figure 5.18) occurred in the lo-
cation corresponding to velocity Contour Plot 1 (Figure 5.21), possibly generated
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by poor resolution in the MSCT images of the contrast lumen. As WSS values
are dependent on both haemodynamics and lumen geometry, poor image quality
can lead to the creation of \articial" plaques. Together with the geometry, mesh
quality has a large impact on the plaque formation. In case of the highly irregular
patient-specic geometries, the impact that sharp dierences in the local WSS
minima and the eect that mesh elements have on the mesh deformation have
been addressed up to a point; they have been minimised using WSS averages
within the considered pro-atherogenic areas.
The simulation results of Case 1 show six plaques in the descending aorta,
ve plaques in the left CIA and two plaques in the right CIA. Of the plaques
developed, three plaques in the descending aorta (a, b and e. Figure 5.18) closely
correspond to Plaques 1, 2 and 3 observed in vivo (Figure 5.9). Plaque f (Fig-
ure 5.19) developed in the left CIA approximately corresponds to Plaque 7 (Fig-
ure 5.9). None of the plaques developed in the recreated right CIA correspond
to the plaques observed in vivo. For this artery, the WSS pattern does not show
atherogenic areas precisely in the location where the plaques are observed in vivo.
The area of low WSS appears at the same longitudinal location but more towards
the inner side of the bifurcation. A WSS pattern dierence due to boundary con-
ditions and simulation settings might cause this error. Furthermore, as the right
CIA artery lumen was manually reconstructed, it is possible that the segmenta-
tion could not precisely capture the anatomy of the artery leading to an incorrect
reproduction of the artery patent lumen.
Case 2 showed the development of a plaque in the right DFA in the tract prox-
imal to the bifurcation (Plaque a, Figure 5.25). This result does not correspond
to in vivo observations. The plaque detected from MSCT observation of the right
SFA (Figure 5.11) is located more proximally, and it is in an area detected as low
WSS area (Figure 5.24). Case 3 developed one plaque in the left CFA (Plaque
a, Figure 5.28). Plaque a developed in the left CFA could correspond to Plaque
1 observed in vivo (Figure 5.13), but more distally and internally located than
the segmented plaque. Areas of low WSS are highlighted in the area proximal to
the bifurcation with the left DFA (Figure 5.27), showing a pro-atherogenic area
where in vivo observation shows a plaque formation (Plaque 3). There is no low
WSS area corresponding to Plaque 2 in the left CFA (Figure 5.28). As shown in
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Table 5.2, there is a good agreement between atherosclerosis-prone areas and de-
veloped plaques in the model and the in vivo observations. 91.7% of the plaques
observed in vivo were identied by the model as atherosclerosis-prone areas, and
41.7% of the plaques observed in-vivo were developed in the model. There was an
over prediction in the model, with plaques developed and atherosclerosis-prone
areas highlighted by the low WSS not having a correspondence with the in vivo
analysis results.
Wall shear stress is the determining factor in this model for both the location
of the atherosclerosis-prone area and possible atherosclerotic formation, when
other factors such as mean blood LDLp levels are kept constant.
A time-averaged blood ow rate based on the pulsatile velocity proles ex-
tracted from Doppler echocardiography data, was imposed at the inlet of each
of the dierent arterial tree sections considered. In silico experiments carried
out by Wood et al.[69] showed that the WSS local minima was located more
distally when a pulsatile velocity was considered. Furthermore, time averaged
WSS (TAWSS) is found to dier in value from steady state WSS in large arterial
branches such the aorta[162], indicating the importance of considering a transient
ow. A steady state ow environment was considered for this rst implementa-
tion, following the same approach used for the modelling of atherosclerosis on
idealised arterial geometries. The application of a pulsatile velocity at the inlet
will require more detailed Doppler echocardiography data than the ones avail-
able for this study, and will be considered among the future improvements for
this modelling of patient-specic atherosclerosis formation. The endothelial re-
sponse to WSS has a much longer time frame than the temporal variations in the
haemodynamics, making the steady ow approximation a valid one up to a point;
however, transient ow will be considered among the possible future implementa-
tions and will be further discussed in the next chapter. Simply considering WSS
as a tuning factor for endothelial response to local haemodynamics might be the
cause of the observed over-prediction in the model. It emerged from Levesque
et al.[32] that the maximum deformation in the endothelial cells shape would
occur in areas where a local WSS maxima would be followed by a local WSS
minima. Spatial Wall Shear Stress Gradient (WSSG) could, therefore, play a role
in dening the local intensity of ow disturbance, becoming an added selective
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criterion in the detection of atherosclerosis-prone areas.
Not only the inlet conditions but the conditions at the other boundaries in-
uence the haemodynamics. A stress free outlet boundary was used in this im-
plementation, neglecting the ow resistance represented by the downstream vas-
culature. A resistive outlet boundary would be expected to change the haemody-
namics in the domain, possibly changing the location of the atherosclerosis-prone
areas[163]. The implementation of resistive outlet boundaries are considered as
future improvements to this model and will be discussed in the following chapter.
The assumption of a rigid wall is not expected to inuence the results as a
steady state simulation is performed. In large arteries such as the aorta, the vessel
compliance should be considered; however, in a steady-state simulations the role
played by compliant walls can be neglected [164]. The rigid-wall assumption can
be considered acceptable also in transient scenarios. In a study on the haemody-
namics of the mesenteric artery by Jeays et al. [165], they showed that dierence
in average wall shear stress value between rigid and moving wall models was less
than 2.1%.
From in vivo observations, it emerged that the majority of plaques would
develop in areas close to arterial bifurcations and this has been already reported
numerous times in the literature[29, 166]. It would be, therefore, necessary to
segment every dierent branch, even the minor ones, to accurately model the
artery haemodynamics. In absence of the two minor right hand side branches
of the descending aorta (Figure 5.21), there would not be ow detachment (Fig-
ure 5.21, Plane 4) leading to no plaque development (Figure 5.18, Plaque a).
As the haemodynamics is highly geometry sensitive, it is necessary to accurately
segment the real healthy state anatomy of the artery considered. The patent
lumen was here obtained by artically removing the atherosclerotic plaque from
the diseased vessel [50, 51, 58]. One of the limitations of this approach is the
assumption that the vessel would retain its initial anatomy after plaque develop-
ment [49]. The lumen compensatory enlargement due to plaque formation [167]
could lead to an overestimation of the diameter of the initial disease-free vessel
[51]. Achenbach et al. [168] considered dierent degrees of atherosclerotic lumen
narrowing, up to a maximum of 75% stenotic diameter reduction, and reported
that the arterial remodelling cause by lumen stenosis is negligible. In Case 1
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the right CIA presented with a severe blockage of the lumen. Even though from
MSCT observation the calcied plaque does not appear as obstructing the en-
tirety of the lumen, the total absence of contrast agent within the arterial lumen
suggests a complete lumen obstruction. This observation leads to the second
limitation of the articial creation of the patent lumen, the assumption that the
patent lumen could be segmented by removal of the calcied plaque [49]. The
atherosclerosis plaque obstructing the left CIA could be a plaque mostly made of
lipids, which are not identied during MSCT plaque scoring. This would justify
the absence of ow in an artery not showing an extensively calcied lumen. As
the calcied plaque does not correspond to the entirety of the plaque, its arti-
cial removal could lead to a false representation of the initial lumen diameter
[51]. The segmentation error introduced by an imprecise plaque removal to recre-
ate the patent lumen has to be considered. A prospective study following the
disease development starting from an healthy artery could help to overcome this
limitation and further validate the model [50, 51].
5.4 Conclusion
To the authors knowledge, this is the rst time the transport and biochemi-
cal interaction between LDLp and monocyte/macrophages have been linked to
plaque growth and wall remodelling in a 3D patient-specic multiscale model
of atherosclerosis [118][58]. It is also the rst model to propose a more artery-
specic approach to shear-dependent transport properties. Novelty of the model
proposed here is the creation of a workow, the atherosclerosis remodelling cycle,
a workow that includes the core processes behind the formation of atherosclerosis
at its early stage and that can constitute the \skeleton" for further development
towards a more detailed and sophisticated atherosclerosis model. The method
developed in this study was able to capture key features of atherogenesis such as
the location of pro-atherogenic areas as also shown by Olgac et al.[58], and to
reproduce the formation of plaques detectable from in vivo observations[149].
From comparison with in vivo observations, it emerged that the model would
identify 91.7% of the locations where atherosclerotic plaque was present if the
artery-specic WSS plots are used. Furthermore, the model managed to simulate
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almost half of the plaques detected from in vivo observation. The majority of
plaques that were successfully modelled were in the descending aorta segment of
Case 1, where the model reproduced 4 plaques out of the observed 8. The model
was less precise in the modelling of plaque development for the two other Cases,
the right DFA and the left CFA. However, the plaques observable from MSCT
for these two sections of the arterial tree were not as visible as the extensively
calcied plaques detained in the descending aorta and the right and left CIA,
leaving a large margin of error in the reported observations. It has emerged that
local decrease in the WSS is a reasonable initial approximation for identifying
plaque location, but other factors must be considered. The model tends to over-
predict the areas at risk of atherosclerosis, suggesting the need of other factors,
such as WSSG to better modulate the endothelial reaction to haemodynamics.
As the haemodynamics is heavily inuenced by arterial lumen geometry, an ac-
curate geometry segmentation of MSCT images is needed. It was observed here
that atherosclerosis-prone areas also developed where there was a poor image
segmentation.
Further developments are necessary in order to overcome the current limita-
tions and to improve the accuracy of the results. The limitations and improve-
ments will be discussed in the following chapter.
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Chapter 6
Conclusion and Future Work
6.1 Atherosclerosis Model
In Chapter 2, Atherosclerosis Model, the mathematical model of atherosclerosis
formation was presented. The model developed integrated a transport model with
a biochemical model approach in order to better characterise the dynamics of the
initial state of atheroma, the fatty streak formation. Starting from a healthy
arterial wall, the model considered the immune system reaction to the oxidised
LDL leading to foam cell accumulation and fatty streak formation. Following
the three pores model developed by Curry[99] and the work of Olgac et al.[83]
the penetration of LDL inside the arterial wall was linked to the haemodynamic
stimuli exerted on the arterial endothelium. Experimental ndings were used to
relate the endothelial permeability with the ratio of local WSS[32] to the normal
WSS for the artery, calculated as Poiseuille WSS[131]. Use of the ratio of local
WSS to the \ideal" artery WSS, allowed the experimentally derived endothelial
response to WSS to be tuned according to the artery considered, making the
endothelial transport properties artery-specic. This initial approach towards
a fully artery-specic model, allowed dierent arterial segments of the human
arterial tree to be modelled, without neglecting their heterogeneity[35].
WSS should be considered along with other haemodynamic stimuli, in this
model. As already presented in the rst chapter of this thesis (Section 1.1.3), ex-
perimental ndings suggest that various Haemodynamic Wall Parameters(HWPs)
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play an important role in characterising the endothelial transport properties[33].
Together with the HWPs, intraluminal pressure and consequently arterial wall
transmural pressure are also of importance. In this model transmural pressure
was kept constant, following the experimental procedures by Meyer et al.[90].
Their experimental ndings[90] showed that for higher intraluminal pressure, the
penetration of plasma macromolecule such as albumin through the arterial wall is
enhanced, suggesting an important contribution when modelling macromolecular
transport. Furthermore, an increase in interluminal pressure has been proven
to be linked to an increase in the permeability of IEL[132]. In this model the
IEL was not dierentiated from the arterial wall, with the exception of the en-
dothelium, as the arterial wall was modelled as a single layer. When modelling
a more advanced stage of atherosclerosis, smooth muscle cell migration from the
media to the intima layer will have to be considered[8] leading to a more detailed
multi-layer approach. Dierentiation of the dierent layers of the arterial wall,
will lead to a more rened modelling of the transport properties of IEL. This
fenestrated membrane will be modelled following the same approach of the en-
dothelium model presented here, with its permeability to macromolecules linked
to the transluminal pressure, as shown in Huang et al.[132].
As this model concentrated on the initial stage of atherosclerosis formation,
only LDL and monocytes/macrophages were considered in the transport model.
LDL inside the arterial wall was modelled with a convection-diusion-reaction
equation (Equation (2.24)) and the transport of monocytes/macrophages was
modelled with a diusion-reaction Equation (2.35), where the reaction term repre-
sents the degradation of the native species. The quantity of migrating monocytes
inside the arterial wall was made dependent from the concentration of oxidised
LDL inside the arterial wall. Linking the immune response of the body to the
concentration of oxidised LDL, is a simplied approach to the characterisation of
cytokine action[25].
Degradation of LDL inside the arterial wall was modelled following the ap-
proach of Cobbold et al.[22], where the oxidation of LDL is the product of the
interaction between native LDL and free radicals. Monocytes, once inside the
arterial wall, instantly dierentiate into macrophages and start reacting with ox-
idised LDL to degrade into lipid laden macrophages, the foam cells. Foam cell
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accumulation was modelled as stratication following close hexagonal packing
and was the basis of plaque formation[6]. Plaque phase of growth is usually mod-
elled using in vivo observations[150, 151]. Clinical validation of the developed
plaque growth was not achieved and future work will be devoted to perfecting
the wall growth function, in order to characterise better the atheroma formation
over time.
Arterial wall inward swelling alters haemodynamics, leading to a change in
the endothelial transport properties, changing the whole cycle of atherosclerosis
formation. Very heterogeneous spatial and temporal dimensions are involved
in a complex biological process like atherosclerosis, where very fast molecular
interactions impact on the organ functioning over the years. The interaction of
such dierent dimensions or scales in the process modelled requires the creation of
a multiscale model. A model where the best spatial and temporal characterisation
for each sub-process is attained, maintaining an integrity in the whole model
thanks to the interplay of the dierent scales considered.
The main objective of this work was to develop a mathematical model that
would integrate the key factors to early stage plaque formation, using dierent
modelling approaches and techniques. This model was developed to describe
the whole early atherosclerosis cycle, from the formation of atherosclerosis-prone
areas, to the initiation of the lesion, ending with the impact of the lesion on
arterial haemodynamics and the progression of the disease. A workow was
proposed as a basis of this model, that enabled the various sub-domains and
scales of denition of the model to function together and to create this integrated
modelling approach of atherosclerosis, the Atherosclerosis Remodelling Cycle.
6.2 Atherosclerosis Remodelling Cycle
Chapter 3 presented the workow created for the implementation of the atheroscle-
rosis model, the atherosclerosis remodelling cycle. The atherosclerosis sub-processes
modelled mathematically were rst integrated together with the help of a theo-
retical workow. The workow was modelled as a feed-back loop, that follows
the events leading to the atherosclerosis plaque formation. Once the disease has
formed the haemodynamic patterns would change accordingly, thus creating a
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new environment for the disease formation and development. Final informa-
tion on the initial atherosclerosis remodelling cycle (geometry update because
of plaque formation) would be used to initiate the new atherosclerosis remod-
elling cycle. Each of these cycles dene the development of the disease in a given
haemodynamic environment.
The temporal development of the atherosclerosis remodelling cycle was dened
using a multiscale approach, as already presented in Chapter 2 (Section 2.2.2).
The smallest time-scale follows the progression of inammatory disease, modelling
the biochemical processes happening within the arterial wall. The second time-
scale updates the endothelial transport model according to the disease progression
inside the arterial wall. The third, and longest, time-scale is the time length of
the whole atherosclerosis remodelling cycle, at the end of which a new cycle
starts. Each time the developed disease produces a plaque of given size, the
haemodynamics are updated leading to the initiation of a new loop.
Ansys CfX v14 was used to describe the lumen uid sub-domain, whilst the
solid sub-domain of the endothelium and arterial wall were described using Mat-
lab. A computational workow was created to computationally implement the
theoretical workow and to link the dierent softwares used within it. The tool
produced aimed to deliver high feasibility and computational eciency. The
atherosclerosis model functioning was not geometry dependent, as each dier-
ent surface node of the geometry was solved separately. A pre-selection of the
atherosclerosis-prone areas allowed the computational cost of the whole geometry
processing to be reduced with a more targeted choice of input data.
The computational workow was structured as to reduce the cost of implemen-
tation. Solving for the CFD model and biochemical model separately, allowed
savings as the computational cost of a constant interaction between the CFD
sofware (Ansys CfX v14.) and the biochemical model software (Matlab) was
reduced. The multiscale time setting allowed a steady-state environment in the
CFD model whilst keeping a fully transient biochemical model, updating the CFD
model only for plaque accurance. Furthermore, the inammatory process for each
CFD surface node could be solved separately from the neighbouring nodes allow-
ing for an easy parallelisation and subsequent reduction in the computational
time.
161
6.3 Atherosclerosis Modelling on Idealised Ar-
terial Geometries
In Chapter 4 an initial implementation of the atherosclerosis formation model
was carried out on three dierent idealised geometries of human arteries. The
eect of local haemodynamics on endothelial transport was rst observed in a
stenotic coronary artery with a steady-state transport-biochemical model of the
arterial wall and endothelium. To observe the role played by LDL as a risk
factor dierent levels of high mean blood LDL were introduced in the model.
LDL conrmed its role as risk factor, making the atherosclerosis formation more
severe in the case of a higher severity of hyperlipoproteinemia. Observing the
behaviour of endothelial apparent permeability, it emerged that the location of
plaque formation was entirely dependent on the local haemodynamics. From
studies on endothelial behaviour to haemodynamic disturbance cause by stenotic
narrowing[32] it emerged that high permeability areas were not only located at
the global WSS minima, but in the areas where there was an high WSS level
followed by a low WSS level. Levesque et al.[32] nding suggests that, for highly
disturbed geometries, the endothelial behaviour is highly dependent on the WSS
spatial gradient (WSSG). This HWP[33] will be included in future modelling of
endothelial behaviour.
To describe better atheroma development, a transient time regime was intro-
duced for the transport-biochemical model. Following the Hoogstraten et al.[131]
model, an idealised common femoral artery presenting two successive bends was
implemented as a geometry at high risk for atherosclerosis formation[29]. To-
gether with the S-shaped anatomy, an idealised stenotic common femoral artery
was implemented. To model shear dependent endothelial transport properties in
arteries anatomically dierent from the aorta studied by Levesque et al.[32] an
artery-specic endothelial SI function was developed.
Plaque development in the stenotic artery had a faster phase than in the S-
shaped artery. This nding suggests that, for the same mean blood cholesterol
conditions, geometry plays an important role as risk factor[29], showing the role
played by the arterial haemodynamics in dening both the location of the disease
and the severity of the disease developed.
162
6.4 Patient Specic Modelling of Atherosclero-
sis Formation
In Chapter 5 atherosclerosis formation on patient-specic arteries was modelled.
Arterial lumen anatomy of a patient with atherosclerosis formations in his pe-
ripheral arteries was extracted from MSCT angiogram images and processed in
Scan IP. In order to produce the anatomy of the disease free arterial lumen the
atherosclerosis plaques visible were segmented as part of the lumen and a tract
where atherosclerosis formation prevented lumen enhancement with contrasting
agent was articially recreated. Three dierent segments of the arterial tree were
considered as dierent modelling cases. Patient-specic mean blood velocity data
were extracted from Doppler Echocardiography data.
An artery-specic endothelial transport behaviour was implemented for each
one of the arteries considered. Dening the transport for each artery following
its specic haemodynamics allowed the WSS atherosclerosis-prone areas to be
highlighted better. It would have not been appropriate to dene a global en-
dothelial transport function for the dierent cases considered, as within them
the haemodynamics of the various arteries were very heterogeneous. The arteries
were dened separately using cutting and selecting tools in Ansys ICEM v14.
The selection of an area belonging to the parent artery or the branching artery
was done arbitrarily; the criterion followed was to dene a cutting edge from one
artery to the other that would not coincide with the location of any of the in
vivo observed plaques, in order not to alter the modelled results. Renement on
the branch selection criterion will be considered as part of improvements to this
model.
To the author's knowledge, this is the rst model implementing a generalised
artery-specic approach for the prediction of atherosclerosis-prone areas in dier-
ent patient-specic anatomies. It is also the rst 3D patient-specic atheroscle-
rosis model characterising plaque development.
The model reproduced the occurrence of almost half of the plaques (41.7%) de-
tected from in vivo observation and highlighted the majority of the atherosclerosis-
prone areas (91.7%). The most precise results in plaque occurrence was in the
descending aorta segment (Case 1), where three of the 4 plaques detected from
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in vivo observation were reproduced by the model. All of the plaques of Case
1 observed in vivo were highlighted in the model as atherosclerosis prone-areas.
This high accuracy in the results could be due to the bigger anatomical size of
the segment considered, allowing for a more precise image segmentation and an
higher precision in the plaques detected from in vivo observations.
As the location of atherosclerotic plaques is in this model dened by the
haemodynamic behaviour, error in the location of plaque formation is linked
to errors in the modelling of the exact haemodynamics. High quality MSCT
images, with low levels of artefacts is important for the correct modelling of
haemodynamics, as haemodynamics are heavily inuenced by the arterial lumen
geometry.
Together with the lumenal geometry, the uid domain boundary conditions
play an important role in the denition of the haemodynamics. The current
boundary conditions are; parabolic time-averaged velocity at the inlet, rigid walls,
and a stress free condition at the outlets. The location of local WSS minima may
alter if pulsatile velocity is applied at the inlet boundary, as shown in an in sil-
ico experiment by Wood et al.[69]. Together with a transient velocity, the WSS
would be inuenced by factors describing the blood rheology. It will be worth
considering the shear-thinning behaviour of blood, in order to better simulate
the haemodynamics in the uid domain. The arterial wall was here assumed as
rigid, not allowing for any compliant behaviour. This assumption will play a
major role when considering the blood pulsatile behaviour. Future improvements
might include a uid-structure interaction model (FSI) to analyse the impact
that a compliant wall would have on the haemodynamics and ultimately on the
atherosclerosis development (currently being investigated at the Multiscale Car-
diovascular Engineering Group of UCL).
A resistive outlet condition could be implemented to account for the ow
resistance given by the downstream branching arteries. In a study by Stergiopulos
et al.[169] the author created a one-dimensional mathematical representation of
the whole circulatory system. The ow resistance values for the main arterial
segments were calculated thanks to this analogical model. These data can be
used for an initial implementation of more physiological boundary conditions.
Dierences in the model haemodynamics given by stress free outlet condition and
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resistive outlet condition will be among the future investigations to be considered.
Implementing the new boundary conditions and comparing the atherosclerosis-
prone areas coming from this implementation with the in vivo observed plaque
formation will allow assessing their importance in this simulation domain.
More patients should be selected for further developing this initial approach
to patient specic modelling of atherosclerosis. For each patient, plaque mea-
surements on MSCTs at follow up times will be used to more precisely tune the
plaque growth function.
The aim of this work was to produce an eective tool for the modelling of
atherosclerosis plaque formation, the atherosclerosis remodelling cycle. At the ba-
sis of this tool is a multiscale model considering some of the main uid dynamics,
biochemical and transport processes leading to the formation of atherosclerosis.
A workow was created to achieve integration between the dierent processes
modelled and to implement them computationally. The reduced computational
cost and data handling allowed to model plaque formation and development for
years of computational time. The atherosclerosis remodelling cycle was able to
handle highly irregular geometries, making its implementation on patient-specic
geometries possible. Together with the anatomy, the atherosclerosis remodelling
cycle can consider other patient-specic factors such as mean blood velocity and
mean blood LDL concentration.
The atherosclerosis remodelling cycle presented here is an initial step towards
the goal of producing an in-silico tool for the clinical management of atheroscle-
rosis.
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Appendix A
Mesh sensitivity analysis of an idealised geometry
of an s-shaped common femoral artery.
A grid independence study was performed for the idealised geometry of a femoral
artery. As this geometry could not be fully compared with the analytical solution
for a Poiseuille ow for a straight pipe, the most suitable mesh was chosen by
comparison among dierent meshes. Three sets of uniform unstructured grids
consisting of 1M, 2.5M and 4.5M elements were built. The converged results for
the WSS magnitude taken on a longitudinal cut of the upper wall of the geometry
were chosen for comparison (Figure A.1). The lower wall area was chosen, as this
is the area where the WSS global minima is located and where the atherosclerosis
plaque formed (Figure A.2).
The relative error (e) in computing the local WSS value is calculated as in
Olgac et al.[129]:
e =
WSSfiner(z) WSScoarser(z)WSSfiner(z)
 (A.1)
whereWSS is the local value of WSS, z is the spatial location and finer and
coarser refers to the quality of the grid being compared. The highest computed
error between the chosen mesh (2.5M) and the nest mesh considered is of 6%.
Figure A.2 shows the global minima of the three meshes considered. As the
grid renement increases a converging trend can be seen, with the relative error
between 2.5M and the nest mesh being of 1.2%.
The chosen mesh is acceptable, as the maximum value in the relative error is
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Figure A.1: Local value of WSS as a function of the axial location z for three
dierent grids were considered for comparison, a 1 million elements grid (1M), a
2.5 million elements grid (2.5M) and a 4.5 million elements grid (4.5M). Boundary
conditions: inlet parabolic velocity prole (equation 43), outlet stress free.
located in areas of high WSS, that are of no interest in the current model, and
the discrepancy in the computed local WSS is much lower in areas of low WSS,
of higher interest in this contest.
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Figure A.2: Global minima of WSS as a function of grid elements number.
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Appendix B
Sensitivity analysis of foam cell formation rate
and cytokines action parameters.
Impact of the parameters for foam cell formation (km) and cytokine action (K5)
on the time of growth was here analysed, where the time of growth is the time
needed for the artery to reach the thickness h (Equation (2.42)).
Figures B.1 to B.4 show how the time of growth varies with km and K5. The
parameters were altered of 10%, 20% and 30%. The percentage change of the
dierent parameters is calculated as:
%km =
km   km
km  100 (B.1)
%K5 =
K5  K5
K5  100 (B.2)
Where km and K5 are the kinetic rates of cytokines action and foam cell
formation rate used in the model (Table 2.1). The percentage change in the time
of growth is calculated as:
%Time of Growth =
Time of Growth  Time of Growth
Time of Growth  100 (B.3)
where the Time of Growth is calculated with the kinetic rates of cytokines
action and foam cell formation rate used in the model (Table 2.1).
The two dierent kinetic constants appear to inuence the time of growth in
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the same way. There is an inverse relationship between the change in the kinetic
constants (K5 and km) and the change in the time of growth h.
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Figure B.1: Impact of the change in km and K5 on the time of growth. The
impact on the time of growth given by an increase of 0%, 10%, 20% and 30%
in K5 and a decrease of 0%, 10%, 20% and 30% in km is here plotted. The km
parameter is kept constant at a dierent percentage for each line in the graph,
the variation in the K5 parameter is represented by the x-axis.
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Figure B.2: Impact of the change in km and K5 on the time of growth. The
impact on the time of growth given by a decrease of 0%, 10%, 20% and 30% in
K5 and an increase of 0%, 10%, 20% and 30% in km is here plotted. The km
parameter is kept constant at a dierent percentage for each line in the graph,
the variation in the K5 parameter is represented by the x-axis.
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Figure B.3: Impact of the change in km and K5 on the time of growth. The
impact on the time of growth given by a decrease of 0%, 10%, 20% and 30%
in K5 and a decrease of 0%, 10%, 20% and 30% in km is here plotted. The km
parameter is kept constant at a dierent percentage for each line in the graph,
the variation in the K5 parameter is represented by the x-axis.
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Figure B.4: Impact of the change in km and K5 on the time of growth. The
impact on the time of growth given by an increase of 0%, 10%, 20% and 30%
in K5 and an increase of 0%, 10%, 20% and 30% in km is here plotted. The km
parameter is kept constant at a dierent percentage for each line in the graph,
the variation in the K5 parameter is represented by the x-axis.
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Appendix C
Mesh sensitivity analysis for the three patient-
specic cases.
Grid independence study was performed for the patient specic geometries of the
three cases considered. For Case 1, four sets of unstructured mesh of 3 million
elements, 6.6 million elements, 7.8 million elements and 10 million elements were
considered. A cloud of points over the surface mesh was used as a probing func-
tion for local WSS values extraction. The converged results for the local WSS
magnitude probed at the points locations for the four dierent cases analysed is
plot in Figure C.1 along the z-axis.
The maximum relative error between the nest grid (10 million elements) and
the chosen grid (6.6M elements) calculated with Equation (A.1) was 2.4%.
Three sets of unstructured grids were considered for Case 2: 0.8 million el-
ements, 1 million elements and 1.9 million elements. The converged results for
the local WSS magnitude probed at dierent geometry locations for the three
dierent cases analysed is plotted in Figure C.2 along the z-axis. The maxi-
mum relative error in WSS calculation between the nest considered grid and the
chosen grid (1 million elements) was 3%.
The three dierent grids considered for grid independence study on Case 3
were a 0.8 million elements grid, a 1.2 million elements grid and a 1.9 million
elements grid. The converged results for the local steady WSS values at dierent
locations in the geometry for the three dierent grids are plot in Figure C.3. The
maximum relative error between the chosen grid (1 million elements) and the
nest grid (1.9 million elements) was 3.2%.
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Figure C.1: Local value of WSS as a function of the axial location z for the four
dierent grids were considered for comparison, a 3 million elements grid (3M),
a 6.6 million elements grid (6.6M), a 7.9 million elements grid (7.9M) and a 10
million elements grid (10M). Boundary conditions: inlet parabolic velocity prole
(equation 43), outlet stress free.
Figure C.2: Local value of WSS as a function of the axial location z for the three
dierent grids considered for case 2, a 0.8 million elements grid (0.8M), a 1 million
elements grid (1M) and a 1.9 million elements grid (1.9M). Boundary conditions:
inlet parabolic velocity prole (equation 43), outlet stress free.
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Figure C.3: Local value of WSS as a function of the axial location z for the three
dierent grids considered for case 2, a 0.8 million elements grid (0.8M), a 1.2
million elements grid (1.2M) and a 1.9 million elements grid (1.9M). Boundary
conditions: inlet parabolic velocity prole (equation 43), outlet stress free.
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